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Immunocompromised individuals are prone to opportunistic infections including
superficial candidiasis. Individuals with severely suppressed immune functions
(AIDS, neoplastic malignancies) as well as pregnant women and diabetics are
examples of immunocompromised hosts who have been reported to have a higher
prevalence of yeast infections. In this study, diabetic individuals were selected as a
model of an immunocompromised group to examine host-pathogen interactions
which might be important in colonization and development of disease due to yeasts.
Oral candidiasis is associated with the genetic characteristic of non-secretion of
ABH blood group antigens. The general objectives of this project were to assess by
epidemiological studies the contribution of non-secretion and environmental factors
to colonization by yeasts and development of oral candidiasis among diabetics; and,
to assess by laboratory studies effects of the differential distribution of H and Lewis
blood group antigens on epithelial cells of secretors and non-secretors on attachment
of Candida albicans.
Since insulin-dependent diabetes mellitus (IDDM) is distinct from non-insulin
dependent diabetes mellitus (NIDDM) with respect to aetiology, pathogenesis and
management, these two groups were considered separately. A total of 439 diabetic
individuals (231 with IDDM, 205 with NIDDM, 3 with unclassified diabetes) were
sampled for carriage of yeasts and oral diseases (denture stomatitis in particular).
Yeasts were isolated by swabbing five different sites to assess colonization of
different parts of the oral cavity and an oral rinse technique for quantitative
assessment of oral carriage.
Yeast isolates were identified by conventional means as well as by the API 20C
Auxanogram kit. Results obtained solely with the kit were not always accurate; the
most frequently misidentified species was C. albicans. The germtube production test
in horse serum is, therefore, necessary for accurate identification of this species.
The epidemiological studies emphasized the need to assess results by multivariate
analyses. Using Wilk's stepwise multivariate analysis, quantitative carriage, assessed
by the oral rinse technique, among individuals with NIDDM who did not wear
dentures was associated with glycaemic control (glycosuria p < 0.01, plasma glucose
p < 0.05)); and, non-secretion was a marginally significantly factor (p = 0.05).
Palatal carriage was, however, associated only with glycaemic control (glycosuria p <
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0.01). Age was a significant factor associated with carriage of yeasts for individuals
with IDDM. When assessed by the palatal swab and oral rinse techniques younger
patients were more prone to carriage.
Introduction of a denture altered predisposing factors involved in colonization.
For individuals with IDDM, glycaemic control was a significant factor associated
with palatal carriage (p < 0.05); quantitative carriage assessed by the oral rinse
technique was influenced by the presence of retinopathy (p < 0.05). Among subjects
with NIDDM, palatal carriage of yeasts was associated with continuous wearing of
the denture (p < 0.01); but, carriage assessed by the oral rinse technique was
influenced by plasma glucose levels (p < 0.05).
Denture stomatitis was associated with glycaemic control among subjects with
IDDM. Patients with NIDDM were prone to develop denture stomatitis if they wore
their denture continuously, harboured large numbers of yeasts and were non-secretors
of blood group antigens. These results show that predisposing factors involved in the
colonization by yeasts and development of denture stomatitis are distinct for
individuals with IDDM compared with those with NIDDM.
Host-pathogen interactions underlying the increased susceptibility of
non-secretors among non-diabetic individuals and those with NIDDM to colonization
by yeasts were explored. Since adhesive ability of microorganisms is associated with
colonization, buccal epithelial cells (BEC) from healthy secretor and non-secretor
donors were assessed by flow cytometry for their ability to bind yeasts. Two strains
of C. albicans were examined in these assays. C. albicans 2346 expresses an
adhesin that binds fucose, the immunodominant sugar of the H and Lewis antigens.
C. albicans 2023 expresses an adhesin that binds N-acetyl D-glucosamine. There was
a trend for BEC from non-secretors to bind more C. albicans 2346 compared with
BEC from secretors. C. albicans 2023 did not show any preferential binding to cells
from secretors or non-secretors. Secretors and non-secretors express similar
quantities of H Type 2 on their epithelial cells. The increased binding of C. albicans
2346 to non-secretors' BEC could not be explained by the presence of a
fucose-recognizing adhesin which bound to H Type 1 or Leb determinants as these
are present only on cells from secretors. These results suggested that the Lewis3
antigen present at higher levels on cells from non-secretors might be one of the
receptors for C. albicans 2346.
The role of Lea as a receptor for the fucose-recognizing adhesin on C. albicans
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2346 was examined. Binding of the extracellular polymeric material (EP) to blood
group determinants was investigated by enzyme-linked immunosorbent assays
(ELISA). Results of the ELISA indicate that all blood group glycoconjugates
including the Type 1 precursor bound to EP; but, Lewisa was bound in greater
amounts than the other glycocojugates examined. This suggests that there are in the
EP, in addition to adhesins that bind to fucose, adhesins that bind to part of the Type
1 precursor chain. Further investigations need to be carried out to assess the proposed
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In order to provide the necessary background to the aims of the study, this chapter
will review oral candidiasis and secretion of blood group antigens. The historical
aspect, types of superficial disease, epidemiology and pathogenesis of oral
candidiasis will be outlined and followed by a review of blood groups and secretor
status. The aims of the study will be stated at the end of the introduction.
Candidiasis
1.1 Early Descriptions and Identification of Candida as a Causative
Agent of Disease
The historical background of Candida and candidiasis has been reviewed by Odds
(1988) and is summarized here in brief. Candidiasis refers to disease caused by
Candida species. The term candidosis conveys the same meaning and is used
sometimes in preference. Thrush, a form of oral candidiasis, was first reported by
Hippocrates in the 4th Century B.C. when he described two cases of oral "aphthae"
associated with severe underlying disease.
The organism causing thrush was discovered by Langenbeck (1839) who
described a fungus in buccal aphthae of a patient with typhus. Although Langenbeck
wrongly suspected that the fungus was the cause of typhus, his description was,
nevertheless, one of the earliest to associate a microorganism with a pathological
process. Berg (1846) is credited with describing the relationship between the thrush
fungus and mouth lesions.
Before 1923, the taxonomy of the thrush fungus was controversial. Gruby (1842)
placed Langenbeck's fungus in the genus Sporotrichum but Robin (1853) named it
Oidium albicans. Plaut (1887) isolated a yeast-like fungus from rotting wood which
produced lesions resembling oral thrush in chickens. He considered his isolate to be
identical with Monilia Candida, a dimorphic species with a complex taxonomic
history. Zopf (1890) named the thrush fungus Monilia albicans and gave rise to the
name moniliasis for infections due to the thrush fungus.
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Since Monilia described the genus of the original botanical molds, Berkhout
(1923) proposed the new generic name, Candida. Candida derived from Latin for
"white robe worn by candidates for the Senate" and albicans is the Latin participle for
albicare, "to whiten".
Many yeasts (88) have been isolated from human sources. Most of the species are
rare; the eight most frequently encountered human isolates are Candida albicans,
Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida guillermondii,
Candida krusei, Candida kefyr and Candida viswanithii (reviewed by Odds, 1988).
Candida infections of virtually every tissue in the human body have been
reported. Their systematic classification creates problems. The general terms of
superficial and deep candidiasis are used here. Superficial includes those infections
that are visible (candidiasis of oral and aural cavities, genitalia, skin and nail); and,
deep or systemic candidiasis refers to all other sites of infection. This classification is
useful in that it separates the common (superficial) and more easily diagnosed forms
from the deep and comparatively difficult to diagnose forms.
One of the most common forms of candidiasis is oral infection associated with
dentures, denture stomatitis. The various forms of oral candidiasis have been
reviewed by Soames and Southam (1985). They are considered below with respect to




This disease is most prevalent in the extremes of age and among the terminally ill.
It also occurs with more serious underlying conditions: diabetes; leukaemia and other
malignancies; and, the acquired immunodeficiency syndrome (AIDS). A prevalence
of 10% and 15% has been recorded for debilitated elderly patients and a lower
incidence (7%) has been reported among neonates (Odds, 1988).
Clinically it presents as a thick white coating on the mucosa which can be wiped
away to leave a red, raw and often bleeding base. Histologically the affected area
shows a hyperplastic epithelium with the superficial layers infiltrated by both hyphae
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and spores and inflammatory cells which are predominantly neutrophils. The
neutrophils can accumulate to form microabscesses. The superficial epithelial cells
are separated by inflammatory oedema from the deeper layer, and, it is along this
plane that the pseudomembrane separates when the lesion is firmly wiped. In
addition, there is infiltration of the lamina propria by acute and chronic inflammatory
cells.
C. albicans is the common cause of oral thrush although occasionally reports
implicate other species. The maternal birth canal is a major source of neonatal
infections but teats, toothbrushes and other fomites have been implicated (Kozinn et
al., 1958).
Newborns are probably susceptible to candidal infection because of their
immature antimicrobial defences. In paired maternal/umbilical blood samples higher
titres of anti-Candida antibodies and lymphocyte transformation responses to
C. albicans were found in the maternal blood than in neonatal blood (Schneider et al.,
1986). Antibodies in cord blood contain mainly IgG whereas maternal blood often
has IgA and IgM antibodies to Candida as well (Mathus et al., 1979).
Cox (1986) found that at birth adherence of C. albicans to BEC was half that
measured 4 days later. This 4 day interval of relative protection from adherence of
C. albicans is of the same order as the usual delay before onset of oral thrush in
neonates. No relation between candidal infection and local trauma, debility,
prematurity, low birth weight, breast or bottle feeding has been found (Ludlam, 1942;
Kaloyannides, 1968).
Pseudomembranous oral candidosis is often treated with oral antifungal agents.
The majority of cases are effectively cured with this treatment (Alban, 1970; Cohen
et al., 1974; Botter, 1980).
1.2.2 Acute atrophic candidiasis
This form of candidiasis is usually seen in patients undergoing prolonged
antibiotic or steroid therapy. The common name is antibiotic sore tongue because the
tongue is most frequently affected.
Clinically, the lesion is red and often painful and resembles thrush without the
overlying pseudomembrane. Histologically the epithelium is atrophic with only
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occasional yeast hyphae and spores penetrating the superficial layers of
non-keratinized epithelium. There is an associated inflammatory infiltrate in both the
epithelium and in the underlying connective tissue.
The aetiology of this condition is not known. It is thought that the antibacterial
therapy alters the oral bacterial flora and allows organisms such as Candida to
flourish. Concomitant administration of antifungal agents and change or termination
of antibiotic and/or steroid therapy is usually the treatment of choice in this condition.
1.2.3 Chronic hyperplastic candidiasis (candidal leukoplakia)
The prevalence of leukoplakia (0.2-4%) varies in different parts of the world
mainly because of different diagnostic criteria. The prevalence of candidal
leukoplakia is generally less than that of leukoplakia; invasion of the lesion by yeasts
has been documented in biopsies from 6-90% of cases (Jepson et al., 1965; Renstrup,
1970; Daftary etal., 1972; Eversole et al., 1986)
Clinically this condition presents as a persistent white patch on the oral mucosa
which is indistinguishable from leukoplakia. The dense, opaque white plaques can be
detached by firm scraping; and, identification of hyphae assists in diagnosis. A
number of these lesions have areas of erythematous mucosa within the outline of the
plaque producing a speckled appearance. They usually occur on the inside surface of
one or both cheeks. Among homosexual men the tongue is involved more often than
the cheeks (Eversole et al., 1986). Males are affected more frequently than females
(Arendorf etal., 1983).
Histological appearance is that of parakeratosis and acanthosis. Many of the cells
in the parakeratinised surface are separated by oedema and numerous polymorphs
which often collect to form microabscesses. Candida hyphae invade the parakeratin
more or less at right angles to the surface but never penetrate deeper. A number of
acute and chronic inflammatory cells are present throughout the prickle cell layer,
and, there is a mixed chronic inflammatory cell infiltrate in which plasma cells are
often prominent in the subepithelial connective tissue. The absence of the infected
parakeratin layer might account for the erythematous appearance seen clinically.
It has not been conclusively shown whether these lesions are primarily
leukoplakia with secondary candidal infection or whether they are primarily chronic
candidal infection which in time lead to epithelial hyperplasia. Krogh et al. (1986)
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have suggested that there might be phenotypic differences between C. albicans
strains associated with leukoplakia and with normal epithelium in the same patient.
The lesion is associated with the following: smoking; denture wearing; iron and
folate deficiencies; raised antibody titre to C. albicans', defective cell mediated
immunity (Jenkins et al., 1977; Mackie et al., 1978; Arendorf et al., 1983).
Langerhans cells show a more irregular distribution in candidal leukoplakia lesions
than in normal epithelia (Daniels et al., 1985). The speckled type of leukoplakia is
more often associated with Candida invasion and malignant changes; but, these
should not be taken as evidence for a causal association between Candida and atypia
(Jepsen et al., 1965; Daftary et al., 1972).
Candidal leukoplakia sometimes responds to prolonged topical antifungal therapy,
but surgical resection is necessary in some cases. In asymptomatic leukoplakia,
treatment is instituted because both erosive and non-erosive forms have been reported
to undergo malignant transformation (Cawson and Lehner, 1968; Mackie et al., 1978;
Daftary et al., 1972).
1.2.4 Chronic mucocutaneous candidiasis (CMC)
This is a rare group of disorders associated with extensive and chronic Candida
infection of mucosae, nails and skin; the oral mucosal involvement is usually a
dominant feature. In 90% of patients with CMC, chronic pseudomembraneous oral
candidiasis is the earliest lesion to appear, and it frequently precedes allied conditions
such as endocrinopathies. Persistent onychia and paronychia are nearly as common
as oral lesions. Skin lesions when present appear principally on the face, ears, neck
and shoulders. Disseminated candidiasis is hardly ever seen (Odds, 1988).
Chronic mucocutaneous candidiasis is not a single disease entity hence its
classification is difficult. Wells (1973) defined four subgroups of CMC patients on
the basis of hereditary factors as well as clinical features (Table 1.1). Various
modifications of the above classification appear from time to time. Most patients
with CMC fall in Group 3 with single or multiple endocrinopathies:
hypoparathyroidism, hypoadrenocorticism, hypothyroidism and/or diabetes mellitus.
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Familial CMC with autosomal recessive inheritance
CMC with unknown/obscure familial factors
CMC associated endocrinopathy with or without
evidence of autosomal recessive inheritance of the
endocrinopathy.
Group 4: Mature onset CMC.
CMC is most often associated with defects in cell mediated immunity (CMI).
Cutaneous delayed-type hypersensitivity (DTH) response to Candida antigens is
absent in over 80% of patients tested compared with 16%-37% of controls (Palmer et
al., 1974; Rothschild et al., 1976). Lymphocyte transformation and production of
macrophage inhibition factor in response to Candida antigens in vitro were impaired
and correlated with absent cutaneous responses in many instances (Ferguson et al.,
1977; Sohnle et al., 1977). In vitro studies suggest that degradation products of
Candida mannans might mediate the suppressive effects (Podzorski et al., 1990).
These deficiencies seem to be the consequence of more fundamental disorders in
lymphocyte function, particularly in co-operative interactions between T cell subsets
(Kirkpatrick et al., 1971). Candida extracts act as specific antigens in these tests and
not as mitogens (Ausiello et al., 1986).
Abnormal ratios of Thelper:Tsuppressor have been noted, a situation similar to that
seen in AIDS patients (Gupta et al., 1979). Lymphoctye suppressor factor (Fischer et
al., 1978; Lee et al., 1986), abnormal immunoglobulin levels (Van Scoy et al., 1975),
presence of autoimmune antibodies and immune complexes (Sohnle et al., 1976;
Zouali et al., 1983), complement factor (Drew, 1973) and granulocyte defects (Van
der Meer, 1978; Bortolussi et al., 1981) have also been noted. The multiple disorders
reflect the heterogeneity of CMC and obscure attempts to elucidate the pathogenic
mechanisms.
In many cases there is a clear evidence of hereditary linkage in CMC. The HLA
B7 haplotype frequency is increased among these patients (Kirkpatrick, 1984). Since
CMC appears to be the result of one or more minor defects in host defences, it is
unlikely that a single gene can be incriminated (Rothchild et al., 1976).
C. albicans accounts for a majority of cases of these infections. As in other
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superficial forms of candidiasis, C. albicans does not penetrate appreciably through
the epithelium. There is a substantial infiltration of acute and chronic inflammatory
cells. Systemic antifungal treatment can usually achieve remission; however,
recurrences are common (Hay, 1981).
1.2.5 Chronic atrophic candidiasis (denture stomatitis)
Denture stomatitis is the commonest form of disease associated with Candida. It
is found in 24-60% of denture wearers (Nyquist, 1952; Budtz-Jorgensen et al., 1975).
Clinically, it presents as chronic erythema and oedema of the portion of the palate
that comes into contact with the denture; lower denture bearing areas are hardly ever
involved.
The histological appearance is of parakeratosis of the palatal epithelium with
vacuolation and neutrophil infiltration of the upper spinous layer. There is
lymphocyte infiltration of deeper spinous layers and diffuse subepithelial
inflammation without any evidence of fungal penetration.
Denture stomatitis is an inflammatory reaction to yeasts promoted by occlusion of
the palatal mucosa with a denture. The inflammation appears to be a response to the
growth of large numbers of yeasts in the space between the denture and the palatal
mucosa; yeasts do not invade the mucosa. Availability of sucrose and metabolic acid
production by yeasts are thought to contribute to the pathology (Olsen and Birkland,
1976; Samaranayake etal., 1982). Folate deficiency has been associated with denture
stomatitis (Jenkins et al., 1977; Samaranayake, 1986); but, iron deficiency is not a
factor (Jenkins et al., 1977). Yeast virulence factors such as proteinase production
might act as inflammatory aggressins; however, there was no correlation between
proteolytic activity of yeasts isolated and the severity of the inflammation
(Budtz-Jorgensen, 1970).
No differences in CMI, leucocyte counts or candidicidal properties are apparent
between patients and controls (Davenport and Wilton, 1971; Budtz-Jorgensen, 1973;
Bergendal et al., 1977; Taafe et al., 1985). Serum antibody levels against C. albicans
are elevated but do not correlate with severity of infection (Budtz-Jorgensen, 1972;
Bergendal and Holmberg, 1982). Treatment is usually aimed at reducing the yeast
concentration; removal of the denture together with antifungal treatment is most
successful (Carter et al., 1986).
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1.3 Epidemiology of Oral Carriage of Yeasts and Denture Stomatitis
Varying frequencies for isolates of yeasts from similar sites in nominally similar
subjects are reported. Patient selection and sampling methods are possible sources of
variation. Oral carriage is best assessed by imprint culture method than from saliva
or a mouthwash sample (Arendorf and Walker, 1979; Oliver and Shillitoe, 1984).
The sensitivity of an imprint culture was equal to that of a 60 s mouthrinse
(Samaranayake et al., 1986). Enrichment culture of swabs increased the isolation of
yeasts (Schonheyder et al., 1984).
Identification can further contribute to apparent disparities in carriage rates of
yeasts (Odds, 1988). Many studies state frequencies of recoveries of C. albicans, but
the tests used for identification of this species might not be stated or are based on
criteria that are presumptive. In some cases it is likely that "C. albicans" is
synonymous with "yeast" and vice versa. Dramatic effects on isolation rates of
different species were reported within the same laboratory following changes in
methods of identification (Hurley and Morris, 1964; Hurley et al., 1973).
Several studies have detailed the relative proportions of different yeast species
isolated from man. The general conclusion is that C. albicans accounts for 60-80%
of oral isolates. C. glabrata and C. tropicalis are both found with modest frequencies
(~7%) (Odds, 1988). 5. cerevisiae was the predominant species found in the mouths
of patients in Zaire (Melbye et al., 1985). It is not known whether the difference is a
true regional variation of yeast flora (perhaps due to diet) or approaches to species
identification.
The prevalence of denture stomatitis varies among populations sampled; but,
24-60% of denture wearers have been reported to be affected. This might be due to
differences in susceptibility of the sample populations. C. albicans is most frequently
isolated from the lesion. Although denture stomatitis is caused by yeasts (Cawson,
1963; Budtz-Jorgensen, 1974), harbouring yeasts does not inevitably lead to the
development of the disease. In the study to elucidate mechanisms underlying the
diseased state, factors which influence carriage are as important as those which
influence the development of denture stomatitis. These can be broadly classified as
genetic and environmental. The latter consists of four categories: (a) digression from
physiological status (diabetes, malignancy); (b) age; (c) physical factors including





Only one study reported that carriage of C. albicans was more frequent among
female diabetic individuals compared with males (Amato and Pecora, 1983). There
have been reports of females being more susceptible to denture stomatitis than males
(Cawson 1966; Davenport, 1970; Challacombe, 1986); but, other workers found no
sex bias (Budtz-Jorgensen et al., 1975; Lamey et al., 1988). This discrepancy might
be due to females wearing dentures more frequently and for longer periods than
males; and, therefore being over-represented in the sample population.
1.3.1.2 Blood group and secretor status
Carriage of C. albicans in healthy individuals was associated with blood group O
and non-secretion of blood group antigens; these associations were independent of
each other (Burford-Mason et al., 1988). Among individuals with non-insulin
dependent diabetes (NIDDM), blood group O non-secretors were more frequently
colonized than O secretors. Individuals with insulin-dependent diabetes (IDDM) did
not show this relationship (Blackwell et al., 1989a). Another study which did not
differentiate the blood groups of their subjects similarly found individuals with
NIDDM who were non-secretors prone to oral carriage of yeasts (Darwazeh et al.,
1990). The latter study is in contrast to a report by the same research group which
found no significant association between secretor status and carriage of yeasts or
development of denture stomatitis among subjects with diabetes (Lamey etal., 1988).
Non-secretion of ABH antigens has been associated with oral candidiasis; and,
non-secretors are over-represented among pregnant women with vaginal candidiasis
(Thorn et al., 1989). The mechanisms by which secretor status might affect carriage
or disease are discussed in Section 1.7.2.
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1.3.2 Digression from physiological status
1.3.2.1 Diabetes
Several investigators have reported higher frequencies of oral yeast carriage
among individuals with diabetes mellitus (Weinstein et al., 1959; Johnston et al.,
1967; Barlow and Chattaway, 1969; Cambon et al., 1979; Lamey et al., 1988). Not
all investigators found higher yeast prevalences in the mouths of diabetics (Young et
al., 1951; Mehnert and Mehnert, 1958; Loiselle et al., 1964; Peters et al., 1966;
Tapper-Jones et al., 1981; Thorstensson et al., 1989). Some authors have found a
higher concentration of yeasts in the mouths of diabetic individuals (Peters et al.,
1966; Tapper Jones et al., 1981).
In studies where individuals with diabetes were compared with non-diabetic
subjects, the prevalence of denture stomatitis was higher in the former group (Lamey
et al., 1988); however, Phelan and Levin (1986) found no difference in the prevalence
of denture stomatitis between the American Indians with diagnosed diabetes and/or
elevated plasma glucose levels compared with non-diabetic individuals. This
discrepancy might be due to the difference in the populations examined; most
American Indians (> 95%) are secretors of blood group antigens and NIDDM is the
commonest form of diabetes in this population (Mourant et al., 1976; Blackwell,
1989).
The mechanisms by which diabetes increases host susceptibility to oral carriage
and disease are not clear. Physical factors such as salivary flow, pH and buffer
capacity have been compared between diabetic and non-diabetic individuals. The
results are controversial because of vague and differing classification of diabetes in
different studies (Kjellman, 1970; Faulconbridge et al., 1981; Sharon et al., 1985;
Tenovuo et al., 1986; Banoczy et al., 1987). In a well defined study of individuals
with IDDM, there was no difference in salivary pH or buffer capacity between well
controlled patients with long term or short term IDDM compared with controls.
There was a small significant difference of mean salivary flow levels between
diabetics and controls. The physiological significance of this difference is probably
negligible (Thorstensson et al., 1989).
Salivary glucose levels are slightly but significantly increased among individuals
with IDDM compared with non-diabetics (Thorstensson et al., 1989). It has been
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proposed that high blood and tissue glucose levels favour growth of Candida (Knight
and Fletcher, 1971; Odds et al., 1978). In a study by Rayfield et al. (1982), a striking
overall correlation between prevalence of disease and mean fasting plasma glucose
levels was found; they concluded that glycaemic control was important in reducing
susceptibility to infection.
Defective chemotaxis, adherence, phagocytosis and killing of bacteria by
granulocytes from diabetic individuals have been reported by some and refuted by
other workers. These differences might be due to different assay techniques and time
of sampling phagocytic activity (Davidson et al., 1984). Reports of phagocytosis of
Candida species are similarly controversial. Wilson and Reeves (1986) noted no
difference in phagocytosis of C. albicans by neutrophils from diabetic subjects;
however, neutrophils isolated from diabetic subjects showed impaired phagocytosis
of C. guillermondii (Davidson et al., 1984), and monocytes had a decreased ability to
phagocytose C. albicans (Geisler et al., 1982). The decrease in phagocytic function
is thought to result from a reaction of glucose with proteins concerned with
phagocytosis resulting in the blocking of serum opsonins (C3b, Fab) and granulocyte
receptors (CR3, FCR) (Davidson etal., 1984).
Wilson and Reeves (1986) measured a decrease in the ability of neutrophils from
individuals with diabetes to kill Candida when the assay was done in the presence of
50 mM glucose or 20 mM P-hydroxybutyrate alone or in combination. They
suggested that in diabetics, conversion of glucose to sorbitol reduces the available
concentration of NADPH; and, this inhibits the oxidative killing mechanisms of the
neutrophils (Wilson et al., 1987). It is interesting that oxidative activity following
engulfment of C. albicans by neutrophils is decreased compared with non-diabetic
controls and was independent of plasma glucose levels (Qvist and Larkin, 1981).
With respect to specific immunity, there is no difference in lymphoproliferative
responses to C. albicans by lymphocytes from diabetics compared with controls
(Ragab et al., 1972). No information is available about the mucosal immunity against
Candida in diabetic individuals.
1.3.2.2 Malignant diseases
The overall prevalence of yeasts in the mouths of normal subjects is generally of a
lower order than in those who have sought medical attention. Candida carriage is
very common among cancer patients, especially those with leukaemia; and, it is
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enhanced by chemotherapy and radiotherapy. Systemic as well as oral candidiasis are
more prevalent particularly during phases of neutropenia; the prevalence of denture
stomatitis is unknown (Odds, 1988).
1.3.2.3 Age
Carriage of yeasts in the mouths of neonates is an exception rather than the rule;
but, within the first year of life, most infants appear to acquire oral yeast flora. Most
cases of oral infection within the first few days of life arise primarily because of
maternal contamination of babies with yeasts in the birth canal (Kozinn et al., 1958;
Tarr, 1980). The relative vulnerability of the very young stems from the immaturity
of their antimicrobial defences.
The prevalence of yeast in the adult mouth has been shown to rise with age. The
effects of age per se are not always easily separated from diseases and medical
treatment associated with increased age (Marples, 1960; Smits et al., 1966). Denture
stomatitis has not been reported to be directly related to age.
1.3.3 Physical factors
1.3.3.1 Diet
Oral yeast concentration in monkeys rose in association with high sugar diet
(Bowen, 1974). Initiation and degree of inflammation of denture stomatitis in man is
increased by repeated sucrose rinses (Olsen and Birkeland, 1976). It has been
suggested that diets rich in refined carbohydrates can cause disease by a process of
enhancing adhesion of yeasts which promotes colonization. The availability of
nutrients with the associated production of metabolic products such as pyruvates and
acetates might damage the mucosa directly, provide an acid millieu for yeast
proteinase activation and lead to the development of denture stomatitis
(Samaranayake and MacFarlane, 1985).
1.3.3.2 Prosthesis
Several workers have detected a higher prevalence of oral yeasts among denture
wearers compared with individuals who did not wear dentures (Peters et al., 1966;
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Budtz-Jorgensen et al., 1975; Berdicevsky et al., 1980; Tapper-Jones et al., 1981;
Mitchell, 1982; Vandenbussehe and Swinne, 1984; Fisher et al., 1987; Lamey et al.,
1988; Hill et al., 1989). It is possible that the main effect of the denture is to increase
yeast concentration rather than to establish yeast populations in mouths that did not
previously carry them. Similar considerations apply to removable and fixed
orthodontic appliances (Addy et al., 1982; Arendorf et al., 1983). In babies, dummies
might serve as occlusive foreign bodies leading to elevated oral Candida
concentrations. High yeast levels are found in patients who wear dentures
continuously (Budtz-Jorgensen et al., 1983).
Continuous wearing of dentures has been found to influence the development of
denture stomatitis (Ritchie et al., 1969; Arendorf and Walker, 1979; Tapper-Jones et
al., 1981). This is hardly surprising considering that denture stomatitis is induced
only in the presence of a denture and that removal of the denture causes remission
even in the absence of treatment with antifungal agents. Trauma due to poor fit
and/or occlusion of the denture has been found to influence the development of the
lesion (Nyquist, 1952; Ritchie et al., 1969; Budtz-Jorgensen and Bertam, 1970).
1.3.3.3 Smoking
Significant increases in oral Candida carriage among smokers have been reported
in both diabetic and non-diabetic sample populations (Tapper-Jones et al., 1981;
Arendorf et al., 1983). Other studies did not find this association (Bastiaan and
Reade, 1982; Hill et al., 1989). The relationship between smoking and denture
stomatitis has not been explored. Smoking has been reported to be a very significant
factor in the development of candidal leukoplakia (Arendorf et al., 1983).
1.3.4 Iatrogenic factors
Evaluation of iatrogenic factors is not easy. It is often difficult to differentiate the
contributions made by the underlying illness from the treatment.
In theory, most antibacterial agents can disrupt microbial populations that
normally compete with yeasts for nutrients; therefore, yeasts are able to multiply
more readily. In practice, the extent of the "antibiotic effect" is difficult to assess. It
is often considered that broad spectrum antibiotics are more likely to lead to Candida
overgrowth than drugs with a more limited range of targets. Tetracycline increased
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the prevalence of oral Candida in a longitudinal study; but, in a cross-sectional study
in which tetracycline-treated and untreated patients were of comparable clinical
status, there was no difference in oral Candida carriage (McKendrick et al., 1967).
Elimination of bacterial competition is almost certainly the mechanism by which
antibiotics affect Candida numbers in vivo. Certain antibiotics might have
immunosuppresive properties that reduce host resistance to Candida. Erythromycin,
cotrimoxazole and several aminoglycosides reduced neutrophil candidicidal activity
in vitro. Penicillin, tetracycline, chloramphenicol, gentamicin, azlocillin and
carbenicillin do not show this effect (Bridges et al., 1980; Ferrari et al., 1980;
Hawkey et al., 1983).
Corticosteroids are compounds with pronounced anti-inflammatory and
immunosuppressive effects. Surveys have shown a higher prevalence of yeasts in
patients receiving corticosteroid therapy (Johnston et al., 1967; Shastry et al., 1969).
Immunosuppressive effects might not be the only means by which corticosteroids can
influence candidiasis. There is an intracellular steroid binding protein in C. albicans
with a high specificity for cortisone and progesterone (Loose et al., 1981). The
function of this protein and the effect of corticosteroid on yeast growth are not known
as yet (Loose and Feldman, 1982; Powell and Drutz, 1983). Some authors have
claimed that steroid inhalers result in increased oral Candida carriage, but other
workers did not find this effect (Kerrebijn, 1976; Pringleton et al., 1977; Toogood et
al, 1984).
The effect of antibiotics and corticosteroids on denture stomatitis have not been
studied in man. Vogt (1979) concluded that the effect of corticosteroid inhalers in the
development of superficial candidiasis was minimal. The role of antibiotics in
superficial candidiasis is also found to be minimal in two large studies of hospitalized
patients (Caldwell and Cluff, 1974; Walker et al., 1979).
1.4 Pathogenesis Of Candidiasis
Candida species are opportunistic pathogens which can be regarded as possessing
multiple properties, each with a low propensity for enhancing infectivity but none
necessarily dominant. Even in combination, these are unlikely to overcome fully
intact host defences. This section outlines the potential virulence factors of Candida
and summarizes the results of several studies of host defense against Candida.
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1.4.1 Virulence determinants of Candida
1.4.1.1 Adherence to host surfaces
The ability of yeasts to adhere to host cells corresponds to their relative virulence.
Among Candida species, C. albicans generally adheres to epithelial and other
mammalian surfaces better than others such as C. tropicalis and C. parapsilosis (King
et al., 1980; Critchley and Douglas, 1985).
For C. albicans, there is general agreement that hyphal germ tubes adhere to host
surfaces better than yeast blastospores (Kimura and Pearsal, 1978; King et al., 1980).
There is variation in the adherence of yeasts to different host cells. Yeasts were more
adherent to epithelial cells from diabetic and pregnant women than those from other
women (Lehrer et al., 1983). In neonates, buccal epithelial cell (BEC) are less able to
bind C. albicans at the time of birth than just a few days later. Epithelia from infants
colonized with C. albicans bind more yeasts than epithelia from non-carriers (Cox,
1986). C. albicans strains isolated from invasive Candida infections adhere better
than those from carriers (Douglas et al., 1981; McCourtie and Douglas, 1984).
Adherence capabilities clearly play a major part in the pathogenesis of candidiasis.
1.4.1.2 Phenotypic variability
The ability to express different phenotypic properties is an advantage which might
account for the ability of C. albicans to infect a wide range of host environments
(Soil et al., 1987). The only evidence linking phenotypic variation in vitro with
virulence in vivo is the switching of colony phenotype occurring with each new
vaginal candidal infection. Restriction fragment length polymorphism confirmed that
the multiple phenotypes represented the same C. albicans strain (Soil et al., 1989).
Another example of phenotypic variation is the observation that sub-populations of
C. albicans adhered more avidly to acrylic surface in vitro (McCourtie and Douglas,
1985).
1.4.1.3 Toxins
Suggestions that C. albicans might contain toxins analogous to bacterial
endotoxins have been explored. Formalin killed blastospores of several Candida
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species and soluble supernatants from mechanically disrupted C. albicans injected
intraperitoneally were lethal for mice. Other biological activities claimed for the
toxins were pyrogenicity (rabbits), induction of hypotension (dogs), anaphylaxis
(rats), histamine release (rats) and complement activation (rodents) (reviewed by
Odds, 1988).
Fractions of C. albicans prepared by mechanical and chemical methods were
tested for toxicity in three animal models. Only the cell wall glycoprotein fraction
had toxic properties. It was pyrogenic in rabbits and lethal to mice provided they
were pretreated with actinomycin D (Cutler et al., 1972). The effects of such toxins
are different from those of bacterial toxins. Their potency is several orders of
magnitude less; this is consistent with the status of C. albicans as an opportunistic
pathogen that contains some molecules with a low but detectable biological potency.
1.4.1.4 Enzymes
Theoretically, hydrolytic enzyme activities expressed on the surface of microbial
pathogens could cause damage to host cells in vivo. For C. albicans, there are two
main candidates, a proteinase and a phospholipase; but, incontrovertible evidence for
a pathological role is lacking for both.
C. albicans proteinase has been shown by immunofluorescence to be synthesized
in infected tissues in vivo; and, antibodies to the purified enzyme are found
predominantly in patients with visceral Candida infections (MacDonald and Odds,
1980; Ruchel, 1981). The non-invasive nature of proteinase-deficient strains has
been documented (MacDonald and Odds, 1983). Secretion of proteinase in vitro is a
ubiquitous property of C. albicans isolates, common in C. tropicalis, occasional in
C. parapsilosis and very rare or absent in other species. The distribution of its
activity coincides with the rank order of virulence of Candida species (Odds, 1985).
Against the view that C. albicans proteinase is a virulence attribute is the
inconsistent correlation between gross proteinase production in plate tests and strain
virulence (Schorlemmer et al., 1977; Germaine and Tellefson, 1981) or severity of
inflammation (Budtz-Jorgensen, 1970). The neutral pH of saliva precludes the
enzyme's activity in the mouth; however, it has been suggested that yeast metabolites
can create an acidic micro-environment conducive to the action of the proteinase
(Samaranayake and MacFarlane, 1985).
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The role of C. albicans proteinase in the pathogenesis of candidiasis is unknown.
A proteinase inhibitor, Pepstatin A, reduced mucosal adherence of C. albicans
(Edison and Manning-Zweerink, 1988). Reports of enzymes with molecular
characteristics almost identical to those of the acid proteinase have shown lytic
activity against human stratum corneum and collagen (Hattori et al., 1984; Kaminishi
et al., 1986). MacDonald and Odds (1983) suggested the enzyme might be involved
in fungal resistance to phagocytosis; but, Walter et al., (1986) have shown that
proteinase-secreting cells are killed more readily by polymorphs than yeasts that do
not secrete the enzyme. They suggest that the enzyme might activate candidacidal
proteins.
Phospholipase activity is secreted in growth media by C. albicans (Banno et al.,
1985). Barrett-Bee et al. (1985) found an approximate correlation between
phospholipase activity, mouse lethality and adherence of yeast to BEC, the only
evidence linking the enzyme with virulence.
1.4.1.5 Dimorphic change in C. albicans
Filamentous phase cells are commonly seen in infected tissues; but, yeasts are
also present, and no one form seems to predominate. Mutant strains incapable of
yeast-mycelial transitions can establish infections (Shepherd, 1985). This, however,
does not exclude the possibility that one form might be more efficient at establishing
infection than the other. A variant which could not form germ tubes was less virulent
than its parent; and, reversion to germ tube formation restored virulence (Sobel et al.,
1984). The hyphal tip is most frequently seen in micrographs to penetrate the
epithelium (Polack and Grenson, 1973); and, it adheres better to BEC than the yeast
form (vide supra). It is possible that the ability to interconvert between blastospores
and hyphae is an important pathogenic mechanism contributing to evasion of host
defences at different stages of the infectious process.
1.4.2 Determinants of host resistance to Candida infections
The sophistication of the host defence system compared with the few virulence
armaments proposed for Candida underlines the fact that Candida species can invade
superficially only when there is a defect in host response and deeply only when the




An intact skin surface does not prevent cutaneous Candida infection since it is
easily overcome in CMC. The skin is mechanically intact, but the patient has defects
in cellular immune responses. Also, when the skin is occluded Candida species are
able to penetrate the epidermis. An intact oral epithelium is present before onset of
pseudomembranous candidiasis. There is evidence to suggest that zinc, iron and
pyridoxine deficiency might predispose to superficial Candida infection because of
the poor quality of the epithelium in such cases (Higgs, 1973; Fletcher et al., 1975;
Edman et al., 1986).
1.4.2.2 Non-specific antimicrobial substances
Most secretions and fluids of the mammalian host contain substances that act
non-specifically to inhibit or kill microbial invaders. For Candida, there are reports
of inhibitory substances in or on the skin, the conjuctiva, and saliva (Aly et al., 1972).
Methodological differences might explain why some studies found saliva inhibitory
and others did not. Bartels et al. (1967) found that saliva induced zones of inhibition
in lawns of Candida species on agar containing high concentrations of tetrazolium
salts. This method is open to the criticism that the physicochemical nature of the test
fluid (pH, ionic strength) might inhibit the fungus rather than a particular inhibitory
molecule. Knight and Fletcher (1971) found no evidence of non-specific anti-fungal
activity in saliva, apart from the growth impairing effects of bacteria which exhaust
the nutrients. In contrast, Pollock et al. (1984) have purified histidine-rich
polypeptides from saliva and shown them to be potent inhibitors of C. albicans.
Lysozyme is only weakly inhibitory for C. albicans (Kayama, 1970). Interferons
provide no significant protection against intravenous C. albicans challenge in mice
(Umenai et al., 1978). Non-specific inhibitors of C. albicans in serum might protect
against intravenous challenge (Hasenclever, 1978).
1.4.2.3 Complement
All yeast mannans activate complement via the alternative pathway (Ray et al.,
1979). The role of complement as an opsonin for intracellular killing of C. albicans
by neutrophils has been suggested. Killing of C. albicans is much reduced in sera
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from animals congenitally deficient in C3 but not in sera devoid of C2, C5 or C6.
Antibodies to C3 reduced the opsonic effect of serum on intracellular killing
(Morrison and Cutler, 1981).
Animal studies confirm a requirement for complement activation to ensure
elimination of Candida in vivo4, but, they do not distinguish between complement
activation as a leukocyte chemotactic factor from its opsonic activity. Guinea pigs
pretreated with cobra venom factor (to deplete components C3 and C5-C9) were
significantly more susceptible to intravenous Candida challenge (Gelfand et al.,
1978). Lyon et al. (1986) found that mice deficient in C5 were more severely
affected by C. albicans challenge than those with intact C5, but they developed
identical humoral and cellular immune responses to the yeasts. This suggests that
their complement deficiency was a significant factor only at the time of initial
microbial challenge and was less important later.
Complement-binding protein receptors (analogues of human CR2 and CR3) have
been reported to occur exclusively in hyphal and germtube phases and not in the yeast
phase; and, they have been found on C. albicans and S. cerevisiae only. They have
been suggested to be virulence factors. These complement receptors might
participate as co-factors in the enzymatic degradation of bound complement, promote
clumping of the organism, and compete with phagocyte receptors for the complement
fractions thus evading phagocytosis (Edwards et al., 1986; Calderone and Braun,
1991). Infection might be facilitated by the presence of CR3 analogue on
C. albicans. The human CR3 is an integrin - a member of a gene family involved in
interaction between cells. The CR3 analogue of Candida has some nucleotide
sequence homology with human CR3. Their role in adherence of C. albicans to host
cells can be postulated since integrin superfamily members mediate binding
reactions (reviewed by Cooper, 1991).
1.4.2.4 Phagocytosis and intracellular killing of Candida
The ability of neutrophils and tissue macrophages to ingest and kill Candida
species is a singularly important mechanism enabling the host to remove and destroy
yeast cells. Many lines of evidence indicate the importance of phagocytes in host
defence against invasive, deep-seated candidiasis: leukopenic patients are more
vulnerable to disseminated Candida infections than comparable patients with normal
leukocyte counts (Fanci et al., 1984). Among patients with AIDS or CMC in whom
19
lymphocyte-based immunity is impaired but phagocytic function is normal, visceral
spread of Candida is highly unusual. Candidiasis is restricted to skin and mucous
membranes. It has been argued that phagocytic cells are major components of
defense against deep-seated candidiasis but are less important in the defence of
superficial body sites. This is a simplistic view because granulocytes are part of the
immune system's effector mechanisms in eliminating superficial candidal infections.
The relative contributions of neutrophils and macrophages to defence against
candidiasis are not easy to determine. From the histological sequence of events in
mice following intratracheal challenge of mice with C. albicans, resident
macrophages were the first line of defence supported by neutrophils (Nugent and
Onofrio,1983). For example, carageenan, a substance toxic to mouse macrophages
but which also stimulates a neutrophil leucocytosis, does not increase vulnerability of
mice to intratracheal challenge and reduces their susceptibility to intravenous
C. albicans (Hurtrel and Lagrange, 1985; Lai et al., 1986).
Some studies show that yeast cells are more vulnerable to intracellular killing
than preformed hyphae (Davies and Denning, 1972; Scherwitz and Martin, 1979)
while others claim the converse is true (Cockayne and Odds, 1984). Of the Candida
species, C. albicans and C. tropicalis are best able to overcome neutrophils and
escape after phagocytosis (Louria and Brayton, 1964; Fontenla De Petrino et al.,
1985).
The mechanisms by which Candida cells are killed within phagocytes have been
partly elucidated. The myeloperoxidase-halide oxidative killing system is the
dominant candidacidal mechanism within neutrophils (Brune et al., 1973; Diamond et
al., 1980). Mannans can inhibit the action of the peroxidase system against the
fungus, possibly by blocking binding of myeloperoxidase to the surface of yeast
(Wright et al., 1983).
In macrophages, as in neutrophils, oxidative and non-oxidative killing
mechanisms have been demonstrated (Lehrer, 1975). Fully differentiated
macrophages are more effective at killing C. albicans than their monocyte precursors;
however, unlike monocytes, they do not have myeloperoxidase so that their oxidative
killing mechanism differs from those in neutrophils and depends on the production of
singlet oxygen and superoxide (Sasada and Johnston, 1980).
An antimicrobial mechanism depending on the generation of reactive nitrogen
intermediates has been recently reported. The candidacidal role of this system is not
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known. Although human monocytes have been reported to produce reactive nitrogen
intermediates, this has not yet been demonstrated in human macrophages (Nathan and
Hibbs, 1991).
1.4.2.5 Specific immune responses to Candida
Humoral immunity to Candida can be measured by detection of antibodies
against the fungus. Cell mediated immunity can be measured by demonstration of
DTH response in skin. The response broadly correlates with in vitro lymphocyte
transformation tests and leukocyte migration inhibition tests.
Passive transfer into humans has provided direct evidence for the role of antibody
in protection against systemic infection (Hiatt and Martin, 1946). Maiti et al. (1985)
rendered newborn mice deficient in B lymphocytes by treating them with mouse
anti-|i serum and showed that the treated mice had enhanced susceptibility to
challenge with C. albicans. Sera from some patients with candidiasis react only with
germ tubes whereas sera from normal individuals react preferentially with yeast cells
(Ho et al., 1979). Antibodies can function by prevention of adherence, opsonization
of the organism, facilitation of cell mediated cytotoxicity and by enhancement of the
function of immune lymphocytes (Diamond, 1974; Epstein et al., 1981; Kagaya et al.,
1981; Vudhichamnong et al., 1982). It has been suggested that antibodies are an
important defense against secondary challenge by C. albicans (Ashman et al., 1990).
T cells are involved in both the generation of specific immunity and resolution of
primary infection. Neonatal thymectomy increased the susceptibility of mice to
systemic candidiasis. This result could not be reproduced in either adult
thymectomized, irradiated, bone marrow reconstituted (ATXBM) mice or in mice
homozygous for the nu or scid mutations. The resistance of ATXBM and nude mice
has been attributed to the activation of the monocyte/macrophage system and appears
to be short-lived; in the later stages of the infection both are substantially more
susceptible than control mice (reviewed by Ashman et al., 1990).
Passive transfer of lymphocytes from an immune animal reduced visceral
Candida counts in the later stages of disseminated Candida infection; the protective
role of cell mediated immunity is important after non-specific phagocytic responses
have dealt with the elimination of Candida in the immediate post-challenge period
(Miyake et al., 1977).
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In systemic candidiasis, immunosuppression follows the process of uptake and/or
presentation of Candida by macrophages and the generation of lymphocytes able to
respond to the antigens. Normal human lymphocytes cultured with a polysaccharide
fraction derived from C. albicans generate T cell suppressor factors that are able to
suppress both T- and B-cell responses to the homologous antigen (Piccollela et al.,
1981). These effects appear to be mediated by an antigen-non-specific inhibiting
factor that can block the synthesis of interleukin 2 (EL-2) and y-inteferon as well as
expression of IL-2 receptors by T cells (Lombardi et al., 1986)). The factor can also
inhibit antigen presentation and production of interleukin 1 (IL-1) by human
monocytes (Lombardi et al., 1985).
Specific immunity is also important in superficial candidiasis. Quantitative
differences in cell mediated immunity, total secretory immunoglobulin levels and
macrophage defects have been reported in chronic recurrent vaginal candidiasis.
There was a significant correlation between the levels of anti-Candida IgA and IgG in
serum and cervico-vaginal secretions (Gough et al., 1984) and isolation of Candida
from women of childbearing age was associated with low levels of anti-Candida
serum IgA but not with anti-Candida serum IgG (Schonheyder et al., 1983).
Qualitative abnormalities in cell mediated immunity are associated with CMC
(Kirkpatrick et al., 1971).
Blood Groups and Secretor Status
After a short historical introduction, three general areas are reviewed to provide
necessary background for the approach used in this study: a) the genetic control and
biochemistry of blood group antigens related to secretor status; b) blood groups and
disease susceptibility; c) the hypotheses proposed to explain the increased
susceptibility of non-secretors to certain infectious agents.
1.5 History
In 1900, the first human blood group system was discovered by Landsteiner when
he observed that red blood cells can be agglutinated by serum from another
individual. Individuals could be broadly classified into four distinct groups i.e. A, B,
O and AB. In 1908, Epstein and Ottenberg suggested that the ABO blood groups
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were inherited (reviewed by Race and Sanger, 1975). This was proved by von
Dungern and Hirzfeld in 1910; and, in 1924, Bernstein showed that the population
and family data were best explained by the hypothesis that A, B and O are
independent alleles at one locus (reviewed by Mourant et al., 1978).
Yamakami (1926) noted that the A and B antigens were present in saliva but it
was not until 1930 that it was realized by Lehrs and Putkonen that the character was
dimorphic; some persons do and others do not secrete into saliva antigens
corresponding to their ABO blood group. Schiff and Sasaki (1932) found that the
ability to secrete antigens into body fluids behaved as a simple Mendelian factor with
secretion dominant to non-secretion (reviewed by Race and Sanger, 1975).
From 1900-1927, the ABO blood group system was the only one known. The
discovery of additional blood groups such as Lutheran and Kell were made in a more
deliberate way: animals were injected with human red cells to stimulate antibody
production. Other blood groups were discovered as a result of materno-fetal
incompatibilities. In 1946, Mourant discovered the anti-Lewis3 antibodies and
Andersen, in 1948, described anti-Lewisb. It is now clear that the Lewis3 antigen
(Le3) was identified earlier in non-secretor saliva by Japanese workers. In 1951,
Grubb proposed a general theory to explain the presence or absence of antigens in the
saliva. Secretors have Lewisb antigen (Leb) and a smaller amount of Le3 whilst
non-secretors have Le3 only in their body fluids (reviewed by Race and Sanger,
1975).
The ABH antigens are not confined to red cells and saliva but are found in most
secretions and tissues of the human body. Phylogenetic and ontogenetic studies have
established that the ABH antigens evolved earlier on epithelial cells than on blood
cells; therefore, they should be considered as histo-blood group antigens (Clausen and
Hakomori, 1989). The antigen now known as H is present on red cells of nearly all
humans. It was long thought to be a product of the O gene; but, its nature became
clearer as a result of the discovery of individuals with the Bombay blood group who
lack this antigen (Bhende et al., 1952, reviewed by Race and Sanger, 1975).
Population studies of blood group frequencies emphasised the differences in the
distribution of the ABO phenotypes (reviewed by Race and Sanger). The function of
the blood group antigens and the significance of the different frequencies in
populations is not known; various hypotheses have been proposed but none have been
convincingly proven (Miller, 1978; Bird, 1983; Mourant, 1983). A hypothesis on the
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dual significance of ABH, Lewis and related antigens has been advanced by Le Pendu
(1989). He argues that the antigens would have primarily been involved in cell-cell
recognition phenomenon; and, the polymorphism would have evolved later from gene
duplication under environmental pressure. The expression on erythrocytes which
occurred very late in evolutionary time is probably of little biological significance;
blood transfusion is an artificial situation in which the antigens on the erythrocytes
are important.
1.6 ABO, Lewis Blood Group Systems and Secretor Status
1.6.1 Biochemistry of ABH antigens
The ABH-active substances are found on cells and tissues as well as in body
fluids linked to lipids (glycolipids) or proteins (glycoproteins). They also exist in
secretions as free oligosaccharides. Glycoproteins carry glucans in two ways.
Glycosylation can occur by linking D-P-N-acetylglucosamine to the amino group of
asparagine (N-linked), or by linking D-(3-N-acetylgalactosamine to the oxygen group
of serine/threonine (O-linked). Glycosphingolipids have (3-D-glucose linked to
ceramide. These lipids are further classified into lacto-, globo- and ganglioseries:
Further variability is generated by the existence of various carrier carbohydrate
chains that differ in branching and length. Taking into account only the terminal
disaccharide, four main precursor chains are now defined (Table 1.3).
The different carrier chains show differential cell and tissue expression and core
structure switching during development and differentiation (Hakomori, 1981; Oriol el
al., 1986; Fenderson et al., 1987). Type 1 chain constitutes the main carrier of ABH








Gala 1 -»Gaip 1—>4Glcp 1 ->Cer
GalNAcP 1 —>Gaip 1 —» 4Glcp 1 —>Cer
24
derived tissues such as lining epithelia and glandular epithelia. Generally, Type 1
chains are not found in ectodermally derived tissues although there are exceptions
such as non-keratinized stratified squamous epithelium. The Type 2 chains are found
mainly in ecto- and mesodermally derived tissues (Oriol et al., 1986). Both Type 1
and Type 2 chains can occur as branches on a single carbohydrate chain (Lloyd et al.,
1968). Type 3 and 4 precursor chains have been discovered relatively recently
(Takasaki et al., 1978; Donald, 1981). Not much information is available with regard
to their biosynthetic regulation and distribution (Breimer and Samuelsson, 1986;
Clausen etal.-, 1986).
1.6.1.1 ABH antigens on red cells
The Type 2 chain is thought to be the main carrier of the ABH antigens on red
cells. The presence of Type 1 chain structure is due to absorption of circulating
glycolipids from the plasma (Marcus and Cass, 1969). The Type 2 precursor chain is
fucosylated by the a.2 fucosyltransferase coded for by the H gene at the C2 position to
form H Type 2 determinant (Figure 1.1). Individuals of blood groups A or B encode
glycosyl-transferases capable of converting the H antigen by the addition of
N-acetylgalactosamine or galactose respectively. In AB individuals the enzymes
coded by these genes will compete for H Type 2; cells of these individuals will
possess some molecules carrying the A determinant and others carrying the B
determinant (Watkins, 1967). Both A and B determinants are not found on the same
carrier molecule (Viitala et al., 1981). This is in contrast with saliva where A and B
specificities are carried on the same macromolecules (Morgan and Watkins, 1956).
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Figure 1.1 Production of A, B and H(0) antigens from precursor Type 1 and 2
chains. The enzymes facilitating conversion of antigens are shown. Note that H







Figure 1.2 Production of H, A, B and Lewis antigens in secretions. Note that the
a 1-2 fucosyltransferase (Se gene-encoded) and the a 1-4 fucosyltransferase (Le
gene-encoded) compete for the precursor Type 1 chain. The a 1-4 fucosyltransferase
also competes with the A and B glycosyltransferases (see text). Symbols as in Figure
1.1.
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1.6.1.2 ABH antigens in secretions
The Type 1 precursor chain is fucosylated in secretions by a 1-2
fucosyltransferase coded by the secretor gene (Se) to form H Type 1 determinant
(Watkins et al., 1988). Subsequently, H Type 1 acts as a substrate to A/B
glycosyltransferases to give rise to their respective determinants. The a 1-2
fucosyltransferase is also able to act on Type 2 chains to a lesser degree and accounts
for the presence of small amounts ofH Type 2 antigens in secretions (Le Pendu et al.,
1982). Figure 1.1 presents the biochemical pathway by which the ABH determinants
are formed from precursor Type 1 and 2 chains.
1.6.2 Biochemistry of the Lewis antigens
Unlike the ABO blood group antigens, those of the Lewis antigens do not form
part of the structure of the cell membrane. They are present in the plasma and in
body secretions such as saliva. In plasma, the Lewis antigens are portions of
oligosaccharide chains that are bound through D-glucose to glycosphingolipids
(Tilley et al., 1975) and in secretions they are bound to glycoproteins (Watkins et al.,
1959). Once the antigens have been assembled in the plasma, they are inserted into
cell membranes (Marcus and Cass, 1969).
The Lewis antigens are based on Type 1 chain structure and are generated by the
a1-3/4 fucosyltransferase coded by the Lewis gene (Le) which adds L-fucose to
N-acetyl-D-glucosamine of the precursor Type 1 chain or the H Type 1 chain to form
Lea and Leb determinants respectively (Oriol et al., 1986). The structure and
formation of the Lewis antigens in secretions is shown in Figure 1.2.
The penultimate N-acetylglucosamine of Type 2 chains can, in parallel with Type
1 chains, be fucosylated to form Lex and Le^, isomers of Lea and Leb. Fucosylation
of the N-acetylglucosamine in Type 2 chains has been proposed to be catalysed by an
X gene-specific al-3 fucosyltransferase specifically acting on Type 2 chains (Prieels
et al., 1981). In addition, it appears that the fucosyltransferase encoded by the Le
gene can fucosylate Type 2 chains. In accordance with this view, expression of Type
2 chain structure has been found in secretions and some endodermally derived tissues
to vary with the Lewis and secretor status.
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Table 1.4
Gene Chromosome Enzyme (transferases) Substrate
A 9 N-acetylgalactosaminyl H Type 1 and 2
B 9 D-galactosyl H Type 1 and 2
0 9 no product no substrate
H 19 al-2 fucosyl precursor Type 2
Se 19 al-2 fucosyl precursor Type 1
Le 19 a3/4 fucosyl precursor Type 1
H Type 1
X ? a3 fucosyl precursorType 2
H Type 2
Table 1.5 ABO, Se and Le genes interactions in secretions
Secretor
status
Blood group antigens in body fluids
H
. **
A B** Lewisa Lewis*5
Secretors
Non-secretors




*H is the antigen formed by the a 1-2 fucosyltransferase encoded by Se gene
**depending on presence of A and/or B genes
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1.6.3 The ABO, H, Se and Le genes
The ABO locus present on chromosome 9 (Westerveld et al., 1976) was first
thought to contain three major alleles: A, B and O (reviewed by Watkins, 1980). It is
now known that there are two alleles encoding for Aj and A2, the two subgroups of
blood group A. The A and B genes differ in four single-base substitutions which
change four amino acid residues. A critical single base deletion was found in the O
gene which results in an entirely different inactive protein incapable of modifying the
H antigen (Yamamoto et al., 1990).
The term H was introduced by Morgan and Watkins (1948) to describe the
antigen found in all ABO phenotypes. The h gene is a rare silent allele of the H.
Individuals homozygous for h (h/h) do not have A or B antigens even if the
glycosyltransferases are present; the absence of H antigen substrate renders these
enzymes redundant.
The ability to produce ABH antigens in secretions is inherited in a Mendelian
dominant pattern. Individuals who are homozygous or heterozygous for the Se gene
(Se/Se or Seise) have Type 1 blood group antigens in their body fluids. Individuals
homozygous for the silent allele {seise) are known as non-secretors. Among
Europeans about 80% are secretors and 20% non-secretors (Race and Sanger, 1975).
These percentages vary among different ethnic groups (Mourant et al., 1976).
More recently, it has been proposed that the H gene codes an a 1-2
fucosyltransferase expressed on red cells whereas the Se gene encodes another a 1-2
fucosyltransferase expressed in salivary glands. The presence of the Se gene means
that individuals with h/h,Se/Se or h/h,Seise will express Type 1 blood group antigens
in their secretions but will have no ABH antigens on their red cells. Such individuals
are known as para-Bombay phenotype. Bombay individuals have the hlh,seise
genotype and fail to express ABH antigens in cells or secretions (Oriol et al., 1981).
Two different forms of fucosyltransferases with the expected properties of H and
Se gene products have been found by different groups to support this genetic model
(Le Pendu, 1983; Kumazaki and Yoshida, 1984). It has been shown that the H and Se
genes are closely linked on the short arm of chromosome 19 (Oriol et al., 1986)
suggesting that they might have been derived by duplication of the Se gene in the
course of evolution (Le Pendu et al., 1985).
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The Le gene is also located on chromosome 19 but is independent of the H and Se
loci (Elberg et al., 1983). It encodes an a3/4 fucosyltransferase which acts on Type 1
precursor chains and, in vitro, on Type 2 precursor chains (Johnson et al., 1981). The
X gene encodes an a3 fucosyltransferase which exclusively uses Type 2 chains as
substrates. The location of the X gene is not yet known; it is expressed in
mesodermal tissues such as the kidney (Caillard et al., 1988). Table 1.4 summarizes
the ABO, H, Se, Le and X genes location, their enzymic product and target
substrate(s).
1.6.4 Interactions of the H, Se, ABO and Le genes
The blood group antigens are assembled through a complex mechanism whereby
a series of enzymes act sequentially and specifically to extend the precursor
carbohydrate chain. The specificity of the enzyme for the substrate is such that the
action of one enzyme often renders the product unacceptable for another enzyme.
The antigens produced thus depend on the genetic make up of the individual and the
efficiency of the enzymes competing for substrates.
In secretions, the expression of the Lewis antigens depends on the secretor status
(Table 1.5). When both Se and Le genes are expressed, the Type 1 precursor chain
can be first fucosylated by the Se enzyme to produce H Type 1 antigen. This
structure can be further fucosylated by the Le enzyme to form Leb. If the precursor
structure is first utilized by the Le enzyme, the structure formed (Lea) is unsuitable as
a substrate for the Se encoded enzyme. As a result, both Lea and Leb are formed in
secretors; the relative amounts found depend on the efficiency of the competing
enzymes (Watkins et al., 1988; Ogata et al., 1988). The A and B enzymes also
compete with the Lewis enzymes for the same substrate (H Type 1). Once the
determinant has been converted to Leb, it cannot function as a substrate for the A and
B transferases. On the other hand, A and B determinants can be further fucosylated
by the enzyme coded by the Le gene to form ALeb or BLeb determinants.
In non-secretors, the absence of the Se encoded enzyme means that the only
determinant formed from the Type 1 precursor chain is Lea. In the absence of both Se
and Le genes, secretions will contain unconverted Type 1 precursor chain structures.
In tissues the interaction of the genes can be generalized as follows: ectodermal
tissues express ABH antigens independent of the Se gene although they can be
quantitatively influenced by the Se gene (Dabelsteen et al., 1982); endodermal tissues
31
express ABH and Lewis antigens under the control of the products of the Le and Se
genes (Oriol, 1987).
1.7 Blood Group and Disease Susceptibility
Following the discovery that blood group frequencies differed in various
populations, the obvious question is "What are the origins of these differences?".
There are two possibilities: genetic drift and natural selection. Both processes are
thought to be operative, but their relative importance is unclear.
The founder effect due to migration of a small non-representative group of
individuals might be responsible for an initial difference in gene frequencies between
the main and migrant populations. Genetic drift could then affect the migrant
population so that it becomes progressively more different from the main population.
Natural selection arises from differences in fitness between individuals with
various blood groups. If a phenotype is at a disadvantage, this might result in the
environment causing a raised early mortality or a lowered fertility in persons with the
particular phenotype compared with those of another phenotype.
One of the outstanding examples of association between blood group and early
mortality is that involving haemolytic disease of the newborn (Levine et al., 1941).
This is the result of anti-Rhesus antibodies which develop in a Rhesus-negative
mother carrying a Rhesus-positive foetus. A similar phenomenon exists with ABO
incompatibility of mother and foetus (Halbrecht, 1944). There is a marked deficiency
of ABH non-secretors among infants suffering from ABO haemolytic disease
compared with the general population (Levene and Rosenfield, 1961).
Incompatibility of the ABO blood group and secretor status are also thought to be
important causes of early abortions, infertility and still births. There is an excess of
spontaneous abortions (42.6% compared with 35% expected) with the ABO
incompatible parents (Levene and Rosenfield, 1961). The association between ABO
blood group and infertility has been suggested on the basis of a study in which there
was a significant excess of ABO incompatible couples (87.3%) in persistently sterile
matings compared with 38.6% in fertile couples (Behrman et al., 1960) These authors
suggest that ABO related infertility is due to the action of antibodies in the secretions
of the mother's genital tract on incompatible spermatozoa. Two other studies found a
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similar trend but the results were not significant. There is, therefore, evidence that in
ABO incompatible matings, there is a marked selection against the birth or survival
of the ABO incompatible foetus and that non-secretors are favoured in utero.
Early mortality could also be influenced by susceptibility to infectious agents.
Disease due to bacteria, viruses, protozoa and fungi have been studied for
associations with blood group and with secretor status in some cases. Selected
examples are described below and summarized in Table 1.6.
1 Protozoa
Malaria is an outstanding example of an infection influencing the genetic
frequency within a population. Only quartan malaria (Plasmodium vivax) and
malignant/tertian malaria (Plasmodium falciparium) have been studied. The disease
has strong associations with several polymorphic genes such as the sickle cell gene,
the Duffy blood group, P-thalassemia (reviewed by Mourant et al., 1978), HLA Bw26
and DQ/DR haplotypes (Hill et al., 1991). The presence of sickle cell gene and the
HLA haplotypes is protective against severe malaria infection; these associations are
not significant among patients with mild or moderate disease. Associations between
ABO blood group and disease await further extensive surveys which differentiate the
type of parasite, the vector as well as severity of the infection. When both forms of
malaria are considered, the data show a marked excess of A patients compared with O
and B individuals. Athreya and Corriell (1967) have suggested that blood group B
confers a selective advantage in relation to malaria infection to explain the high
frequency of blood group B corresponding to where malaria is endemic.
2 Bacteria
One of the earliest observation of particular blood groups and secretor status
associated with bacterial disease was that by Glynn et al. (1956) (reviewed by
Haverkorn and Goslings, 1969). Scarlet fever is caused by Group A P haemolytic
Streptococcus pyogenes. Carriers of the bacteria show a consistent deficiency of ABH
secretors but no blood group bias (Haverkorn and Goslings, 1969). Scarlet fever
patients, however, show a significant excess of blood group O individuals (Mourant
et al., 1978). It appears that non-secretors are prone to carriage; and, of these, blood
group O individuals might develop disease.
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Table 1.6 Associations between blood group and/or secretor status and susceptibility
to infections
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Gastrointestinal Tract

















Streptococcus pyogenes (Group A)
Streptococcus pneumoniae
Neisseria meningitidis
































Table reproduced from Blackwell (1989) with modifications.
? indicates lack of information in the literature
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Over the last decade, other diseases caused by bacteria have been found to be
associated with secretor status. Non-secretors are prone to invasive disease due to
Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, urinary
tract infections due to Escherichia coli and cholera (reviewed by Blackwell, 1989).
3 Viruses
Among viral diseases, two influenza A viruses appear to infect more blood group
O individuals than A or B (McDonald and Zuckerman, 1962). Examination of sera
from survivors of past epidemics shows only a slight and non-significant increase of
group O individuals among strong reactors for each of the two different influenza A
virus strains (Watkin et al., 1975). Both Cuadrado and Davenport (1970) and Otter
and Schild (1967) found an increase in group O individuals among positive reactors
(reviewed by Mourant et al., 1978). A recent study of upper respiratory infection
viruses reported a significant increase of secretors of ABH antigens among patients
with acute infections from whom viruses were isolated (Raza et al., 1991). Secretors
are also over-represented among individuals who have acquired human
immunodeficiency virus (HIV) through heterosexual intercourse (Blackwell et al.,
1991).
1.7.1 Blood groups and other associations
Apart from infectious diseases, secretor status has been associated with other
diseases for which infectious triggers have been proposed, e.g. Graves' disease,
insulin dependent diabetes mellitus and peptic ulcers (Blackwell, 1989; Mourant et
al., 1978). Blood groups have also been associated with other conditions such as
neoplasms, thromboembolic and developmental disorders (Mourant et al., 1978).
These associations might influence mortality but will not be discussed here.
1.7.2 Mechanisms by which blood group and secretor status influence disease
susceptibility
Genetic susceptibility to infectious diseases has been accepted for many years.
The mechanisms underlying the genetic susceptibility are obscure in most cases.
Theoretically, genes can exert their influence directly (through the encoded product)
or indirectly via modification of end-products encoded by other genes. For example,
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although the association between HLA and various diseases has been known for
several decades, researchers have concluded that genes at other loci contribute to the
overall susceptibility of an individual to disease (Ryder et al., 1981). The following
are hypotheses suggested to explain associations between susceptibility to infectious
agents and blood group or secretor status.
1.7.2.1 Secretor status and complement system
Although components of the complement system are encoded by genes on
chromosome 6, the gene that codes for the C3 component is in the same linkage
group as the Se gene on chromosome 19 (Elberg et al., 1983). Compared with
healthy individuals, C3 levels are lower among individuals with insulin-dependent
diabetes mellitus (IDDM) but not those with non-insulin dependent diabetes mellitus
(NIDDM) (Charlesworth et al., 1987). These two reports together with the
observation that non-secretors are over-represented among individuals with IDDM
(Blackwell et al., 1987a) promoted a study of C3 and C4 levels among patients with
EDDM with respect to secretor status. Significantly lower levels of C3 and C4 were
found among individuals with EDDM who were non-secretors compared with those
who were secretors (Blackwell et al., 1988).
The mechanism whereby lower C3 levels are found in non-secretors and its effect
on disease susceptibility is not clear. The reduced C3 levels are not due to a more
rapid clearance of complement factors, exhaustion of complement factors, or
attachment to immune complexes (Charlesworth et al., 1987).
Furthermore, the gene that codes for C3 exhibits genetic polymorphism (Alper,
1986). The alleles are inherited in an autosomal co-dominant manner. Several C3
variants have been found and characterised by agarose gel electrophoresis. Only two
forms occur frequently i.e. C3F (fast) and C3S (slow). The gene frequency of C3S
ranges between 77%-99% depending on the population sampled.
The biological significance of C3 polymorphism is not known. Several studies
have reported a significant increase of C3F allele among patients with chronic
inflammatory diseases such as rheumatoid arthritis (Bronnestam, 1973), Crohn's
disease (Elmgreen et al., 1984) and autoimmune diseases such as multiple sclerosis
(Jans and Sorensen, 1980) and cirrhosis (Srivastave and Srivastave, 1985). The C3F
protein exhibits increased capacity for binding onto receptors of mononuclear cells
compared with the C3S protein (Arvillomi, 1974) suggesting that the functionally
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active site of the molecules differ. A relationship between C3S and high titres of
antibodies to A and B blood group antigens in mothers with ABO incompatible
foetuses has been reported (Bronnestam and Cedegren, 1973); and, these authors
suggest that the C3S variant might influence antibody production through unknown
mechanisms. Since the Se and C3 genes are linked, it is possible that the inheritance
of se along with the C3F allele could account for the increased susceptibility of
non-secretors to disease.
1.7.2.2 Secretor status and immunoglobulins
The only hypothesis proposed to explain the association between blood groups
and susceptibility to disease was that anti-A and anti-B isohaemagglutinins acted as
"natural" antibodies against microorganisms expressing antigens cross-reacting with
A or B (Springer et al., 1961). Grundbacher and Scheffler (1970) reported a
significantly higher level of B isoantibodies in the serum of secretors compared with
non-secretors. These authors extended their studies by examining serum IgG levels
of anti-B and found them to be higher among secretors compared with non-secretors.
Subsequently, studies of total serum and salivary IgA levels and total serum IgG were
shown to be higher among secretors compared with non-secretors (Waissbluth and
Langman, 1971; Grundbacher, 1972).
Studies by Blackwell and colleagues however, have not demonstrated this trend.
Among women recently referred for assessment of recurrent urinary tract infections
(UTI), the total serum IgA and IgG levels were found to be similar for secretors and
non-secretors; however, among long term sufferers of UTI, non-secretors had
significantly higher titres of total serum IgA and IgG than secretors (Blackwell et al.,
1987b).
In the Stonehouse survey for carriage of Neisseria meningitidis, carriers had
significantly higher levels of total salivary IgA compared with non-carriers. Among
non-carriers, basal salivary IgA levels were similar among secretors and
non-secretors; however, total serum IgA was significantly higher among secretors
compared with non-secretors. No difference in total serum and salivary IgA was
found between secretors and non-secretors among carriers of N. meningitidis
(Blackwell et al., 1989b). Similarly, among patients with spondyloarthropathies no
difference in total serum and salivary IgA was found between secretors and
non-secretors (Shinebaum et al., 1987).
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Table 1.7 Blood group antigens that are receptors for microorganisms
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Recent work on antibodies specific for Neisseria lactamica and N. meningitidis
isolates found that salivary IgM antibodies are significantly elevated among secretors
compared with non-secretors (Zorgani et al., 1992). Infants are dependent on
secretory IgM to protect mucosal surfaces since very little secretory IgA is present
(Melande et al., 1984). This might explain the increased susceptibility of
non-secretors to colonization and disease by Neisseria spp (Blackwell et al., 1989b).
This study emphasises the importance of recording specific antibodies against a
known infecting agent in future studies on the role of secretor status in humoral
immunity.
1.7.2.3 ABH and Lewis antigens as receptors for infectious agents
The susceptibility of individuals of certain blood groups to infectious agents has
been explored in terms of variability of attachment of microorganisms to host cells
expressing different blood groups. Table 1.7 lists examples of blood group antigens
that act as receptors for microorganisms (Blackwell, 1989). The best example is the
Duffy blood group antigens and susceptibility to Plasmodium vivax.
The Duffy alleles Fya and Fyb are associated with susceptibility to P. vivax
(Miller et al., 1975). Africans and American Blacks do not have the Duffy antigens
(Fya",F_yb~) and are resistant to these infections; non-African populations possess
either or both of these antigens. Plasmodium knowlesi is closely related to P. vivax
and has been used for in vitro studies which showed that erythrocytes with Fya+b~,
Fya_b+ and Fya+b+ phenotypes were invaded equally by P. knowlesi. Almost no
invasion was observed for Duffy negative erythrocytes (Fyab). When the Duffy
antigens were removed by proteolysis, the erythrocytes became resistant to invasion.
Subsequent studies showed that the Duffy determinant Fy6 is a receptor for P. vivax
and P. knowlesi merozoites (Barnwell et al., 1989). This structure is expressed on all
human erythrocytes except those from individuals with Fya~b~ genotype (Nichols et
al., 1987). The erythrocyte receptors for P. falciparum are probably glycophorin A
and an anion transport protein (Wallach, 1986). The resistance to invasion by
P. vivax of Duffy negative individuals compared with the other Duffy blood groups
was confirmed in a clinical study using human subjects (Miller et al., 1976).
Non-secretors of the ABH antigens are at an increased risk of superficial disease
due to Candida (Thorn et al., 1989) and carriage of these yeasts (Burford-Mason et
al., 1988). Fucose has been identified as a receptor for C. albicans isolated from oral
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lesions. Fucose is the immunodominant sugar of the H and Lewis blood group
antigens. Two hypothesis were proposed to explain the increased susceptibility of
non-secretors to C. albicans. The first is that the H and Leb antigens in the body
fluids of secretors might act to block the attachment of Candida to epithelial cells.
This was supported in a study which showed that Candida treated with boiled
secretor saliva were inhibited from binding to buccal epithelial cells (BEC) from
non-secretors. Yeasts treated with boiled non-secretor saliva, however, bound in
greater numbers to BEC of both secretors and non-secretors compared with untreated
blastospores (Thorn et al., 1989). This gave rise to the second hypothesis: Lea
antigen found in greater quantities on cells and in saliva of non-secretors might act as
a receptor which promotes binding of yeasts to BEC. Support for this hypothesis was
provided by a study in which binding of Candida to BEC from non-secretors was
inhibited by polyclonal anti-Lea antibody; treatment of BEC from secretors with
either anti-Lea or anti-Leb did not inhibit binding of the blastospores (May et al.,
1989).
1.8 Aims of the study
Oral candidiasis affects individuals whose host defences are compromised.
Patients with diabetes were chosen as a sample population because they represent one
of the immunocompromised groups who are susceptible to candidiasis and can be
used as a model for other immunocompromised groups such as individuals with HIV
or those undergoing immunosuppresive therapy. Patients with diabetes are a large
population who are easily accessible and relatively safe to sample compared with
individuals with HIV infection. The aims of the study were two fold:
1. to define the role of the secretor gene and other risk factors in oral carriage of
Candida species and in development of denture stomatitis among individuals with
insulin dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes
mellitus (NIDDM).
2. to investigate the factors underlying the increased susceptibility of
non-secretors to oral disease and carriage of yeasts, particularly the role of secretor





Oral candidiasis is most prevalent as chronic atrophic candidiasis (Odds, 1988).
Individuals with diabetes are prone to infection; and, chronic atrophic candidiasis has
been reported to be more prevalent among diabetic individuals compared with
non-diabetic controls (Lamey et al., 1988). Since disease is frequently preceded by
colonization, it is important to identify factors which predispose to colonization. Few
studies have examined the factors which predispose to colonization of diabetic
patients by C. albicans', and, none of these specifically analysed patients with IDDM
separately from those with NIDDM (Barlow and Chattaway, 1969; Tapper-Jones et
al., 1981; Fisher et al., 1987; Lamey et al., 1988; Hill etal., 1989).
Both genetic (Burford-Mason et al., 1988) and environmental factors (Ryley,
1986) have been reported to affect carriage of Candida species. Group A (3
haemolytic Streptococcus pyogenes are isolated more frequently from the pharynx of
individuals who are non-secretors of ABH antigens (Haverkorn and Goslings, 1969)
and non-secretors were significantly over-represented among carriers of
meningococci (Blackwell et al., 1990). Among non-diabetic individuals and
individuals with NIDDM non-secretors of blood group O are over-represented among
carriers of C. albicans compared with secretors (Burford-Mason et al., 1988;
Blackwell et al., 1989a).
Environmental factors variably reported to be associated with carriage of yeasts
include: presence of a denture; continuous wearing of a denture; denture fit,
occlusion, trauma, hygiene and age; smoking; and control of diabetes
(Budtz-Jorgensen and Bertram, 1970; Tapper-Jones et al., 1981).
This was the first study designed to compare the factors contributing to carriage
of yeasts in individuals with IDDM or NIDDM; its aims were:
1. to compare the oral rinse technique with the palate swab method for isolation
of yeasts.
2. to compare the species of yeasts isolated from patients with IDDM or NIDDM.
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3. to assess the association between secretor status and carriage of yeasts among
individuals with IDDM or NEDDM taking into account denture status.
4. to dissect the contributions of the following variables to the carriage of yeasts
and, specifically, C. albicans: age; gender; type of diabetes; control of diabetes as
measured by glycosylated haemoglobin Aj (HbAj); random plasma glucose levels;
persistent glycosuria and albuminuria; diabetic complications - retinopathy,
neuropathy, nephropathy; antibiotic usage; corticosteroid treatment; smoking; alcohol
consumption; presence of the denture in the mouth at night; denture fit, extension,
occlusion, hygiene and age; presence of denture stomatitis; and history of superficial
Candida infections.
2.2 Materials and Methods
2.2.1 Subjects
A total of 439 subjects attending for routine follow up examination at the Diabetic
Outpatients' Department (DOPD), Royal Infirmary, Edinburgh were sampled. An
initial pilot study examined 80 individuals and was followed by a study that sampled
359 individuals between September 1988 and March 1989. The method of selection
was stratified random selection according to gender and type of diabetes.
2.2.2 Clinical history
Each subject was classified as insulin dependent (IDDM) or non-insulin
dependent (NIDDM) according to family history of diabetes, clinical history of onset,
requirement for insulin and progression of the disease. Of the 439 subjects sampled,
three could not be classified.
A full medical history including the presence of diabetic complications
(retinopathy, neuropathy and nephropathy) was obtained during interview and from
the patients' records. A history of medications, with particular reference to
antibiotics or corticosteroid-containing preparations, within the past 6 months was
noted. A social history of alcohol consumption and smoking was recorded. Subjects
were questioned about history of superficial infections due to yeasts. Glycosuria and
albuminuria were recorded as persistent if subjects had positive urine samples on
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more than two consecutive appointments at the DOPD. None of the subjects used
any oral preparations containing antiseptics within the previous 6 months.
2.2.3 Clinical examination
A thorough oral examination of both soft and hard tissues was carried out. Any
of the following abnormalities were noted: angular cheilitis; leukoplakia; median
rhomboid glossitis; fissured, geographic or hairy tongue; and denture stomatitis. The
occlusion, fit, extension and hygiene of a denture where present was recorded as
"good" or "poor". The age of the denture was recorded as well as whether it was left
out of the mouth at night.
2.2.4 Samples
Venous blood was obtained for ABO blood grouping and Lewis antigen
determination. Routine analyses for glycosylated haemoglobin (HbAj) and random
plasma glucose were recorded. The Corning electrophoresis method was used for
measuring HbAj (normal range 4.5-8.0%, Coefficient of variance = 4%).
Swabs were obtained from five sites of the mouth including the palate and
inoculated immediately into malt broth. Each subject provided a fresh, unstimulated
sample of saliva which was collected in a sterile Universal container.
Subjects were requested to rinse with 10 mis of sterile phosphate buffered saline
(PBS) for 1 minute and to return the contents to a sterile Universal container.
2.2.5 Laboratory analysis
ABO blood group was determined by slide agglutination with monoclonal anti-A
and anti-B antibodies (Scottish National Blood Transfusion Service). Secretor status
was determined by the presence of Lewis antigen on red blood cells by the tube
agglutination with monoclonal anti-Lea and anti-Leb antibodies (Scottish National
Blood Transfusion Service). Saliva was boiled within 1 hr of collection and stored at
-20 °C. The haemagglutination inhibition method with boiled saliva was used to
confirm the Lewis antigen results for 159 individuals (Mollison, 1983).
The swabs in malt broth were incubated at 37 °C for 36-48 hr, plated onto malt
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agar and incubated for a further 36-48 hr.
The mouth rinse was concentrated by centrifugation and resuspended in 1 ml of
PBS, 20 ul of the suspension were inoculated onto malt agar plates and incubated at
37 °C for 36-48 hr. The number of colonies per sample was recorded.
Pure colonies were subcultured and identified with the API 20 C Auxanogram
(API Systems S.A, France). All were also identified by the conventional methods of
germ tube production in horse serum, urease test and hyphae production on com meal
agar following incubation at 28 °C for 48 hr (Milne, 1989).
2.2.6 Statistical analysis
All results were coded and a computerised database was set up to facilitate
analysis by the SPSSX statistical programme. Univariate analysis was by chi-square
(with Yates' correction) or Wilcoxon rank sum tests. MacNemar's test for paired
alternatives was used to compare the results of the oral rinse and the palate swab.
Stepwise linear discriminant analysis (Wilk's method) was used to identify which
combinations of factors best predicted yeast carriage. The grouping variable is a
binary variable i.e. carrier or non-carrier. The programme selects the linear
combination of variables that best predicts the grouping variable. During the
analysis, predictor variables can be added or removed in a stepwise manner, each
variable being selected on the basis of an F-level of 4 for entry or removal,
corresponding to p = 0.05.
2.3 Results
Table 2.1 summarizes the characteristics of the population sampled with respect
to their diabetic status. Individuals with IDDM were younger, had a higher mean
value of HbAj; and, a significantly higher proportion of non-secretors (36.4%)
compared with individuals with NIDDM (22%){y} = 10.15; p < 0.005). The mean
number of cigarettes per day smoked by subjects with IDDM or NIDDM were
similar.
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Only 29% (128/439) of the individuals examined had no yeasts in any of the five
sites swabbed; this compared well with the oral rinse technique in which 34%
(144/439) of the individuals were culture negative. The concordance between the
results obtained by these methods was 85%. By MacNemar's test for paired
alternatives, there was no significant difference between the discordant pairs obtained
by the two sampling methods (p > 0.1). Table 2.2 compares the species of yeasts
cultured from swabs of the five sites of the mouth with those obtained from the oral
rinse from individuals with IDDM or NIDDM. T. glabrata and C. tropicalis were
isolated more frequently from those with dentures. Yeasts were isolated significantly
more frequently from the palate of individuals with IDDM compared with those with
NIDDM (Table 2.3); similar results were obtained with the oral rinse method.
2.3.2 Univariate analysis
Isolation of yeasts from the palate or from the oral rinse was not associated with
secretor status when the results were analyzed by type of diabetes and/or denture
status.
Blood group was not associated with palatal carriage. When carriage was
assessed by the oral rinse, however, individuals with NIDDM who wore dentures and
who were of O blood group were more likely to be carriers than those of blood group
A (x2 = 7.93, p = 0.005) (Table 2.4). Comparisons with B and AB were not done
because of the small numbers of individuals with these blood groups. Analysis of
secretor status with reference to blood group revealed a significant association
between non-secretion and increased frequency of carriage of yeasts among
individuals with IDDM who were blood group A and who wore dentures (9/19
A-secretor carriers compared with 12/12 A-non-secretors carriers y} = 7.07, p =
Tables 2.4 to 2.8 present analysis of factors examined and carriage of yeasts;
similar results were obtained when carriage of C. albicans was analysed separately.
Increase in age was associated with a decreased frequency of isolation of yeasts
from the palate (Table 2.5). Similar results were obtained by the oral rinse technique.
The HbAj values of palatal carriers were higher compared with non-carriers
0.008).
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40.3 (16.0) 10.3 (2.1) 41 17.3(11.1) 36.4 63.6
NIDDM
(205)
58.1 (9.3) 9.8 (2.3) 34 17.3 (11.7) 22.0 78.0
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Table 2.2 Species of yeast isolated from individuals with IDDM or NIDDM
with or without dentures (figures represent percentages).
Patient
category Sample none C.albicans C.tropicalis C.glabrata Other
No dentures
IDDM
(n = 150) PBS oral rinse 33 47 2 0 18
Palate swab 44 48 1 1 6
Tongue swab 38 54 2 0 6
Floor of mouth swab 41 54 1 1 3
Right angle swab 56 38 0 0 5
Left angle swab 60 35 0 0 5
NIDDM PBS oral rinse 40 28 2 0 31
(n=70) Palate swab 63 28 0 0 9
Tongue swab 63 32 0 0 5
Floor of mouth swab 70 27 0 0 3
Right angle swab 68 27 0 0 5
Left angle swab 75 24 0 0 2
Dentures
IDDM
(n = 79) PBS oral rinse 24 43 4 0 29
Palate swab 33 47 9 2 9
Tongue swab 37 49 5 2 8
Floor of mouth swab 34 49 5 3 8
Right angle swab 50 29 9 1 10
Left angle swab 42 41 6 2 9
NIDDM PBS oral rinse 41 24 6 3 27
(n=135) Palate swab 51 29 6 3 12
Tongue swab 51 34 8 2 6
Floor of mouth swab 53 31 7 3 7
Right angle swab 54 25 9 3 9
Left angle swab 58 24 10 3 6
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Table 2.3 Type of diabetes and isolation of yeasts from the palate swab
Patient Type of non -carriers carriers* X2 P
Category diabetes no. (%) no (%)
All IDDM 70 (39) 108 (61)
8.5 <0.01
NIDDM 101 (55) 82 (45)
no dentures IDDM 48 (44) 62 (56)
5.03 0.01
NIDDM 40 (62) 24 (38)
dentures IDDM 22 (33) 44 (67)
4.81 0.01
NIDDM 61 (51) 58 (49)
*All yeasts including C. albicans
p value refers to comparisons between IDDM and NIDDM
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Table 2.4 Blood groups and carriage of yeasts assessed by oral rinse technique





IDDM 0 22 (39) 34 (61)
1.49 0.22
no dentures A 11 (26) 32 (74)
IDDM 0 5 (16) 26 (84)
1.24 0.27
dentures A 10 (31) 22 (69)
NIDDM O 9 (33) 18 (67)
0.13 0.72
no dentures A 7 (44) 9 (56)
NIDDM 0 17 (32) 36 (68)
7.93 <0.01
dentures A 20 (67) 10 (33)
p refers to comparison of carriage between individuals of blood group O with those of
blood group A.
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Table 2.5 Median age and carriage of yeasts determined by palate swab
Patient
Category
Median age (years) P
non-carriers carriers
IDDM
dentures 58.00 49.00 0.03
(n) (22) (44)
no dentures 38.50 29.00 0.01
(n) (48) (62)
NIDDM
dentures 61.00 59.00 0.07
(n) (61) (58)
no dentures 56.00 50.50 0.09
(n) (39) (24)
p determined by Mann-Whitney test
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Table 2.6 Glycaemic control (HbA j) and carriage determined by palate swab
Patient
Category
Median P bAT units
Pnon-carriers carriers
IDDM
dentures 9.55 11.10 0.067
(n) (18) (236)
no dentures 9.30 10.60 0.017
(n) (45) (55)
NIDDM
dentures 9.30 9.50 0.15
(n) (57) (52)
no dentures 8.70 9.90 0.26
(n) (40) (21)
p determined by Mann-Whitney test
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Table 2.7 Smoking and carriage of yeasts determined by palate
swab
Category Mean cigarettes/day P
non-carriers carriers
ALL 4.54 7.83 <0.01
(n) (156) (181)
IDDM
dentures 7.95 9.20 0.24
(n) (20) (44)
no dentures 5.72 7.32 0.43
(n) (43) (59)
NIDDM
dentures 2.89 6.87 0.05
(n) (57) (54)
no dentures 4.28 9.09 0.13
(n) (36) (23)
p determined by Mann-Whitney Test
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All Yes 30 (40) 45 (60)
6.61 0.01
No 32 (65) 17 (35)
IDDM Yes 10 (32) 21 (68)
0.00 1.00
No 5 (38) 8 (62)
NIDDM Yes 20 (45) 24 (55)
5.97 0.015
No 27 (75) 9 (25)
p value refers to comparison between carriage and the presence or absence of the
denture at night
53
Table 2.9 Palatal carriage of yeasts: variables isolated by multivariate
analysis (Wilk's Method)








Age (p < 0.05)









of denture (p < 0.01)
64%
Table 2.10 Oral carriage of yeasts: variables isolated by the multivariate
analysis (Wilk's Method).




Age (p < 0.01) 68%
dentures
(n = 71)




Glycosuria (p < 0.01)
plasma glucose(p < 0.05)




plasma glucose (p < 0.05) 48%
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particularly among individuals with IDDM (Table 2.6). Results from the oral rinse
technique showed a similar trend but did not attain significance at p < 0.05 for
individuals with IDDM or NIDDM.
The mean number of cigarettes per day was a highly significant factor associated
with carriage of the whole population sampled (Mann-Whitney p < 0.001). When
results were analysed with respect to type of diabetes and denture status, smoking
was of marginal significance (p = 0.051) only among denture wearers with IDDM
(Table 2.7).
Yeasts were isolated more often from the palate of subjects who left their dentures
in the mouth at night; however, this was observed only among individuals with
NIDDM (Table 2.8). This pattern was not found when carriage was assessed by the
oral rinse method.
The following variables were not associated with frequency of carriage of yeasts
by either isolation technique: gender; duration of diabetes; complications -
neuropathy, nephropathy and retinopathy; alcohol consumption; contraceptive pill;
systemic corticosteroid treatment; topical corticosteroid application; antibiotics; fit,
occlusion, age or hygiene of denture; persistent albuminurea; history of superficial
Candida infections. Denture status was not significantly associated with frequency or
density of colonization by yeasts.
2.3.3 Multivariate analysis
Univariate analysis might incorporate dependent variables which need prior
knowledge to control for their effect. The multivariate analysis identified factors
which contribute to carriage of yeasts among individuals with IDDM or NIDDM who
wear dentures and those without dentures. Tables 2.9 and 2.10 summarize the results
obtained from the palate swab and oral rinse techniques; similar results were obtained
when carriage of C. albicans was analysed separately. The percentage of carriers
correctly predicted by the isolated variables indicates their prognostic value.
Individuals with IDDM who did not wear dentures were best segregated on the
basis of their age into non-carriers and carriers of yeasts; carriage decreased with
increased age. This was true when carriage was assessed by either technique (Tables
2.9 and 2.10). The univariate analysis showed similar associations; younger
individuals were more prone to carriage of yeasts (Table 2.5).
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Among individuals with IDDM who wore dentures, an increase in the frequency
of palatal carriage of yeasts was associated with an increase in HbAj level (p < 0.01);
younger individuals (p < 0.05) and increased random plasma glucose levels (p < 0.05)
(Table 2.9). The variable which was the most efficient predictor of carriage when
assessed by the oral rinse technique was, however, the presence of retinopathy (p <
0.05) (Table 2.10). Univariate analysis of this category showed age to be associated
with palatal carriage (Table 2.5).
Individuals with NIDDM who did not wear dentures were more likely to be
palatal carriers of yeasts if they had persistent glycosuria (p < 0.05) (Table 2.9).
Carriage assessed by the oral rinse method was influenced by persistent glycosuria (p
< 0.01), higher random plasma glucose levels (p < 0.05) and non-secretion of blood
group antigens (p = 0.05) (Table 2.10). Univariate analysis revealed an association
between persistent glycosuria and carriage among individuals with NIDDM (%2 =
5.32; p = 0.02).
Individuals with NIDDM who wore dentures were at risk of palatal carriage of
yeasts if they wore their dentures continuously (p < 0.01) (Table 2.9). Carriage of
yeasts as assessed by the oral rinse technique was best predicted by an increased
random plasma glucose levels (p < 0.05) (Table 2.10). Comparison with univariate
analysis showed that continuous wearing of dentures was a significant factor only
when carriage was assessed by palatal swab (Table 2.8).
2.4 Discussion
The results are discussed in the context of the objectives of the study. The first
objective of the study was to compare the rate of isolation of yeasts by the oral rinse
technique with that obtained by the palate swab. The oral rinse technique compared
well with the results of the swab technique; there was 85% concordance between the
results obtained with the two methods.
C. albicans was the species most frequently isolated from the swabs while species
other than C. albicans were isolated more often from the oral rinse. This might be
due to incubation of swabs in the malt broth suppressing other species of yeasts. By
the swab technique, yeasts were isolated most frequently from the tongue followed by
the palate, floor of the mouth and the angles of the mouth. Similar results have been
reported (Tapper-Jones et al., 1981). This supports the suggestion that the tongue
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might act as a reservoir for yeasts (Soames and Southam, 1985). For future work, the
appropriate technique should be selected to best assess the objectives of the study.
The oral rinse technique can be used where quantitative and overall carriage of yeasts
are required; swabs can be used for examination of specific sites for carriage.
Previous studies of diabetics in which a mouth wash technique was used reported
yeasts prevalence of 41% to 62% (Odds et al., 1978; Tapper-Jones et al., 1981; Fisher
et al., 1987; Lamey et al., 1988; Hill et al., 1989). In this study 66% of the diabetics
were carriers of yeasts by the oral rinse technique.
The second objective was to compare species of yeasts isolated from patients with
IDDM compared with those with NIDDM. C. glabrata and C. tropicalis were
isolated more frequently from patients with either IDDM or NIDDM who wore
dentures. There were significantly more carriers among individuals with IDDM
compared with NIDDM subjects. No other study has found this association (Odds et
al., 1978; Tapper-Jones et al., 1981; Lamey et al., 1988). This might be due to the
smaller sample size, differences in populations sampled and their distinction of
IDDM from NIDDM based solely on treatment of the diabetic condition. In this
study subjects were classified as IDDM or NIDDM according to family history of
diabetes, clinical history of onset, requirement for insulin and progression of the
disease.
By the API identification system, some studies have found 77% to 91% of their
isolates to be C. albicans (Fisher et al., 1987; Hill et al., 1989; Darwazeh et al.,
1990). In this study only 54% of the isolates were C. albicans (Table 2.2); this figure
includes the proportion that was not identified by API 20C Aux as C. albicans but
found to be so by conventional methods (see Chapter 3 for more detailed discussion
of methods for identification of yeasts). These results are similar to studies which
found 60% of isolates from diabetics to be C. albicans (Odds et al., 1978;
Tapper-Jones et al., 1981). This emphasises the need for accurate identification as
patients with diabetes are more likely to carry and to have disease due to species other
than C. albicans (Chapter 3) which might not be sensitive to routinely prescribed oral
antifungal agents (Dick etal., 1980).
The third objective was to assess the association between secretor status and
carriage of yeasts among individuals with IDDM separately from those with NIDDM.
In most diseases the influence of blood group or secretor status is marginal; sample
sizes need to be large enough to discern such relationships with confidence (Mourant
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et al., 1978). Because of the large number of patients in this study, those with IDDM
could be analysed separately from those with NIDDM taking other factors into
account by the use of multivariate discriminant analysis. By the univariate analysis,
other studies of patients with diabetes found a relationship between non-secretion of
blood group antigens and carriage of yeasts (Blackwell et al., 1989a; Darwazeh et al.,
1990). These studies did not take into account the denture status (Blackwell et al.,
1989a) or type of diabetes (Darwazeh et al., 1990) of its sample population. Another
study did not report an association between secretor status and carriage of yeasts or
development of disease (Lamey et al., 1988); however, in this study, the number of
subjects were much smaller, denture status and type of diabetes were not considered.
Among individuals with NIDDM, the results of the multivariate analysis show
that non-secretion of blood group antigens was a marginally significant factor
influencing carriage in the oral cavity as a whole. Palatal carriage of yeasts was not
dependent on secretor status. Quantitative carriage of yeasts (assessed by the oral
rinse technique) is associated with non-secretion; carriage per se does not depend on
secretor status.
The fourth objective of the study was to dissect the contribution of various other
factors to carriage of yeasts. The following factors were not associated with carriage
by either univariate or multivariate analyses: gender; duration of diabetes; diabetic
complications of neuropathy or nephropathy; alcohol consumption; contraceptive pill;
systemic corticosteroid treatment; topical corticosteroid application; antibiotic usage;
age, fit, occlusion or hygiene of denture; persistent albuminuria; or history of
superficial Candida infections. Those for which significant associations were found
are discussed below with reference to previous reports.
The prevalence of yeasts in the adult mouth has been shown to rise with age. The
effects of age are not always easily separated from disease and medical treatment
(Marples, 1960; Smits et al., 1966). Age was not related to isolation of yeasts from
diabetics (Tapper Jones et al., 1981; Lamey et al., 1988; Darwazeh et al., 1990). In a
Canadian study (Hill et al., 1989) diabetics over 50 years of age had a higher density
of yeasts compared with those less than 50 years old. Age was not isolated as a
significant factor in the multivariate analysis, and the authors' suggested that carriage
in the older age group might be due to the higher number of denture wearers. In this
study, increase in age was associated with a decrease in the frequency of carriage,
especially among non-denture wearers with IDDM (Tables 2.5 and 2.9). This was
unexpected; one explanation might be that decreased isolation of yeasts with
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increasing age reflects the efficiency of the mucosal immune defences against yeasts
with increased frequency of challenge. Studies on vaginal carriage of yeasts found an
inverse correlation between isolation of yeasts and levels of serum anti-Candida IgA
(Schonheyder et al., 1983). Secretory anti-Candida IgA has been reported to
correlate with levels of serum IgA (Warnock and Hilton, 1976). Analysis of
secretory and humoral immune responses of the study population to yeasts are needed
to obtain evidence for this hypothesis.
Poor glycaemic control (HbAj and plasma glucose levels) was a significant factor
associated with palatal carriage of yeasts among patients with IDDM who wore
dentures. Carriage assessed by the oral rinse was not associated with HbA1 levels;
similar results were reported in other studies (Fisher et al., 1987; Lamey et al., 1988).
The single study in which multivariate analysis was used found an association
between HbAx level and colonisation determined by palate or denture base swab;
however, this study did not differentiate individuals with IDDM from those with
NIDDM (Hill et al., 1989). Further evidence that diabetic control is associated with
carriage was the significant associations between carriage and plasma glucose levels
or persistent glycosuria among patients with NIDDM who did not wear dentures.
Studies on other diabetic populations reported similar results (Odds et al., 1979), but
the majority did not find this association (Tapper-Jones et al., 1981; Lamey et al.,
1989; Hill et al., 1989; Darwazeh et al., 1990).
Retinopathy was of marginal significance as a predictor of carriage among
denture wearers with IDDM. This complication results from microvascular changes
associated with diabetes which might also impair immune response through
inadequate diffusion of tissue mediators and indicates that systemic changes
associated with diabetes predispose to colonization.
Studies in non-diabetic populations reported a positive correlation between
smoking and carriage of bacteria (Blackwell et al., 1990; Blackwell et al., 1992) and
yeasts (Arendorf et al., 1983). Among diabetics, smoking was a significant factor
influencing carriage of yeasts; however, the type of diabetes and denture status were
not taken into account (Tapper-Jones et al., 1981). A significant association between
carriage and smoking was found in this study; however, this association disappeared
when results were analysed with respect to type of diabetes and denture status. This
implies that these two factors were dependent variables in the overall univariate
analysis.
59
In contrast to other studies which reported a higher prevalence and/or density of
yeasts among diabetics who wore dentures (Tapper-Jones et al., 1981; Lamey et al.,
1988, Fischer et al., 1987; Hill et al., 1989), we found no correlation with presence of
denture and frequency or quantity of yeasts isolated with either technique. Similar
results were reported by Darwazeh et al. (1990). There is no obvious explanation for
these discrepancies. Continuous denture wearing might influence analysis of denture
status results; however, we found this association only for palatal carriage among
patients with NIDDM (Tables 2.8 and 2.9). Other studies found continuous presence
of dentures is associated with increased frequency and density of yeasts
(Tapper-Jones et al., 1981; Darwazeh et al., 1990).
The contribution of factors such as antibiotics and corticosteroids to carriage of
yeasts is not easily differentiated from that of the underlying illness. Most of the
studies in which associations between carriage and these treatments were found were
carried out on hospitalized patients. The present study examined out-patients, the
majority of whom were not on either of these treatments; therefore, no inferences can





The genus Candida contains more than 150 species. The common feature is the
absence of any sexual form; but, they have a range of markedly different properties
and they are classified in the genus by default rather than by design. The medically
significant species represent only a minority subset of a large and widely disparate
group.
Taxonomy is not a static discipline. Sexual forms of Candida guillermondii,
Candida kefyr and Candida krusei have been described (Barnett et al., 1983; Meyer
et al., 1984). The species Candida paratropicalis described in 1981 has not been
accepted as distinct from Candida tropicalis by yeast taxonomists (Meyer et al.,
1984). In the cases of Candida clausenii and Candida stellatoidea, their synonymity
with C. albicans has been acknowledged for a long time (Hasenclever et al., 1961;
Leth Bak and Stenderup, 1969; Lyon and Domer, 1985).
The most sweeping taxonomic revision was the merging of the two genera
Candida and Torulopsis. Proponents of this fusion argue that separation on the basis
of a single morphological character (production of pseudohyphae) is insufficient to
warrant differentiation at the genus level. Against this are those who consider
pseudomycelium formation as a valid and workable intergeneric distinction.
Guanine:cytosine ratios of Candida species vary over a wide range which includes
the Torulopsis species range of G:C ratio (Table 3.1). Endonuclease treatments of
yeast DNA are at a preliminary stage but might provide more substantial evidence
(Ashman et al., 1990).
The principal unifying characteristics of the species presently classified in the
genus Candida have been summed up by Meyer et al. (1984). The genus comprises
yeasts with a variety of cell shapes, fermentation and assimilation reactions but
without carotenoid pigments, ascospores, teliospores, ballistospores or arthrospores.
Within the genus, species are separated primarily on the basis of their physiological
properties. Each species has a specific pattern of abilities and inabilities to assimilate
various organic compounds and to ferment particular carbohydrates. In some
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Table 3.1 Estimates ofmoles % guanine and cytosine (% G + C) in DNA
from medically important Candida species
Species No. isolates tested % G+ C
C. albicans 7 32.0 - 36.9
C. glabrata 6 35.5 - 40.2
C. guillermondii >1 41.0-45.6
C. kefyr >1 37.0-41.3
C. luscitaniae >5 44.7 - 45.2
C. parapsilosis >2 37.5-41.5
C. tropicalis 5 32.0- 36.1
C. viswanathii 1 46.3
Table reproduced with modifications from Odds (1988)
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instances, the patterns are very similar for two species and a close relationship can be
inferred.
Morphological and physiological characteristics are by no means the sole criteria
for the establishment of species. Serological tests, DNA base composition and DNA
restriction fragment length polymorphism have shown differences between most of
the pathogenic Candida species and confirms the traditional species separation
(Meyer and Phaff, 1970; Tsuchiya et al., 1974; Magee et al., 1987; Mason et al.,
1987).
Strain differentiation of C. albicans has been pursued for obvious reasons.
Methods examined include antigenic differences (serotype A and B) (Hasenclever et
al., 1961), cell dimension (Kockova-Kratochvilova et al., 1963), susceptibility to
lysis by virus (Mehta et al., 1982), resistance to certain chemicals (Odds and Abbott,
1980), differences in enzyme activities (McReight and Warnock, 1982) and DNA
restriction fragment length polymorphism (Scherer and Stevens, 1988). The latter
offers distinction of the strains based on their genetic make-up compared with
phenotypic differences the expression of which can be affected by the environment.
The most commonly encountered pathogenic Candida species usually grow well
in aerobic cultures on rich or poor nutrient media (pH range 2.5-7.5) between 20-38
°C (Van Uden and Buckley, 1970). The optimum growth temperature of the two
most virulent species, C. albicans and C. tropicalis, is closer to 37 °C
(Lemos-Carolino and Madeira-Lopes, 1984). They all assimilate and ferment glucose
as a carbon source; and, none use nitrate as a nitrogen source. They vary in their
abilities to utilize other carbon and nitrogen sources (Meyer et al., 1984). Candida
species grow best under elevated concentrations of C02 in air; anaerobic conditions
inhibit growth (Webster and Odds, 1987).
C. albicans is distinguished from other species by the following unique
properties: formation of true mycelium; clamydospore formation (Beheshti et al.,
1975); and, germ tube formation in serum (Taschdjian et al., 1960). All other
Candida species form pseudomycelium; the members of the former genus Torulopsis
do not form filaments. Very rare isolates of C. tropicalis are able to form
clamydospores (Hasenclever, 1971); and, true hyphae and germ tubes have been
reported to be formed by some C. tropicalis isolates (Martin and White, 1981; Joshi
et al., 1983). These "germ tubes" can be differentiated from C. albicans germ tubes
by the presence of a septum or a marked constriction dividing the cell from the
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filamentous portion (Hedden and Buck, 1980).
Clinically, identification of the causative yeast is not important. Isolation and
demonstration of sensitivity to antifungal agents is sufficient for the care of a patient
with fungal infection. Identification of yeasts results in accurate epidemiological
accounts which are of local/international interest for recognition of novel yeast
pathogens and shifts in sensitivity to antifungal agents.
Although detailed recommendations for the identification of Candida species
from human sources vary, the general principles are the same. The yeast is isolated in
a suitable primary culture, examined for pigmentation and the presence of
Cryptococcus neoformans. The sample is then subjected to a set of tests for
properties specific for C. albicans. If the isolate is not clearly identified as C.
albicans on this basis, it is subjected to detailed tests for speciation (Milne, 1989).
As the API 20C Auxanogram kit (API System S.A., France) has been used in
several studies which have found higher proportions of C. albicans (77 - 91%) than in
the present survey, the aim of this part of the study was to assess the accuracy of the
kit in identification of C. albicans compared with conventional methods.
3.2 Materials and Methods
Details of the preparation of malt broths, cornmeal agar and Christensen's agar
slopes are provided in the Appendix. These were obtained, ready for use, by the
Media Preparation Laboratory, Department of Medical Microbiology, University of
Edinburgh. The population examined and collection of samples has been described in
Chapter 2; relevant information is repeated here. Five sites were swabbed: palate,
floor of the mouth, tongue, right and left angles of the mouth. The swabs were placed
immediately in malt broth and transported to the laboratory. Additionally, each
subject rinsed his/her mouth with 10 ml of sterile PBS for 1 min and the contents
were recovered. All samples were collected between 0900 and 1200 and processed
within 1 hour.
The swabs in the malt broths were incubated at 37 °C for 24-36 hr before plating
onto malt agar plates. The oral rinse was concentrated by centrifugation and
resuspended in 1 ml of PBS; 20 ul of the suspension were plated onto a malt agar
plate. The plates were incubated at 37 °C for 24-36 hr. Colonies were examined for
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Plate 3.1: Production of filaments by C. albicans grown in commeal agar.
Magnification ca. 400. Arrow indicates a chlamydospore structure.
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Table 3.2 Percent identification of species by the API 20C Auxanogram
Species 99.9-99.0% 98.9-96.6% 96.5-85.0% < 85.0% Total
C. albicans 506 22 18 0 546
C. glabrata 88 5 0 9 102
C. parapsilosis 12 0 20 0 32
C. cereviciae 21 8 3 0 32
C. tropicalis* 10 4 0 8 22
T. beigelii 2 0 8 6 16
C. /u.vitaniae 1 5 0 2 8
C. guillermondii 4 0 4 0 8
C. pseudotropicalis 6 0 0 0 6
C. humicola 3 0 0 0 3
Rhodotorula spp. 0 0 1 2 3
C. lambica 0 0 2 0 2
C. laurentii 0 1 1 0 2
C. famata 1 0 0 0 1
Total 783
^includes one species classified as C. pavfropicalis at 99.9%
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Table 3.3 Isolates not identified to species level by the API 20C Aux.




Genus Candida 18 6000104
Low discrimination 13 6000004
*Other profiles differed in number occurring in parenthesis
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Table 3.4 Germ tube positive isolates identified as other than C. albicans by the
API 20C Auxanogram
Isolate no Most frequent
API profile**
Differing sugar assimilation
Doubtful* 62 2(7)7617(5) Ara (+)/ Mlz(+)
Unacceptable* 21 217213 Xyl(-)
C. tropicalis* 19 25(5)6175 Mlz(+)
C. parapsilosis 10 6776175 Ara(+)/Mlz(+)
Genus Candida 8 6576175 Mlz(+)
C. lusiimiae 3 (6)472175 2Kg(-)/Mdg(-)/Mlz(+)
C. cerevuciae 2 2042007 2Kg(-)/Xyl(-)/Ado(-)/Mdg(-)/
Nag(-)/Tre(-)/Mlz(+)/Raf(+)
C. guillermondii 2 6776(3)77 Ara(+)/Mlz(+)/Raf(+)
C. humicola 1 6757776 Ara(+)/Ino(+)/Cel(+)/Lac(+)/
Raf(-)
T. beigelii 1 2556(7)77 Mlz(+)/Raf(-)
Total 129
*At least one isolate with the stated profile was sent to the Mycology Laboratory,
Western General Hospital, Edinburgh. Isolates were confirmed as C. albicans.
**Other profiles differed in number occurring in parenthesis.
C. albicans are negative for Raf, Lac, Cel, Ino; positive Glu, 2Kg, Gal, Mai
Glu= glucose, Gly= glycerol, 2Kg= 2-Keto-D-Gluconate, Ara= L-arabinose,
Xyl= D-xylitol, Gal= galactose, Ino= inositol, Sor= sorbitol, Lac= lactose,
Mdg= -methyl-D-glucoside Nag= N-acetyl-D-glucosamine, Cel= cellobiose,
Mal= maltose, Sac= sucrose, Tre= trehalose, Mlz= melezitose, Raf= raffinose
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morphology and pigmentation. Pure cultures were obtained by subculturing a single
colony.
Cultures that appeared to be yeasts by Gram's stain were tested for germ tube
production in horse serum after incubation for 2 hr at 37 °C. Care was taken to
inoculate the horse serum lightly with the yeast.
Production of filaments by yeasts was tested using the Dalmau culture plate
(Milne, 1989). Briefly, cornmeal agar plates were inoculated with yeasts and deep
dilution strokes made by drawing the loop away from the well. A coverslip sterilized
by flaming after dipping it in alcohol was placed on the plate so that it covered part of
the tract and the well. The plates were incubated at 22 °C for 48 hr before
examination. Plate 3.1 illustrates an isolate which produced filaments.
Urease production was determined only when sugar assimilation results and no
filament production suggested that Torulopsis species might be present. A colony
was inoculated into Christensen's agar slope and incubated at 30 °C for 24-48 hours;
a colour change to red of the medium indicated urease production.
All API sugar assimilation strips were used as instructed by the manufacturer
(API System S.A, France). The density of the inoculum was adjusted to 0.5
absorption units at 550 nm by a spectrophotometer (corresponds to approximately 2 x
10 7 yeasts/ml) and cornmeal agar plates were used instead of ricemeal agar plates.
The cupules were inoculated with the yeast in the API suspension medium, incubated
at 30 °C in 5% C02 air mixture and read after 48 hours. A few strips were read
between 48 and 72 hours and none required reading after 72 hours. The APILAB
computer soft ware was used for identification of the isolate.
3.3 Results
Species identified correctly by the API 20C Aux system are shown in Table 3.2.
C. albicans comprised 48.2%(546/1050) of all the isolates tested. The percent
identification is a mathematical computation based on the results of each sugar
assimilation test and indicates the probability of identity of the species. In order to
display the results obtained in this study more clearly, the percent identification
categories used in Table 3.2 are different from those used by the manufacturer. The
manufacturer's categories are Excellent (99.9%), Very good (99.8-99.9%), Good
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(98.9-88.9%) and Acceptable (88.8-85.1%). C. albicans was identified with >99.0%
accuracy in most cases. C. tropicalis and T. beigelii were most often identified at
<85% level; the manufacturer's level of "Unacceptable".
The categories of "Genus Candida" and "low discrimination" contained 18 and 13
isolates respectively. A further 69 isolates had a "doubtful" profile and 38 profiles
were "unacceptable". The most frequent API profile in each of these categories is
shown in Table 3.3.
A minority (129/1050, 12.3%) of germtube positive species were not identified as
C. albicans by the kit. These included species that had been identified by the kit as
C. tropicalis, C. parapsilosis, S. cereviciae, C. guillermondi, C. luscitanea and as
doubtful/unacceptable profiles. The frequently encountered profile of these germ
tube positive species is summarized in Table 3.4 with the variation in the sugar
assimilation tests of the misidentified species. Torulopsis and Rhodotorula species
were all correctly identified by the kit.
3.4 Discussion and Conclusions
C. albicans was frequently misidentified by the API 20C kit as C. tropicalis and
C. parapsilosis confirming the similarities of these species. A large fraction of the
isolates (107/1050, 10.2%) could not be identified to an acceptable level by the kit.
Some could only be classed as "Genus Candida" or "low discrimination".
The majority of C. albicans isolates misidentified could assimilate melozoite;
and, some strains could metabolise arabinose (Table 3.4). The API database from
which the probable identification of species is computed is made up of clinical as
well as reference isolates of yeasts. Only a small fraction of C. albicans included
within the API database are able to utilize melozoite (4%) or arabinose (2%)
(personal communication, API Laboratories, Basingstoke, U.K). The results indicate
that for epidemiological studies as well as for clinical purposes, the germ tube test
should be carried out for all yeast isolates. The manufacturer of the API 20C Aux.
kit indicates the germtube test as an optional test. Conventional methods should be
used to identify yeast species that are classed as "low discrimination" or
"unacceptable" by the API computerbase. Milne (1989) has summarized the basic
identification tests for yeasts to species level.
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In conclusion, the lower proportion of C. albicans in this study compared with
other studies among diabetic individuals is a characteristic of the population sampled.
It was found that the kit under-represented C. albicans isolates; therefore, the
prevalence figures of C. albicans quoted by studies which use the kit are probably




Chronic Atrophic Oral Candidiasis
4.1 Introduction
Chronic atrophic oral candidiasis (denture stomatitis) is solely associated with
wearing dentures. The studies of Cawson (1963) and Budtz-Jorgensen (1974)
established the link between Candida and denture stomatitis. Subsequently,
numerous studies have examined the prevalence of and factors predisposing to
denture stomatitis. Presence and continuous wearing of dentures at night, dietary
sucrose in the oral environment, traumatic effects of the denture, antibiotics and
corticosteroid treatment, diabetes mellitus and smoking have all been implicated as
potential factors contributing to development of denture stomatitis (see Section 1.3).
The genetic inability to secrete ABH blood group antigens in body fluids has been
associated with a variety of infectious diseases (Blackwell, 1989). Non-diabetic
individuals and pregnant women who are non-secretors are over-represented among
patients with superficial Candida infections (Thom et al., 1989). Non-secretors are
also over-represented among carriers of C. albicans in normal subjects
(Burford-Mason et al., 1988) and patients with non-insulin dependent diabetes
mellitus (Blackwell et al., 1989a).
The aims of the study were:
1. to examine the prevalence of denture stomatitis and other oral conditions
(angular cheilitis, fissured tongue, geographic tongue, median rhomboid glossitis, dry
mouth and leukoplakia) among individuals with diabetes.
2. to examine the species of yeasts isolated from diabetic patients with denture
stomatitis.
3. to assess the influence of secretor status on the development of denture
stomatitis among patients with insulin-dependent diabetes (IDDM) and those with
non-insulin dependent diabetes (NIDDM).
4. to assess the contributions of the following variables to the development of
denture stomatitis: age; gender; duration of diabetic state; type of diabetes; control of
72
diabetes measured by glycosylated haemoglobin (HbA^; diabetic complications -
retinopathy, neuropathy and nephropathy; antibiotic usage; corticosteroid treatment;
smoking; alcohol consumption; presence of dentures at night; type of denture; denture
fit, extension, occlusion, age and hygiene; presence of persistent glycosuria and
albuminuria; and history of superficial candidal infections.
4.2 Materials and Methods
The study population, epidemiological data obtained, isolation and
characterization of yeasts have been described (Chapters 2 and 3). Similar statistical
analyses were applied.
4.3 Results
Oral conditions among patients with dentures are compared with those without
dentures in Table 4.1. Of the 216 denture wearers, 76 (35%) had denture stomatitis
(Table 4.2). In 18% (14/76) the rinsing technique failed to isolate any yeasts. Similar
results were obtained with the swab taken from the palate. The concordance between
the results obtained by these methods was 78%. By MacNemar's test for paired
alternatives, there was no significant difference between the discordant pairs obtained
by the two sampling methods (p > 0.1). The species most frequently isolated from
the palate of patients with denture stomatitis were C. albicans (33/76, 43%), followed
by C. glabrata (6/76, 8%) and C. tropicalis (3/76, 4%). In 9%, the isolate could not
be identified to a species level. Other species were isolated in 15% (11/76) of denture
stomatitis cases (Table 4.3).
4.3.1 Univariate analysis
4.3.1.1 Blood group and secretor status
Denture stomatitis was more prevalent among individuals who are non-secretors
than among secretors. This trend was not significant at p < 0.05. Analysis with
respect to blood group and secretor status revealed that among individuals with blood
group O with denture stomatitis, non-secretors (13/27, 48%) appeared to be more
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Table 4.1 Prevalence of oral conditions among diabetic individuals
Prevalence among Prevalence among
Condition non-denture wearers denture wearers
(n = 223) (n = 216)
Angular cheilitis 17 (8%) 25 (12%)
Denture stomatitis 0 (0%) 76 (35%)
Fissured tongue 10 (5%) 15 (7%)
Dry mouth 2 (1%) 13 (6%)
Geographic tongue 4 (2%) 7 (3%)
Median rhomboid glossitis 3 (1%) 7 (3%)
Hairy tongue 3 (1%) 5 (2%)
Glossitis 2 (1%) 5 (2%)
Leukoplakia 0 (0%) 2 (1%)
None 182 (82%) 61 (28%)









IDDM 32 (41) 47 (59) 79 (100)
NIDDM 43 (32) 91 (68) 134 (100)
75 138 213
Missing = 3
X2 = 1.20; p = 0.27
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Table 4.3 Mycological profile of diabetic individuals (Palate swab)
Isolate
all denture wearers with denture stomatitis
no. (%) no. (%)
C. albicans 67 (31) 33 (43)
T. glabrata 13 (6) 6 (8)
T. beigelli 5 (2) 3 (4)
C. tropicalis 4 (2) 3 (4)
C. paratropicalis 3 0) 2 (3)
S. cerevisiae 2 (1) 0 (0)
C. stellatoidea 1 (*/2) 1 (1)
T. incospicua 2 0) 1 0)
C. humicola 1 (V2) 0 (V2)
C. pseudotropicalis 1 (V2) 1 (1)
Unidentified 24 (11) 7 (9)
Missing 5 (2) 2 (3)
Other 4 (2) 3 (4)
No isolate 83 (38) 14 (18)
Total 216 (100%) 76 (100%)
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Secretor 45 (31) 100 (69)
2.56 0.11
Non-secretor 24 (44) 30 (56)
IDDM
Secretor 18 (40) 27 (60)
0.03 0.87
Non-secretor 13 (45) 16 (55)
NIDDM
Secretor 27 (27) 72 (73)
1.90 0.17
Non-secretor 11 (44) 14 (56)
p value refers to comparison of denture stomatitis between secretors and non-secretors
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Total* Yes 45 (52) 42 (48)
23.2 <0.01
No 7 (12) 53 (88)
IDDM Yes 18 (49) 19 (51)
3.50 0.06
No 3 (18) 14 (82)
NIDDM Yes 27 (54) 23 (46)
18.82 <0.01
No 4 (9) 39 (91)
* Of a total of 216 denture wearers, 43 were recruited during the pilot study
and were not questioned about their denture wearing habits. For 26
individuals this information was not recorded during the main study period.
Table 4.6 Multivariate analysis (Wilk's method)
Sample % cases correctly
predicted
Variables isolated
IDDM 63 glycosuria (p < 0.05)
(n = 52)
NIDDM 82 Denture in at night (p<0.01)
(n = 88) No. of yeast colonies (p<0.01)
non-secretion (p<0.01)
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prone to denture stomatitis than secretors (19/68, 28%); %2 = 2.69, df = 1, p = 0.10. A
similar trend was evident among individuals of blood group A; 45% (10/22) A
non-secretors had denture stomatitis compared with 29% (15/50) A secretors (%2 =
1.1, df = 1, p = 0.3). Secretor status of individuals of blood groups B and AB were
not compared because the numbers were too small for statistical analyses.
4.3.1.2 Continuous wearing of denture
Significantly more individuals who did not remove their dentures at night (45)
had denture stomatitis compared with those who removed their dentures at night (7)
(p < 0.01). This was found particularly among individuals with NIDDM (Table 4.5).
4.3.1.3 Density of colonization
Subjects who did not have denture stomatitis had significantly fewer colony
forming units (median = 10 cfu/ml) than subjects with denture stomatitis (median =
1850 cfu/ml, p < 0.01). This was seen particularly for patients with NIDDM (median
= 1500 cfu/ml with denture stomatitis and 25 cfu/ml without denture stomatitis, p <
0.01). Those with IDDM did not show this relationship (median = 2400 cfu/ml with
denture stomatitis, 502.5 cfu/ml without denture stomatitis, p = 0.07). Among
subjects without denture stomatitis there was a non-significant trend of increased
density of colonization of individuals with IDDM compared with those with NIDDM
(p = 0.07).
4.3.1.4 Random plasma glucose
Lower values for random plasma glucose were observed among the 132 patients
without denture stomatitis (median = 9.55 mmol/1) compared with those observed for
the 72 patients with denture stomatitis (median = 10.95 mmol/1, Mann-Whitney p =
0.02). This was seen particularly among individuals with NIDDM (median = 10.75
mmol/1 with denture stomatitis and 9.5 mmol/1 without denture stomatitis, p =
0.04). Individuals with IDDM did not show this relationship (median 11.25 mmol/1
with denture stomatitis and 10.15 mmol/1 without denture stomatitis, p = 0.24).
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4.3.1.5 Previous candidal infections
Among 33 individuals with a history of superficial candidiasis 18 (55%) had
denture stomatitis compared with 58 (32%) of the 182 subjects with a negative
history of candidiasis (x2 = 5.33, df = 1, p = 0.02). Separate analysis with respect to
insulin dependency revealed a trend for individuals with NIDDM with a history of
candidiasis to be more prone to denture stomatitis: for IDDM individuals %2 = 1-2, df
= 1, p = 0.30; for individuals with NIDDM, %2 = 3.26, df = 1, p = 0.07.
4.3.1.6 Variables not associated with denture stomatitis
No significant association was found between denture stomatitis and the
following variables: gender; age; type of diabetes; control of diabetes (HbAj);
duration of diabetic state; ABO blood group; smoking; alcohol consumption;
persistent glycosuria or albuminuria; denture fit, hygiene, occlusion, age, or type
(partial or full); presence of diabetic complications (neuropathy, nephropathy,
retinopathy); contraceptive pill; antibiotics; or corticosteroids (systemic or topical).
4.3.2 Multivariate analysis
In order to determine the relative contributions of variables to the development of
denture stomatitis, a stepwise discriminant analysis (SPSSX) was used. Initially, all
variables were screened at an F-value of 4 (p < 0.05). Analysis was then confined to
the variables isolated as significant to increase the number of cases examined. Table
4.6 summarizes the contributory variables and the significance of their contribution in
predicting infection. For patients with IDDM, the only variable identified by the
analysis was persistent glycosuria (p < 0.05). For patients with NIDDM three factors
were identified: presence of denture in the mouth at night (p < 0.01), number of
yeasts isolated (p < 0.01) and non-secretion (p < 0.01).
4.4 Discussion
The results are discussed in the context of the objectives stated at the end of
section 4.1. The first objective was to determine the prevalence of oral conditions
among patients with diabetes. All forms of the oral conditions listed in Table 4.1 are
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more prevalent among the patients with dentures than those without dentures.
Fissured tongue was encountered in 6% of the diabetic individuals. This figure is
similar to that reported for 2478 dental patients (Halperin et al., 1953). The
prevalence of geographic tongue and median rhomboid glossitis was slightly higher
among diabetics than among dental and dermatology patients (McCarthy, 1941). The
prevalence of all the above conditions were much lower than those reported for
diabetic individuals by Farman (1976) who examined Coloured South Africans.
These differences might be due to genetic and/or environmental factors between the
predominantly North European population sampled here and that sampled by Farman.
Dry mouth was a spontaneous complaint in only 3% of the subjects compared to 34%
reported by Sharon et al. (1985). The univariate analysis showed that prevalence of
denture stomatitis was similar among patients with IDDM or NIDDM. The
prevalence of denture stomatitis reported (35.2%) here is within the range (24-60%)
reported for non-diabetic individuals (Odds, 1988).
The second objective was to examine the species of yeasts isolated from diabetic
patients with denture stomatitis. C. albicans was isolated from only 43% of the
patients with denture stomatitis. Isolation of C. glabrata (8%), and other yeasts (28%)
from patients with denture stomatitis indicate that, among diabetic individuals,
species other than C. albicans are important causes of disease. The sensitivity of the
oral rinse technique was comparable to that of the palate swab.
The third objective was to assess the contribution of secretor status to
development of denture stomatitis. By univariate analysis, secretor status was not
significantly associated with denture stomatitis among individuals with either
NIDDM or IDDM. Multivariate analysis, however, revealed that non-secretors with
NIDDM were more prone to development of denture stomatitis after adjusting for
denture wearing habits and density of yeast colonization. This suggests that the
univariate relationship might have been obscured by the other two contributory
factors.
It has been suggested that patients with IDDM are more immunocompromised
than those with NIDDM so that any protective effect of secretion of blood group
antigens does not make a significant contribution to prevention of disease (Blackwell
et al., 1989a). A previous study did not find an association between secretor status
and denture stomatitis among diabetic individuals (Lamey et al., 1988); however, the
number of patients examined was much smaller, there was no differentiation between
IDDM and NIDDM, and multivariate analysis was not applied to the data.
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The fourth objective of the study was to assess the contributions of other factors
to development of denture stomatitis. The results are discussed in context of other
published studies.
The following factors were not associated with denture stomatitis by either
univariate or multivariate analyses: age; gender; duration of diabetic state; type of
diabetes; control of diabetes (HbAj); ABO blood group; smoking; alcohol
consumption; persistent albuminuria; denture fit, hygiene, occlusion, age or type
(partial or full); presence of diabetic complications (retinopathy, neuropathy,
nephropathy); contraceptive pill; antibiotic usage; or treatment with corticosteroids.
In non-diabetic populations some studies found a significant association between
denture stomatitis and the female gender (Davenport, 1970; Cawson, 1966), but one
study did not (Budtz-Jorgensen et al., 1975). Of the two studies which found an
association between gender and denture stomatitis, one was a retrospective study;
and, neither gave details of the proportion of the sexes in their sample population.
Corticosteroid inhalants have been reported in some studies to precipitate oral
thrush, but other investigators have found no effect. Vogt (1979) concluded from an
extensive literature review that use of inhalers was associated with 4-13% of oral
candidal infections. In this study, all four patients on corticosteroid inhalers had no
evidence of denture stomatitis. In the case of systemic corticosteroid treatment,
10/11(91%) of the recipients did not have denture stomatitis. There have been no
reports on the effect of corticosteroids on denture stomatitis in man; but, it seems
likely that the absence of denture stomatitis is due to the anti-inflammatory effects of
corticosteroids.
The effect of antibiotics in precipitating superficial candidiasis is thought to be
minimal (Walker et al., 1979). In this study, antibiotics did not influence the
development of denture stomatitis; however, the number of individuals on antibiotics
was too few to draw firm conclusions.
Control of diabetes as measured by glycosylated haemoglobin (HbA^ was not
associated with denture stomatitis. Although this was unexpected, it is well
established that blood glucose levels and salivary glucose levels among diabetic
individuals do not correlate linearly (Sharon et al., 1985).
Discriminant analysis indicated that factors contributing to development of
denture stomatitis among patients with NIDDM are clearly different from those with
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IDDM. Patients with NIDDM who do not remove their denture at night harbour a
large number of yeasts; and, non-secretors of blood group antigens are particularly at
risk of developing denture stomatitis. In contrast, none of these factors influence the
development of denture stomatitis among individuals with IDDM. This is further
supported by the results of the univariate analysis in which the p value for these
factors among individuals with IDDM are consistently higher than the p value among
NIDDM individuals.
Persistent glycosuria was the only predictor of denture stomatitis among patients
with IDDM. The presence of 11.10 mmol/1 or more of glucose in the arterial blood
results in the appearance of glucose in the urine. It was unexpected that neither HbAj
nor random plasma glucose were implicated as both are more precise indicators of
glucose availability than glycosuria.
Identification of factors contributing to the development of denture stomatitis
among individuals with IDDM and NIDDM might have implications for treatment of
this condition. Treatment of denture stomatitis among patients with NIDDM might
be similar to that in non-diabetic individuals i.e. removal of the denture especially at
night (Turrell, 1966). Among patients with IDDM, treatment of denture stomatitis




Adhesion of Candida albicans to buccal epithelial
cells of secretors and non-secretors
5.1 Introduction
Colonization of the host is a pre-requisite for invasion by microorganisms. In the
oral cavity, adhesion is an important factor contributing to colonization by
microorganisms (Gibbons and Van Houte, 1975). The role of adhesion in
pathogenesis of Candida was summarized in Section 1.4.1.1. Studies by different
researchers on adhesion of Candida have reported conflicting results. Factors that
influence in vitro studies of attachment of Candida to epithelial cells (which include
the nature of the yeasts, the epithelial cells, the assay environment); methods of
measuring attachment and mechanisms of adhesion will be outlined briefly.
5.1.1 Factors associated with yeasts
5.1.1.1 Concentration and viability
Both viable and non-viable yeasts adhere to epithelial cells. The ability of
non-viable C. albicans to adhere was dependent on the severity of treatments used to
kill the yeasts. Less rigorously treated yeasts retained their adherent capacities even
though they were killed by these procedures; higher formalin concentrations or
prolonged exposure to heat or ultraviolet light rendered C. albicans non-adherent
(Lee and King, 1983). These results suggest that protein cell surface components
might be involved in adherence. As yeast concentration increases so do the numbers
that adhere to epithelial cells (King et al., 1980), suggesting a "dose-dependent"
pattern of binding with saturation of binding sites.
5.1.1.2 Phase and temperature of growth
The hyphal phase adheres better than blastospores by 2 to 50 fold (reviewed by
Rotrosen et al., 1986). Heat-killed germinated yeasts demonstrated no better
adherence than heat-killed ungerminated yeasts and lower adherence than viable,
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ungerminated yeasts. Factors which might contribute to the enhanced adhesion of
hyphae include: qualitative changes in adhesin; expression of germtube-specific
adhesins; and, increased surface area (Sobel et al., 1981). The yeast phase represents
the initial colonizing form and has been used often for in vitro experiments
(Taschdjian and Kozinn, 1957). Compared with yeasts in the logarithmic phase of
growth, adherence of organisms harvested in the stationary phase has been reported to
be higher in one study and lower in another (King et al., 1980; Segal et al., 1982).
Blastospores grown at 25-28 °C adhered to exfoliated vaginal epithelial cells (VEC)
to a greater extent than did organisms grown at 37 °C (Lee and King, 1983; Segal et
al., 1982).
5.1.1.3 Growth medium composition
The adherence of some strains of C. albicans to buccal epithelial cells (BEC),
VEC and acrylic is substantially increased after growth in defined media containing
high concentrations of certain sugars (galactose, maltose or sucrose) as the sole
carbon source (Douglas et al., 1981; McCourtie and Douglas, 1984). Enhanced
adherence appears to result from the production of an additional fibrillar-flocullar
layer on yeast cell surfaces (McCourtie and Douglas, 1981). The induced changes in
surface composition might be important in vivo, particularly in the mouth where high
concentrations of sucrose and other dietary sugars are commonly found. Growth
medium was the single most important factor influencing results of adhesion
experiments (Kennedy and Sandin, 1988).
5.1.1.4 Species and strain
There is ample evidence for a hierarchy of relative virulence among the
pathogenic Candida species (Odds, 1988). C. albicans is unquestionably the most
virulent species, followed by C. tropicalis and C. stellatoidea. These differences
were clearly reflected in the ability of the organisms to adhere to VEC and BEC
(King et al., 1980), vascular endothelium (Klotz et al., 1983) and fibrin-platelet
matrices (Maish and Calderone, 1980) in vitro. Differences in adhesion between
strains of the same species are less obvious. Compared with isolates from active
infections (I strains), isolates from asymptomatic carriers (C strains) were less
virulent for mice (Segal et al., 1984). Virulence for mice, adhesion and ability to
synthesise the outer fibrillar-flocullar layer in response to high concentrations of
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sugar were related to each other and were higher in I strains than C strains
(McCourtie and Douglas, 1984). Adherence of isolates from oral thrush patients and
those from healthy individuals were reported to be similar (Kearns et al., 1983).
5.1.2 Factors associated with epithelial cells
5.1.2.1 Variability of surface components
Most studies of adhesion of Candida to mucosal epithelium rely on exfoliated
cells. The resulting cell population is not uniform with respect to a number of
properties: viability; contamination by commensal bacteria, yeasts, food debris; and,
adsorbed immunoglobulins and secretory components (reviewed by Rotrosen et al.,
1986). Other factors such as age (Segal et al., 1984) and phase of menstrual cycle
(Botta, 1981) affect the adhesiveness of cells. Most researchers have used healthy
comparable donors and extensive washing of cells in an attempt to minimize some of
these factors. Despite such precautions, significant donor-to-donor variability, as
well as day-to-day variability in studies restricted to a single donor, have been
demonstrated (King et al., 1980; Sobel and Obedeanu, 1983). The use of cell lines
such as HeLa provide a homogeneous population free of contamination; however,
cell surface characteristics might be altered and differ from those expressed by
epithelial cells in vivo.
Adherence of yeasts to VEC has been reported to be greater than BEC (King et
al., 1980), less than BEC (Sobel et al., 1981) or equal to BEC (Botta, 1981).
C. albicans adhered to VEC of pregnant and diabetic women in greater numbers than
to those from non-pregnant or non-diabetic women (Segal et al., 1984). C. albicans
adhered more to BEC from individuals with diabetes compared with non-diabetic
controls (Darwazeh et al., 1990). In neonates, receptivity of BEC to C. albicans is
less at the time of birth than it is just a few days later (Cox, 1986); and, epithelial
cells from infants who are colonized by C. albicans bind more yeasts than those from
non-carriers (Cox, 1983).
5.1.3 The assay environment
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5.1.3.1 Temperature, time and concentration of hydrogen ions
Optimum pH and temperature for in vitro adhesion are approximately 37 °C
(King et al., 1980) and pH 6-8 (Kimura and Pearsall, 1978; Cox, 1986). Although a
60 min incubation period was determined to be optimal for adhesion, results after 30
minutes incubation were not significantly different from those at 60 minutes (King et
al., 1980).
5.1.3.2 Bacteria
Influence of resident bacteria on colonization by Candida has been reported for
many years. Streptococcus salivarius and Streptococcus minor, but not
Streptococcus mutans, reduced attachment of Candida to HeLa cell monolayer
(Samaranayake and MacFarlane, 1982). Preattachment of lactobacilli diminished
adhesion of Candida to VEC (Sobel et al., 1981). Adherence of Candida to
uroepithelial cells was enhanced if the cells were incubated with mannose-sensitive
piliated Gram-negative rods (Centeno et al., 1983); microscopic studies confirmed
that the enhancement was a result of adhesion of Candida to the preattached bacteria.
Strains of Streptococcus viridans coaggregate with C. albicans in vitro and might aid
adherence indirectly to the oral epithelium; however, S. mutans and S. salivarius did
not co-aggregate with C. albicans (Jenkinson et al., 1990).
5.1.3.3 Antibodies
Antibodies to Candida might inhibit adhesion to BEC. There was an inverse
relationship between titres of salivary IgA and adhesion of Candida-, however,
adhesion increased in 4 out of 13 experiments following partial removal of
anti-Candida antibodies and in 4 of 20 experiments following removal of all antibody
classes by immunoprecipitation (Epstein et al., 1982).
5.1.4 Methods for measuring attachment
The principal methods of quantifying adhesion in vitro are light microscopy and
radiometric assays. Light microscopy assay with yeasts was first developed by
Kimura and Pearsall (1978). The basic method consists of mixing epithelial cells
with yeasts and incubating for an appropriate period. Excess yeasts are removed by
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centrifugation and the final mixture filtered through a membrane filter with a pore
size of 8-12 um which theoretically retains epithelial cells and allows free yeasts to
pass through. The filters are dried, stained and observed under a light microscope.
The mean number of yeasts adherent to 100 epithelial cells and/or the mean
percentage of epithelial cells binding yeasts is calculated. The radiometric assay
utilizes yeasts labelled with radioiodine (King and Lee, 1980) or grown in nutrient
tagged with C14 (Reinhart et al., 1985). Scintillation counts of adherent yeasts are
performed by immersing the filters in scintillation solution.
One of the technical problems in attachment studies is the tendency of yeasts to
aggregate either alone or attached to epithelial cells making counting difficult or
impossible. The light microscopy attachment assay is laborious, prone to subjective
errors in counting and samples few epithelial cells. The radiometric assay is less
laborious, less prone to subjective errors and rapid; the associated risks of handling
radioactive materials is the main disadvantage of this technique. Both assays suffer
from a common technical problem. Separation of host cells from non-adherent yeasts
by filtration might generate a high reading of yeasts attachment to epithelial cells due
to occlusion of the filter pores by epithelial cells. Particle trapping by filters might
involve factors more complex than relative particle and pore size. In one study,
10-15% of an inoculum of Candida was retained presumably via electrostatic or
hydrophobic forces by filters of the pore size routinely used in adherence studies
(reviewed by Rotrosen et al., 1986).
An automated image analysis for attachment of yeasts to hard, transparent
surfaces was developed by Shakespeare and Verran (1988). The attachment was
quantified by scanning for the presence of yeasts and calculation of the mean number
of cells per unit area. This method is, however, not suitable for attachment studies
using epithelial cells.
5.1.5 Mechanisms of adherence, adhesins and receptors
Adherence is defined here as a specific and essentially irreversible attachment of
a microorganism to a host surface. Non-specific attachment involving van derWaal's
forces, charge attraction, hydrophobic and surface tension might aid adherence
through promoting the proximity of receptors and adhesins. The indiscriminate
ability of Candida to attach to multiple surfaces has been suggested to indicate that
no specific receptor molecules are necessary; adherence of yeasts to glass beads and
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VEC was similar (Reinhart et al., 1985). The interaction of yeasts with BEC is
unlikely to be due to charge attraction since attachment was not substantially affected
by pH value, high salt concentration or divalent cations (Lee and King, 1983).
Hydrophobic forces influenced the attachment of Candida to dental resin materials;
however, hydrophobicity did not correlate with adhesion implicating the influence of
other mechanisms on adhesion (Minagi et al., 1985). It has been suggested that
hydrophobic forces might act indirectly to influence attachment to epithelial cells by
promoting coaggregation of yeasts (Kennedy and Sandin, 1988).
Adherence of an organism to the host tissue commonly involves ligand-receptor
interactions of the following three types (Ofek and Perry, 1985).
1. The ligand on the organism is a protein that specifically interacts with a
carbohydrate receptor on the host cell, e.g. P fimbriaeof Escherichia coli binding to
Gall-4Gal receptor on uroepithelial cells (Svanborg-Eden et al., 1977).
2. The receptor on the host cell is a protein and specifically interacts with a
carbohydrate on the microorganism. There is no conclusive evidence which indicates
that proteins or peptides in the epithelial cell membrane are involved in the specific
recognition of bacteria. It is, however, well accepted that carbohydrate structures on
microorganisms bind to lectin receptors on macrophages (Freimer et al., 1978).
3. Both the ligand and receptor are of the same nature i.e. polysaccharide or
protein and bind via an intermediate substance such as Ca^ ions. The human
complement-binding protein receptor which binds to C3d fragment is an example of
such interaction (Ross et al., 1985).
Numerous studies have been carried out to attempt to identify the adhesins of
C. albicans which bind to host cells. Results of various investigators differ; but, there
is compelling evidence that Candida mannoproteins can act as adhesins (reviewed by
Rotrosen et al., 1986). Pretreatment of C. albicans with a mannose-specific lectin,
Concanavalin A, resulted in inhibition of attachment which could be restored by
preincubation of the lectin with a specific haptenic sugar (D-methyl
mannopyranoside) prior to the assay (Sandin et al., 1982). Yeast adhesion was
inhibited by preincubation of BEC with a crude mannoprotein preparation, indicating
that the supernate contained the adhesin(s). The protein portion of this mannoprotein
was more important than the carbohydrate moiety in mediating attachment to BEC
(McCourtie and Douglas, 1985). Tunicamycin, an antibiotic which specifically
inhibits the synthesis of mannoprotein in S. cerevisiae, resulted in a decreased
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adhesion of C. albicans to BEC by over 60% compared to untreated organisms. It
also inhibited the formation of the outer fibrillar flocullar layer (Douglas and
McCourtie, 1983).
Mannoproteins are probably important in adhesion of Candida to cells other than
BEC. Cell wall fragments of C. albicans pretreated with a-mannosidase did not
adhere to VEC; blastospores pretreated in a similar fashion were unaffected (Lee and
King, 1983). Adherence of Candida cell wall extract conjugated with sheep
erythrocytes to fibrin-platelet matrix was abolished by pretreatment of the extract
with a-mannosidase; however, there was no reduction of adherence of blastospores to
fibrin-platelet matrices when they were pretreated in the same manner (Maish and
Calderone, 1981). The null effect of a-mannosidase on Candida might be due to the
inability of the enzyme to penetrate the intact cell wall (Lee and King, 1983).
One report proposed that chitin (a homopolymer of N- acetylglucosamine) which
is localized to the inner layers of the cell wall of Candida might be involved in
adhesion to VEC (Segal et al., 1982). A soluble extract of chitin inhibited the
adhesion of yeasts to human VEC and murine vaginal mucosa pretreated with the
extract; fractionation revealed that the active component was low in protein and
contained aminosugars (Lehrer et al., 1988).
Most researchers view the evidence supporting an adhesive role for a deeply
situated cell wall constituent as less compelling. Aminosugars are components of
glycocalyx of host cell surfaces and candidal mannoprotein as well as chitin (Kom
and Northcote, 1960). Mannose and N-acetylglucosamine share a common three
dimensional structure except at the C-2 position; and, N-acetylglucosamine can
compete with mannan for uptake by hepatic mannan-binding proteins (Kawasaki et
al., 1978). Additionally, more than one adhesin might be available on the surface of
Candida (Critchley and Douglas, 1987b). This is not a novel concept; multiple
adhesins have been shown to exist on E. coli (Svanborg-Eden et al., 1977).
Participation of the protein portion of yeast mannoprotein in the adhesion process
would be analogous to most bacterial adhesion mechanisms in which a proteinaceous
adhesin interacts with a carbohydrate constituent of the host cell (Jones and Isaacson,
1983). It would also be consistent with the findings that yeast adherence to epithelial
cells is not always inhibited by mannose (Sobel et al., 1981), methyl
a-D-mannosidase (Lee and King, 1983) or mannoprotein in which the protein
component is absent or denatured (Lehrer et al., 1983).
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Fewer studies have investigated receptors for Candida on the host cell. The
nature of BEC and VEC receptors appeared to be protein in some studies (Lee and
King, 1983; Sobel et al., 1981). Fibrinogen, a common mammalian cell surface
glycoprotein, is a putative receptor for Candida (Skerl et al., 1984). Other studies
show glycosides such as L- and D-fucose, D-mannose and N-acetylglucosamine to be
associated with receptors on buccal and vaginal epithelial cells (Sobel et al., 1981;
Critchley and Douglas, 1987a; Sandin et al., 1982). The extracellular polymeric
material (EP) from C. albicans 2346 could block attachment of the yeast to BEC by
over 50%. Further studies of EP from five strains of C. albicans showed that EP
from four of the strains primarily recognised L-fucose whilst one strain (C. albicans
2023) recognised N-acetyl D-glucosamine. L-fucose might be more commonly
involved in adhesion of C. albicans (Critchley and Douglas, 1987b).
On the basis of epidemiological studies, a genetic characteristic, non-secretion of
blood group antigens in body fluids, has been associated with susceptibility to some
infectious diseases (Section 1.3.1.2). There was a significant inhibition of binding of
two strains of Candida (3091 and 3118C) isolated from oral infections by pretreating
the blastospores with boiled saliva from secretors whereas pretreatment of the
blastospores with non-secretor saliva significantly enhanced attachment (Thorn et al.,
1989). Binding of strain 3091 to non-secretor BEC pretreated with polyclonal
anti-Lea antisera was reduced; neither anti-Lea nor anti-Leb antisera inhibited binding
of the two strains to secretor BEC (May et al., 1989).
The objectives of this study were
1. to develop a flow cytometric assay for adhesion of yeasts to epithelial cells;
and,
2. to examine the hypothesis that non-secretor cells bind more yeasts than
secretor cells.
5.2 Materials and Methods
The composition of solutions and buffers are given in the Appendix.
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5.2.1 Subjects
Donors were healthy individuals of blood group O who were matched for age and
gender. Blood group was determined by slide agglutination with monoclonal anti-A
and anti-B antibodies (Scottish National Blood Transfusion Service). Secretor status
was determined by the haemagglutination inhibition assay using saliva (Mollison,
1983). The presence of Lewis antigens in the saliva of the donors was detected in an
ELISA assay (Raza et al., 1991) using monoclonal anti-Lea and anti-Leb antibodies
(SAPU, Carluke, Scotland).
5.2.2 Collection of buccal epithelial cells (BEC)
BEC were collected between 0900h and llOOh by swabbing of the buccal mucosa
with six cotton wool swabs per subject. The swabs were agitated in phosphate
buffered saline (PBS) to release the cells. Cells were washed three times in PBS by
centrifugation at 480g in a Sorvall RC2B centrifuge for 10 minutes each. Random
checks on the cells revealed no yeasts attached to BEC on any occasions. The BEC
were counted with a Neubauer Improved haemocytometer and resuspended in
Dulbecco A + Supplement B to the desired concentration. Cells from each subject
were analysed separately and were agitated vigorously to disrupt clumps prior to use
in the adhesion assay.
5.2.3 Preparation of C. albicans
A freeze dried stock culture of C. albicans 2346 was reconstituted and
subcultured onto malt agar and maintained by subculturing every other day. Once a
month, a fresh freeze-dried stock culture was used. A loopful of C. albicans 2346 was
inoculated into 100 mis of yeast nitrogen base (Difco) with 500 mM galactose and
incubated for 24 hr at 37 °C with continuous shaking.
C. albicans was harvested after 24 hours and washed three times with distilled
water by centrifugation at 480g for 10 minutes at each wash. The cells were counted
with a Thoma counting chamber and suspended to a fixed concentration in PBS.
Cells were in yeast form or budding phase; very few hyphae were present.
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5.2.4 Labelling of C. albicans
Fluorescein isothyocyanate (FITC) (Sigma) was sonicated in lOmls of 1 M
carbonate-bicarbonate buffer (pH 8.9) for 3 min at 1000 Hz. Yeasts were incubated
in FITC for 30 min at 37 °C with continuous shaking. Labelling was also carried out
by addition of 0.4 mg/ml of sonicated FITC to the growth medium and culturing at
37 °C overnight. Excess FITC was washed off with PBS by centrifugation at 480g
for 10 min until the supernatant was clear. Rhodamine 123 (Sigma, U.K) was also
examined as a fluorescent label; 200 ul of rhodamine (1mg/ml in PBS) was incubated
with a pellet of yeasts for 10 minutes at 37 °C and the excess removed by washing the
yeasts three times in PBS.
5.2.5 Adhesion assay
A suspension of BEC (0.2 ml of 2.5 x 105 BEC/ml) was mixed with 0.1 ml of
C. albicans in a centrifuge tube (Elkay) and incubated with continuous shaking. The
cells were washed three times by centrifugation at 18g for 5 min in 2 mis of PBS to
remove unattached yeasts. This was the optimal centrifugation speed at which nearly
all of the excess unattached yeasts were eliminated. Finally, the cells were fixed with
2% buffered paraformaldehyde before assessment by the flow cytometer (EPICS-C).
The adherence of C. albicans to BEC was also examined in some experiments with
the light microscope; a higher number of yeasts attached to BEC in the microscopic
assay was roughly associated with a higher fluorescence value.
5.2.5.1 The flow cytometer - EPICS C
The EPICS "C" (Coulter Electronics, Luton, U.K.) equipped with a 5 W laser
with a power output of 300 mW at 488nm was used to detect binding of
fluorescein-labelled yeasts to BEC. The BEC were selected from the two parameter
display of forward angle light scatter and 90° light scatter by a bitmap. The forward
angle light scatter is proportional to the size of the particle and the 90° light scatter is
proportional to the granularity of the particle. The background fluorescence was set
at 1% by using the untreated BEC of the donor.
The amount of fluorescence associated with the BEC was an indication of the
FITC-labelled yeasts adhering to the cell. Over 2000 BEC were analysed from each
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subject. The readings were obtained at a photomultiplier sensitivity of 1000-1200
mV. The percentage (%) of BEC which were fluorescent above the background level
was recorded on a one parameter histogram measuring fluorescence on a logarithmic
scale. The mean fluorescent channel (MFC) value for the positive cells was obtained
from a one parameter histogram measuring fluorescence on a linear scale.
The percentage of BEC which were read as positive when BEC were mixed with
fluorescent yeast instantaneously was taken as the control reading.
5.2.6 Analysis of the results
The total fluorescence of the BEC of each sample was calculated by multiplying
the mean fluorescent channel (MFC) value by the percentage of positive cells. This
indicates the BEC population adhesiveness (PA). Statistical analysis was by multiple
regression on logarithmically transformed data.
5.3 Results
5.3.1 Fluoresceination of yeasts
FITC binds to proteinaceous material (Rinderknecht, 1962). In order to achieve
uniform fluoresceination of the yeasts, various methods were tried. C. albicans
incubated overnight were brighter than those incubated for 30 min (% yeast
fluorescent = 98%, mean fluorescent channel = 453; % yeast fluorescent = 97%,
mean fluorescent channel = 259 respectively).
No difference in brightness was evident when yeasts were treated with 0.4mg/ml
or 0.8 mg/ml of FITC. The standard deviation of fluorescence of FITC treated yeasts
was high (Figure 5.1). Rhodamine which stains the mitochondria (Darzynkiewicz et
al., 1982) was examined; although the standard deviation of rhodamine-stained yeast
was very low (Figure 5.2), these yeasts adhered to BEC at very reduced levels.
Yeasts utilized in the adhesion assays were fluoresceinated for 30 min with 0.4 mg/ml
FITC.
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Figure 5.5: Binding of C. albicans 2346 to 2.5 x lOVml BEC from non-secretors
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Figure 5.6: Time course of attachment of C. albicans to 2.5 x 105/ml BEC
























Figure 5.7: Time course of attachment of C. albicans to 2.5 x 105/ml BEC
expressed as % BEC binding yeasts
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Table 5.1 Adherence of C. albicans 2346 to blood group O BEC
Experiment Secretor
status*
% BEC MFC PA (103 )
l secretor 76 101 7.7
non-secretor 84 143 12.0
2 secretor 96 306 29.4
secretor 97 544 52.8
secretor 92 258 23.7
non-secretor 98 346 34.9
non-secretor 97 517 50.2
non-secretor 96 695 66.7
3 secretor 93 222 20.6
secretor 94 202 19.0
secretor 62 117 7.3
secretor 84 204 17.1
non-secretor 93 228 21.2
non-secretor 84 496 41.7
non-secretor 62 186 11.5
non-secretor 92 297 27.3
MFC = Mean linear Fluorescent Channel
PA = Population Adherence (MFC x %BEC)
*A11 donors expressed the Fewis antigen.
Multiple regression analysis of difference between secretors and non-secretor
BEC binding to yeasts p = 0.07
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Table 5.2 Adherence of C. albicans 2023 to blood group O BEC
Experiment Secretor
status*
% BEC MEC PA(103)
1 secretor 56 132 7.4
secretor 72 140 10.1
secretor 86 101 8.7
secretor 75 90 6.8
non-secretor 80 107 8.6
non-secretor 97 120 11.6
non-secretor 70 132 9.2
non-secretor 68 150 10.2
2 secretor 90 99 8.9
secretor 67 104 7.0
secretor 54 103 5.6
secretor 86 109 9.4
non-secretor 54 102 5.5
non-secretor 97 105 10.2
non-secretor 69 87 6.0
non-secretor 73 94 6.9
MFC = Mean linear Fluorescent Channel
PA = population adherence (MFC x %BEC)
*A11 donors expressed the Lewis antigen
Multiple regression analysis of difference between secretors and non-secretors
BEC binding to yeasts p = 0.65
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Table 5.3 Comparison of adhesion of C. albicans strains 2023 and 2346 to





% BEC MFC PA (103)
1 2346 secretor 80 205 16.5
2023 secretor 55 213 11.8
2346 non-secretor 87 202 17.5
2023 non-secretor 71 151 10.8
2 2346 secretor 56 315 17.7
2023 secretor 48 146 7.0
2346 non-secretor 70 171 12.0
2023 non-secretor 55 205 11.2
3 2346 secretor 70 100 7.0
2023 secretor 78 150 11.7
2346 non-secretor 50 599 30.0
2023 non-secretor 70 348 24.0
MFC = Mean linear Fluorescent Channel
PA = Population Adherence (MFC x %BEC)
*A11 donors expressed the Lewis antigen
Multiple regression analysis of differences between C. albicans 2023 and 2346
p > 0.05 .
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5.3.2 C. albicans concentration
The optimal concentration of C. albicans 2023 and 2346 used in the binding assay
was determined experimentally (Figure 5.3 and 5.4). Control values represent
readings obtained when BEC and yeasts were mixed instantaneously and read by the
flow cytometer. These values were low at yeast concentration of 107 ml1. Higher
control values represent yeasts and BEC traversing the path of the detecting laser
stream at the same time and being read as adherent yeasts. At a concentration of 107
ml-1 of yeasts, corresponding to BEC:yeast ratio of 1:40, the epithelial cell receptors
were not fully saturated and the background control values were low. Using BEC
from donors who were Lea+,b+ (secretors), Lea+>b" (non-secretors) and Lea"-b"
(secretors), maximum differences were similarly found at yeast concentration of 107
ml"1 (Figure 5.5).
5.3.3 Period and temperature of incubations
Attachment of yeasts to BEC after 45 min incubation was selected because it
represented a period where binding was complete (Figure 5.6 and 5.7). There was no
difference in attachment at 4 °C compared with that at 37 °C (Figure 5.3 and 5.4); an
incubation temperature of 37 °C was chosen because it approximates physiological
conditions. The background control values were low at yeast concentration of 107
ml"1. These parameters were similar for both strains.
5.3.4 Attachment of C. albicans to secretor and non-secretor BEC
C. albicans 2346 attached preferentially to non-secretor BEC compared to
secretor BEC; however, this difference was not significant at p < 0.05 (Table 5.1).
Experiments with C. albicans 2023 also showed that non-secretor BEC bound more
yeasts compared with secretor BEC (Table 5.2). C. albicans 2023 was not
significantly different from C. albicans 2346 (Table 5.3).
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5.4 Discussion
The results are discussed in the context of the objectives stated at the end of
Section 5.2. The majority of studies of adherence of yeasts to exfoliated epithelial
cells in vitro have been carried out by light microscopy and are severely limited by
technical considerations already discussed. These limitations have been overcome in
this study by the use of fluoresceinated C. albicans and analysis of the adherence by
flow cytometry. The advantages of flow cytometry are: over a thousand BEC can be
analysed within a few minutes; it is less prone to subjective errors; and, unattached
yeast cells are not recorded by the instrument.
The variation in fluoresceination of yeasts was probably due to budding cells
which were at different growth and maturity phases. Although this variation was
reduced by using rhodamine, these yeasts did not adhere to BEC for reasons that are
not obvious. The binding of rhodamine to C. albicans mitochondria might suppress
respiration and reduce viability of yeasts.
An assay temperature of 37 °C was used to mimic as closely as possible the
physiological conditions although no difference in attachment was observed at 4 °C
compared with 37 °C. Experiments on the effect of pH on adhesion were not
necessary because pH in the mouth varies widely and, other studies have shown no
influence of pH on binding of yeasts to BEC (section 5.1.3.1).
The second objective was to examine the difference in binding of yeasts to BEC
from secretors and non-secretors. C. albicans 2346, which has fucose-recognising
adhesin, bound in greater numbers to BEC from non-secretors compared with those
from secretors; the 95% confidence limit of binding of yeasts to non-secretors BEC
was 91% to 720% more compared with secretors BEC (p = 0.07). There was no
difference in the binding of C. albicans 2023 to BEC from secretors or non-secretors
(p = 0.65; 95% confidence limits 65% to 194%). The major adhesin on C. albicans
2023 binds N-acetyl D-glucosamine which might account for these results. There was
no difference in the binding of C. albicans 2023 and 2346 to BEC. This is
compatible with the fact that both isolates are from active infections.
A recently published study (Tosh and Douglas, 1991) reported that C. albicans
2346 bound in significantly greater numbers to BEC from non-secretors compared
with those from secretors; however, the number of donors was small (numbers not
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stated).
If the fucose determinant of H were the receptor, BEC of secretors would have
bound more yeasts than non-secretors BEC because secretors have significantly
greater amounts of H in the form of H Type 1 on their epithelial cells (Rahat et al.,
1990). Similarly, Leb which is present exclusively on BEC from secretors, cannot be
the receptor for the fucose-recognising adhesin on C. albicans 2346 that accounts for
the increased binding of yeasts to BEC from non-secretors. The Lea determinant
might be one of the receptors for the fucose-recognizing adhesin of C. albicans 2346
because it is usually found in greater quantities on BEC from non-secretors and
non-secretors bound more yeasts than secretors. Individuals who were secretors but
did not express the Lewis antigens (le/le) bound fewer yeasts than either secretors or
non-secretors who expressed the Lewis antigens (Figure 5.5).
Although secretors express Leb predominantly, some of these individuals have
substantial amounts of Lea in their body fluids (Ogata et al., 1988). Monoclonal
anti-Lewis® has been shown to bind to cells of secretors; but the amount detected
varied greatly compared with uniformly high levels of binding observed for BEC
from non-secretor (Blackwell et al., 1992, in press).
In conclusion, the fucose molecule present in the H Type 1 and Leb determinants
might bind to the adhesin on C. albicans 2346 but do not account for the increased
binding of yeasts to non-secretor cells. The role of Lea determinant as a receptor is
explored in the next chapter.
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Chapter 6
The role of blood group antigens as
epithelial cell receptors for Candida albicans
6.1 Introduction
In the context of the qualitative and quantitative distributions of H Type 2, H
Type I and the Lewis antigens on cells of secretors and non-secretors, the results of
the previous chapter suggest that Lea might be a receptor for the fucose-recognising
adhesin of strain 2346.
The cell wall of C. albicans has been studied by extraction techniques, conjugated
lectins and antibodies and chemical stains. Figure 6.1 depicts the layers and
components of the cell wall of C. albicans (Odds, 1988). There is general agreement
that mannan polysaccharides are located throughout areas of high electron density
and that the innermost layer is rich in chitin and (3-1,6 glucans (Evron and Drewe,
1984; Poulain et al., 1985a). Glucans are probably the major components of the
electron transparent layer adjacent to the innermost layer (Poulain et al., 1985a).
Lipids are located in several wall layers (Poulain et al., 1985b).
The outer fibrillar layer, also known as the extracellular polymeric material (EP),
is not peculiar to in vitro grown cells. A number of investigators have described a
prominent fibrillar-floccular layer on C. albicans in scrapings taken from the tongue
and buccal mucosa of patients with oral candidiasis (Howlett and Squier, 1980;
Marrie and Costerton, 1981). Its synthesis is depressed by tunicamycin, an inhibitor
of mannoprotein synthesis in S. cerevisiae (Douglas and McCourtie, 1983). The
lectin Concanavalin A can agglutinate C. albicans, confirming that there is mannan
at the outer surface of the cell wall (Janson and Paktor, 1977; Cassone et al., 1978).
This layer can be easily removed by mild procedures such as treatment with hot salt
solutions or even water washes (Sikl et al., 1964; Evron and Drewe, 1984). This
loosely bound material can be found in C. albicans culture filtrates (Massler et al.,
1966), although it is unclear whether mannoproteins from culture filtrates have been
actively exported by the cells, leached into solutions or released by autolysis.
Electron microscope studies suggest that EP is involved in adhesion of
C. albicans to buccal and vaginal epithelial cells (Marrie and Costerton, 1981;
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Calderone et al., 1984). This interaction has been described as a loose attachment in
vivo; but, in vitro the yeasts appear to lie close to or within the epithelial cells
(Calderone et al., 1984). Other studies have shown that EP contains yeast adhesin(s)
and that the protein portion of the mannoprotein is more important in mediating
adhesion to epithelial cells. Chemically it is composed of 65-82% carbohydrate
(mannose is the main component), 7% protein, 0.5% phosphorous and 1.5%
glucosamine (McCourtie and Douglas, 1985).
The objective of this part of the study was to assess the ability of the EP from
C. albicans 2346 to bind purified glycoconjugates carrying blood group determinants.
6.2 Materials and Methods
The compositions of buffers and solutions are given in the Appendix.
6.2.1 Growth of C. albicans
A loopful of C. albicans 2346 grown on malt agar was used to seed the yeast
nitrogen base (Difco) containing 500 mM galactose medium. Yeasts were incubated
for 24 hr at 37 °C with shaking.
6.2.2 Extraction of EP
EP was obtained by the method of Critchley and Douglas (1987a). Batches of
medium (500 ml in 2 litre Erlenmeyer flasks) were inoculated with overnight yeast
cultures (50 mis) and incubated at 37 °C for 5 days in an orbital shaker. Yeasts were
removed by centrifugation and the culture supernatant (500 ml) was dialysed for one
week against 5 changes (12 litres) of distilled water. The retentate (EP) was freeze
dried, weighed and stored at -20 °C. The EP was dissolved in PBS before use and the




Buccal epithelial cells (0.2 ml of 2.5 x 105 cells/ml) were incubated for 30 min at
37 °C with 0.2 ml of EP. Excess EP was removed by washing three times with PBS
and resuspending the BEC to the original concentration in Dulbecco's PBS with
supplement B. Control BEC were incubated with PBS only. The ability of EP-treated
and PBS-treated BEC to bind fluorescein-labelled yeasts was examined by flow
cytometry as described in Chapter 5.
6.2.4 ELISA assay for the detection of binding of EP to blood group antigens
conjugated to human serum albumin (HSA)
The glycoconjugates used are illustrated in Figure 6.2. They are manufactured by
BioCarb (Lund, Sweden) and were obtained from Russel Fine Chemicals, Chester,
U.K. The method described by Gray (1979) was used to attach EP from strain 2346 to
microtitre plates. EP (0.2 ml of lmg/ml) was added to 1 ml of NaOH (0.01N)
containing a phenolphthalein indicator. When the solution turned pink, 1 mg of
cyanuric chloride was added. After 10 s the mixture was added to 0.1 ml
poly-L-lysine (0.1%) and incubated for 1 hr at 4 °C. The conjugated EP (100 ul) was
pipetted into polystyrene microtitre wells (M129B, Dynatech, Sussex, U.K) and left
at room temperature for 24 hr with constant shaking. The wells were washed three
times with distilled water; 100 ul of distilled water was added to each well and the
plates stored at 4 °C.
Each well was washed with distilled water before blocking with blocking buffer
for 1 hr. Unless otherwise noted, all procedures were carried out at room
temperature. The plates were washed three times with washing buffer and 40 ul of
one of the glycoconjugates (1 mg/ml in PBS) diluted with 10 ul of blocking buffer
was added and incubated for 1 hr. The plates were washed and biotinylated chicken
anti-HSA (Sera-Lab LTD, Sussex, U.K) (100 ul/well, dilution 1/100 in blocking
buffer) was added and left for 1 hr. Unbound antibody was removed by washing
three times and streptavidin biotinylated HRP complex (Amersham, U.K) (100 ul,
dilution 1/100 in blocking buffer) was added. The plates were washed three times
and 100 ul of substrate solution, 40 mg O-phenylenediamine in 100 ml 0.1 M citrate
buffer activated immediately before use with 40 ul of 30% (v/v) H202, was added and
the reaction allowed to develop in the dark for 10 to 15 min. The reaction was
stopped by adding 50 ul of 12.5% H2S04. The colour development was read by a
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Figure 6.2: Purified blood group glycoconjugates used in the ELISA. Symbols as
in Figure 1.1. The human serum albumin (HSA) backbone molecule is represented
by /53?f- The acetylphenylenediamine molecule (APD) Avvwis a spacer used to
conjugate the oligosaccharide chain to the HSA molecule. Each HSA molecule had




Figure 6.3: Inhibition of binding of C. albicans 2346 to 2.5 x lOVml BEC





Figure 6.4: Inhibition of binding of C. albicans 2346 to 2.5 x lOVml BEC
pretreated with EP2346 expressed as total fluorescence (PA)
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Table 6.1 Binding of glycoconjugates to EP 2346: ELISA reading
Batch Protein
(mg/ml)
Lewisa Lewis'3 H Type 1 Precursor
1 7.0 0.717
2 6.8 0.403 0.317 0.321 0.364
3 6.1 0.228 0.154 0.167 0.204
4 6.5 0.325 0.291 0.276 0.301
^maximum ELISA reading was 2.00








1 11 88 228 2.0 47 10
2 10 40 246 9.8 53 50
3 10 36 221 7.9 50 53
4 10 46 160 7.3 57 57
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Dynatech micro-plate reader MR 700 equipped with a tungsten halogen lamp
(GE#787) at 490 nm. Control wells contained: 1) 40 ul of lmg/ml of HSA (Sigma,
Dorset, U.K) and 10 ul of blocking buffer; and, 2) 50 ul of PBS instead of the
glycoconjugate.
6.3 Results
6.3.1 Protein content of EP2346
Four separate 1 litre batches of 5 day cultures of yeasts were analysed for protein
content. Table 6.1 shows that the protein content ranged from 6.1 to 7.0%
comparable with the results of McCourtie and Douglas (1985) of 6.9 ± 0.2% protein
determined by the Lowry method on one 1 litre batch of the growth culture.
6.3.2 The adherence inhibition activity of EP2346
Each batch of EP was tested for the presence of inhibitory activity before use in
the ELISA assay (Table 6.2). At a concentration of 10 mg/ml, all four batches of EP
inhibited the binding of C. albicans 2346 to BEC by 47-59% as estimated by the PA
values. When only the % of BEC binding C. albicans 2346 is considered, the
inhibition at lOmg/ml of EP is more variable (10-57%). The differences are
illustrated in Figures 6.3 and 6.4. There are obvious variations in the activity of the
inhibitory components of different batches of EP; and, this difference was
independent of the protein content of the EP.
6.3.3 Binding of glycoconjugates to EP
All batches of EP bound the HSA avidly and this reading was subtracted from the
readings obtained from the other wells. All glycoconjugates carrying the blood group
determinants bound to EP (Table 6.1). There was a consistent trend: the ELISA
reading for the glycoconjugates with the Lea determinant was highest followed by
that with the precursor Type 1 determinant. There was no consistent trend for Leb
determinant compared with the H Type 1 determinant; the ELISA reading for both
were lower compared with Lea and precursor Type 1. As the protein content of the
EP decreased, so did the readings obtained with the Lea glycoconjugates; however,
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this decrease was not proportional to the decrease in protein content.
6.4 Discussion
Binding of the yeasts to BEC pretreated with EP was carried out to determine if
the inhibitory activity of the EP was intact. The EP batches were not identical in their
inhibitory activities. This is illustrated in Figures 6.3 and 6.4 in which the slopes of
the graphs for batches 1 and 2 are different. This might be due to an absolute
difference in the inhibitory component and/or the variation in the BEC from the
single donor on different days. The latter possibility could account for the greater
part of the variation as is seen from the wide range of inhibition results (10-57%)
when only percentage of BEC inhibited are examined. It can also be concluded that
the PA scale provides a better and less variable (47-59%) representation of the results
of the adhesion assay; the slopes in Figure 6.4 are almost parallel compared with
those in Figure 6.3. Other investigators have suggested that measurement of mean
number of bacteria attached to the entire host cell population provided a more
accurate estimate of adhesiveness (Freter and Jones, 1983). The adhesion assay was
not affected by subjective reading errors; therefore, this aspect was not responsible
for the variation in the slopes of the graphs.
The PA figures compare well with the results of other studies in which the
adhesion assay was carried out by light microscope to quantitate inhibition of binding
of yeasts to BEC pretreated with EP; 50% inhibition was achieved with 10 mg/ml EP
in two experiments and with 5mg/ml in another (McCourtie and Douglas, 1985;
Critchley and Douglas, 1987a; Critchley and Douglas, 1987b).
In the ELISA assay, there was a clear trend for binding of blood group
determinants to EP; ELISA readings were highest for Lea followed by those for
precursor Type 1 determinant. The readings for H Type 1 and Leb determinants were
consistently lower compared with Lea, possibly because the fucose molecule was in a
less favourable conformation. The precursor Type 1 determinant, which has no
fucose molecules, bound to the EP. This might be a due to other adhesins present in
the EP reacting with the precursor Type 1 structure and/or due to more effective
binding of adhesin(s) in the EP to sites that are unmasked as a result of the absence of
fucose molecules. Differences in the strength of bacterial binding to glycoconjugates
with different blood group determinants on a Type 1 precursor chain have been
reported (Rosenstein et al., 1988). Modification of the precursor structure by addition
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of monosaccharide (in H and Leb determinants) interfered with binding of E. coli.
In general the results of the ELISA assay complement those of the adhesion assay
(Chapter 5). Cells from non-secretors which should have more Lea on their surfaces
had the highest PA values than those from secretors; and, the two Lea~b~ individuals
had the lowest PA values. C. albicans 2346 was also found to co-agglutinate
Sepharose-Protein A beads to which anti-idiotype antibody to monoclonal anti-Lea
was conjugated. In contrast, C. albicans 2023 did not co-agglutinate the Sepharose
beads (S. Essery, personal communication). This strongly suggests that C. albicans
2346 can bind to Lea-like structure.
A recent study reported that the C. albicans fucose-containing lectin could be
isolated by an affinity system containing the H determinant (Douglas, 1991). The
material eluted from the column inhibited adherence of BEC 220 fold more
efficiently than crude EP; experiments with Lea were not done. This complements
the results of the ELISA assay in which binding of EP to glycoconjugate containing
the H determinant was demonstrated; however, it predicts that the Lea determinant is
probably a more efficient receptor than the H determinant.
Another recent publication reported that human milk oligosaccharide could inhibit
the binding of C. albicans 17113 to BEC. The yeast has fucose-recognising adhesins
and the minimal structure requirement for the inhibitory activity was found to be
Fucal —> 2Gal(3 (H determinant) which is present on both H Type 1 and H Type 2.
In contrast, the fucosylated determinants of the Lewis blood group system were found
to be totally inactive (Brassart et al., 1991). Although the H determinant inhibited an
adhesin on this particular strain, H Type 1 is not present on cells or in secretions of
non-secretors; therefore this mechanism cannot explain the increased binding of
C. albicans 2346 to non-secretor cells. There is an additional argument against H
Type 1 playing a role in vivo. In most populations >95% of secretors have the Le
gene; therefore, most of the H Type 1 will be fucosylated by the product of the Le
gene to Leb, ALeb or BLeb.
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Chapter 7
General Discussion and Conclusions
This chapter summarizes the findings and conclusions presented in the previous
chapters in the context of the objectives stated in Chapter 1.
7.1 Epidemiology of oral disease and carriage of yeasts
Diabetics are immunocompromised individuals prone to oral and vaginal
candidiasis. In this study, denture stomatitis was used as a model of superficial
candidiasis. The objective of the epidemiological study was to identify the factors
predisposing to carriage of yeasts and to denture stomatitis.
Previous epidemiological studies of diabetic individuals did not use multivariate
statistical analyses, some did not differentiate IDDM from NIDDM and some
examined small numbers of patients. This meant that factors analysed by univariate
analysis could be obscured by other dependent variables. In this study, eighteen
variables were analysed for their contribution to carriage of yeasts and development
of denture stomatitis: gender; age; type of diabetes; diabetic treatment (insulin,
biguanides, sulphamideureas, dietary); duration of diabetes; HbAp random plasma
glucose; diabetic complications (retinopathy, peripheral neuropathy, autonomic
neuropathy, nephropathy); antibiotic treatment; corticosteroid usage (local and
systemic); smoking; alcohol consumption; dentures (extension, occlusion, fit,
hygiene, continuous wear); ABO blood group; secretor status; glycosuria;
albuminurea and past history of candidiasis. The variables with p values < 0.01
isolated by the multivariate analysis were, in most cases, also those that were
significant in the univariate analysis. The advantage of the multivariate analysis was
that it detected marginally significant variables (p < 0.05) such as plasma glucose,
retinopathy and non-secretion of blood group antigens not isolated by the univariate
analysis.
The multivariate analysis also indicates the prognostic value of the isolated
variable(s). Among patients with NIDDM a combination of continuous presence of a
denture (p < 0.01), increased number of yeasts (p < 0.01) and non-secretion of blood
group antigens (p < 0.01) were used to predict correctly 82% of subjects with denture
stomatitis. Persistent glycosuria (p <0.05) was not a good indicator of denture
117
stomatitis among subjects with IDDM (Table 4.6) because it could only predict 63%
of the patients with denture stomatitis. This suggests that variable(s) other than those
investigated contribute to development of denture stomatitis among individuals with
IDDM.
Palatal carriage of yeasts was correctly predicted by glycosuria (p < 0.01) as the
sole predicting variable in 78% of NIDDM carriers who did not wear dentures. It is
tempting to assume that variables with lower p values would be better predictors;
however, this is not the case. Among individuals with IDDM who wore dentures the
analysis correctly predicted only 71% of palatal carriers from three factors: HbAj
levels (p < 0.01), age (p < 0.05) and random plasma glucose levels (p < 0.05).
The epidemiological studies showed that risk factors influencing carriage of and
disease due to yeasts were distinct among individuals with IDDM compared with
those with NIDDM (Tables 2.9, 2.10 and 4.6). Future studies examining other factors
such as the role of vitamins and immune system functions can be analysed in a
similar manner to reveal their contribution towards colonization and disease.
7.2 Studies on adherence of C. albicans 2346 to BEC
The second aim of the study was to investigate the reasons underlying the
increased susceptibility of non-secretors to oral disease due to yeasts. The adherence
of C. albicans 2346 to BEC from secretor and non-secretor individuals was
compared. Epithelial cells from secretors bound fewer C. albicans 2346 than BEC
from non-secretors. Cells of blood group O individuals were used to eliminate
interference by other blood groups such as blood group A which is known to be a
receptor for some strains of Candida (Tosh and Douglas, 1991). The number of
individuals sampled was limited by the availability of non-secretors who make up
approximately 25% of the population. Despite examination of over 2000 BEC per
individual assay, the significance value for the difference between secretors and
non-secretors did not achieve p < 0.05. The results agree with those of Douglas and
Tosh (1991) obtained in studies in which light microscopy was used to determine
binding of C. albicans 2346. BEC from blood group O and A non-secretors bound
more yeasts than those from secretors. In their study, these differences were
significant probably due to their small sample size (number of donors not given);
secretor donors with very low levels of Lea might have been included in their
experiments.
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Two important points arise from these observations. First, binding assays with
epithelial cells will need to take into consideration the amount of the putative receptor
on the cells of secretors and non-secretors. Second, the higher binding of C. albicans
2346 to non-secretor cells cannot be due to differences in H antigen on secretor and
non-secretor cells. Non-secretor and secretor cells express similar quantities of H
Type 2 antigen (Rahat et al., 1990). The cells of secretors bind significantly greater
amounts of Ulex europaeus lectin; this is due to H Type 1 which non-secretors are
incapable of producing. Additionally, H Type 1 is a substrate for the product of the
Le gene that converts it to Leb in vivo.
In this context, the conclusions of a recent study in which human milk
oligosaccharide probes were used to inhibit the binding of C. albicans 17113 to BEC
need to be reassessed. The yeast has fucose-recognizing adhesins and the minimal
structure requirement for the inhibitory activity was found to be Fucal —» 2Gaip (H
determinant) which is present on both H Type 1 and H Type 2 chain structures. The
determinants of the Lewis blood group system which are fucosylated at the
subterminal position of the Type 1 precursor chains were found to be totally inactive
(Brassart et al., 1991). While the in vitro studies appear to be valid, the authors have
not considered the conditions that prevail in vivo.
7.2.1 Lea as a putative BEC receptor for C. albicans 2346
Since BEC from non-secretors bound more yeasts compared with cells from
secretors, the role of Lea antigen as a receptor for the fucose-recognising adhesins of
C. albicans 2346 was explored. Experiments were designed to examine the ability of
yeasts to adsorb Lewisa from saliva. Serial dilutions of partially purified Lea antigen
adsorbed with the yeasts were analysed for the presence of Lea by an ELISA method
(Raza et al., 1991). Results of this experiment were inconclusive because compared
with the unadsorbed control, a higher reading of Lea was obtained from solutions
adsorbed with the yeasts. It was suggested that there might be cross-reaction between
C. albicans 2346 antigens and the Lea antigen detected by the monoclonal
anti-Lewisa antibody; and, C. albicans was secreting or sloughing the cross-reactive
antigens into the solution.
A different method was, therefore, developed to test whether the
fucose-recognising adhesin on C. albicans 2346 bound Lea. Binding of purified
glycoconjugates to EP from C. albicans 2346 showed that the highest readings in the
119
ELISA were obtained with the Lea glycoconjugate. The other glycoconjugates also
bound to the EP, but the ELISA readings were lower. These results are compatible
with other published accounts indicating that blood group antigens, and especially
Lea might be receptors for yeasts in vivo (Thorn et al., 1989; May et al., 1989).
The Lea determinant on host cells is considered to be the most likely receptor for
the fucose-recognising adhesin of C. albicans 2346. The higher binding of Lea
glycoconjugate to EP 2346 compared with those containing Leb or H Type 1
determinants help to explain the increased colonization of non-secretors. The amount
of anti-Lewisa antibody bound to BEC has been shown to vary among individuals. In
flow cytometry assays, consistently high levels of anti-Lewisa antibodies were bound
to cells of non-secretors; and, consistently low levels of the antibody were bound to
cells from Lea~'b~ individuals. Cells from secretors, however, bound variable amounts
of anti-Lewis3 antibodies. Cells from some secretor donors bound as much anti-Lea
antibody as cells from non-secretors; for other secretor donors, the levels were as low
as those for Lea",b" cells (Blackwell et al., 1992, in press). The presence of variable
amounts of Lea on cells of individuals who are secretors might account for the high
standard error found in the adhesion assay and the inability to achieve a p value of <
0.05 in the present study in which secretor/non-secretor pairs were selected only by
age and gender but not the amount of Lea on their cells.
7.3 Pathogenesis of denture stomatitis among individuals with
diabetes mellitus
The mechanisms underlying the development of superficial candidiasis remain
obscure. In non-diabetic individuals, carriage of yeasts is a stable characteristic over
a period of time (Burford-Mason et al., 1988). A scheme of carriage leading to
denture stomatitis was proposed by Samaranayake and MacFarlane (1985). The
presence of a denture created an environment in which yeast virulence factors such as
proteinases act. Sucrose from dietary sources helps in the establishment and
proliferation of the yeasts. Production of acidic metabolic waste products would
allow yeast proteinases to act as low grade aggressins. The host will react to the
insult by producing an inflammatory response. This sequence of events does not
contradict the histological appearance of the disease process.
Except for the increased levels of glucose, conditions leading to the development
of denture stomatitis in individuals with diabetes mellitus have not been considered
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before in any detail. In this section, two models for colonization by yeasts and
development of denture stomatitis are proposed based on the different risk factors
identified in these studies for patients with IDDM compared with those with NIDDM.
Factors influencing palatal colonization of individuals with NIDDM who did not
wear dentures were persistent glycosuria, and, for denture wearers, the continuous
presence of the denture in the mouth. Development of denture stomatitis was
influenced by a combination of continuous wear of denture, increase in the density of
colonization and non-secretion of blood group antigens.
High levels of glucose reflected by persistent glycosuria result in an increase in
nutrients and adhesiveness of yeasts. Introduction of a denture and its continuous
wear provides a microenvironment whereby proliferation of yeasts might occur. In
the protected microenvironment under the denture, there is no cleansing action of
saliva and yeasts might accumulate. The anaerobic growth conditions will result in
the production of acidic metabolites. Yeast proteinases might be activated in this acid
environment and act as low grade aggressins to induce inflammation. For those
strains such as C. albicans 2346 which might use Lea as a receptor, the epithelial cells
might bind more yeasts initially and would be more densely colonized.
Other indirect mechanisms by which secretor status might influence disease
include differences in the secretory immune responses of secretors and non-secretors.
Non-secretors have lower levels of total salivary IgM and salivary IgM specific for
Neisseria species compared with secretors (Zorgani et al., 1992).
Factors influencing palatal colonization of individuals with IDDM who did not
wear dentures were age; and, for denture wearers HbAj levels, age and random
plasma glucose levels. Development of denture stomatitis was influenced by
persistent glycosuria.
Colonization is increased among the relatively younger individuals. The
increased colonization with decreasing age has not been reported before. This finding
might be a unique feature of this population; but, an alternative hypothesis is
suggested. Secretory IgA levels against Candida might increase with increasing age
and increased frequency of exposure to Candida. Studies of specific secretory
antibodies in this population will provide evidence to refute or support this
hypothesis.
Introduction of a denture alters the colonization risk factors. Glycaemic control
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(HbAj) is most important followed by age and plasma glucose levels. As with
patients with NIDDM, poor glycaemic control probably predisposes to colonization
by increased availability of glucose as a nutrient. Development of denture stomatitis
is precipitated by very poor control where persistent glycosuria is evident.
This is the first study to provide definite links between glycaemic control and
development of denture stomatitis. This was found only for individuals with IDDM.
In addition to effects on growth and acid production, there are other mechanisms by
which increase in glucose levels might influence development of disease among
patients with IDDM. They have lower levels of C3 (Charlesworth et al., 1987) and
binding of glucose to the biochemically active site of the C3 inhibits the attachment
of this protein to the microbial surface and thereby impairs opsonisation (Davidson et
al., 1984). Yeasts can also bind complement reaction products by Complement
Receptor Proteins (CRP) which are analogous to the human CRP. The yeast CRP has
been shown to be induced by increased glucose level. Phagocytic (Davidson et al.,
1984) and killing ability (Wilson and Reeves, 1986) of granulocytes from diabetic
individuals is reduced with increases in glucose levels. Yeast secretory proteinase is
also induced by glucose levels; and, can act as a low grade aggressin (Ruchel, 1991).
These factors might act synergystically to promote development of disease.
7.4 Future Aims and Investigations
Adhesion assays are limited because of variability of epithelial cells. Since recent
studies have found a significant correlation between binding of anti-Lewisa and
binding of Staphylococcus aureus to BEC from secretors and non-secretors (Saadi et
al., submitted for publication), future binding studies with C. albicans 2346 need to
control for this variable. Binding of yeasts to H Type 1 and Lewis antigens coupled
to inert particles such as latex might provide clearer results. Other experiments which
might elucidate the role of Lea are immunoblotting techniques whereby yeast cell
wall antigens separated by gel electrophoresis and blotted onto nitrocellulose could be
tested for binding to purified blood group antigens. Experiments similar to that by
Douglas (1991) with synthetic H determinant (Synsorb) might be undertaken to assess
the binding affinity of the adhesin for different blood group determinants.
The obvious question at the end of this section is that of the practical applications
of the study. The study has shown the advantages of using multivariate analysis in
epidemiological studies. With reference to management of patients with denture
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stomatitis, among individuals with IDDM improvement of glycaemic control should
be strongly recommended; and, among those with NIDDM the denture should not be
continuously worn. Correct identification of yeast species is also important from the
therapeutic aspect of treatment. C. albicans accounts for just over half of the yeast
isolates from denture stomatitis lesions; other species of Candida are important
pathogens in this population. The API kit should not be relied on to identify
C. albicans-, the germ tube test should be used to confirm the presence of this isolate.
Other Candida species are best identified by conventional methods described by
Milne (1989).
The studies on identification of the fucose-containing receptor on host cells have
long-term potential towards development of vaccines against Candida. Researchers
involved in the development of vaccines for meningococcal meningitis have accepted
that a cocktail vaccine is needed since different strains of the bacteria have different
immunogenic determinants. The identification of the fucose-containing receptor(s)
for the EP of C. albicans 2346 would be an initial stage leading to isolation of the
adhesins and assessment of their immunogenicity. If the adhesin is
non-immunogenic, this would be excluded from further studies to develop a vaccine.
If there is evidence that antibodies to the adhesin are associated with decreased
density of colonization or protection from denture stomatitis, it might be included as
part of a vaccine for individuals at risk of candidiasis such as non-secretors who are
diabetics and individuals in the early stages of AIDS.
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All chemicals were analytical grade obtained from BDH Chemicals Ltd. (Poole,
Dorset, UK) or Sigma (Poole,Dorset, UK).
1.1 1M Carbonate-bicarbonate buffer (pH 8.9)
Stock solution of 1M sodium carbonate and 1M sodium bicarbonate were
prepared. The buffers were mixed in the proportion 1:9 (v/v) and adjusted to pH 8.9
with one of the stock solutions (carbonate raises pH, bicarbonate lowers pH). The
bicarbonate solution was prepared fresh for each experiment.
1.2 Dulbecco's phosphate-buffered saline, solution A (DPBS)
This buffer consisted of the following: 136 mM sodium chloride, 2.6 mM
potassium chloride, 8.1 mM sodium hydrogen phosphate, 1.47 mM potassium
dihydrogen phosphate, 0.2% aqueous phenol red (pH 7.3).
1.3 Dulbecco's phosphate-buffered saline with supplement B
This was prepared from DPBS by the addition of 0.9 mM Ca++ and 0.4 mM Mg++
ions.
1.4 Phosphate-buffered saline (PBS)
This was prepared by the addition of 0.01 M phosphate buffer pH 7.2 to 0.15 M
NaCl.
1.5 Phosphate citrate buffer (PCB)
Sodium hydrogen phosphate at 0.1 M and 0.1 M citric acid solutions were mixed
and the pH adjusted to pH 5.
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1.6 Coating buffer
Coating buffer was composed of 15 mM sodium carbonate, 35 mM sodium
bicarbonate and 3 mM sodium azide (pH 11).
1.7 Washing buffer
Washing buffer was prepared by adding gelatin (0.03% w/v) and Tween-20
(0.05% v/v) to 0.01 M PBS (pH 7.2).
1.8 Blocking buffer
This was composed of 0.01 M PBS containing 0.3% (w/v) gelatin (pH 7.2).
1.9 Substrate solution
The substrate solution used in the colour development reaction with horseradish
peroxidase contained 40 mg O-phenylenediamine in 100 mM phosphate citrate buffer
activated immediately before use by the addition of 40 ul H202 (30% v/v).
2 Culture Materials
2.1 Malt broth
Made up from 20 g malt extract (desiccated) in 1 litre of water. Steam was used
to aid dissolution and the solution adjusted to pH 5.4. Sterility was obtained by
autoclaving at 120 °C for 20 minutes. Aliquots of 5 ml were dispensed into sterile
bijou bottles.
2.2 Cornmeal agar
This medium was prepared from commercially available dehydrated ingredients
(Oxoid) according to the manufacturer's instructions. The ingredients present in the
dehydrated medium were: 2g K2HP04, lg glucose, lg peptone and 5g NaCl. This
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was dissolved in 1 litre of distilled water by steaming. The pH was adjusted to
6.8-6.9 before the addition of 6 ml of 0.2% phenol red solution. Agar (20 g) was
added and the mixture autoclaved at 115 °C for 15 minutes. After sterilization, 40
mis of 50% urea was added and allowed to cool to 50 °C before pouring into Petri
dishes. The pH of the medium was 6.0 ± 0.2.
2.3 Christensen's urea agar containing glucose
This contained 5g of glucose and 5g of sodium chloride.
2.4 Malt agar plates
Contained 30g desiccated malt extract (Oxoid) , 5g mycological peptone and 15g
of agar dissolved in 1 litre of distilled water. The pH was adjusted to pH 5.4 by
addition of lactic acid and autoclaved at 115 °C for 10 min before being dispensed
into Petri dishes.
2.5 Yeast nitrogen extract (Difco) with 500 mM galactose
A ten times strength solution was prepared by dissolving 5 M galactose in 100 ml
distilled water and addition of 6.7 g of Bacto yeast nitrogen base. The solution was
filter sterilized and diluted with distilled water before use (pH 5.4 ± 0.1).
2.6 Buffered paraformaldehyde
Sodium calcodylate (10 g) was added to 1 litre of distilled water and adjusted to
pH 7.2. Paraformaldehyde (10 g) was added and dissolved by boiling the solution.
Finally, 7.5 g sodium chloride was added and the solution stored at 4 °C.
2.7 Candida albicans strains
C. albicans 2346 and 2023 were obtained from Dr. J. Douglas, Department of
Microbiology, University of Glasgow. These strains were isolates from patients with
denture stomatitis. C. albicans 2346 had a fucose-recognising adhesin and was used
as a test strain in the adhesion assays. C. albicans 2023 had an
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SUMMARY
Non-diabetic individuals who are non-secretors of blood group antigens are prone
to superficial infections by Candida albicans. In this study, 216 patients with
diabetes mellitus who were denture wearers were examined for the presence or
absence of denture stomatitis. There was an overall trend for non-secretors to be
prone to denture stomatitis compared with secretors. Stepwise linear discriminant
analysis was used to dissect the contribution of secretor status and other variables
to the development of the disease. Secretor status was found to be a contributory
factor among patients with non-insulin dependent diabetes but not among those
with insulin-dependent diabetes. The possible reasons for this are discussed.
INTRODUCTION
Chronic atrophic oral candidiasis (denture stomatitis) is solely associated with
the wearing of dentures. The studies of Butdz-Jorgensen [1] and Cawson [2]
established the link between Candida sp. and denture stomatitis. Yeasts were
recovered from over 90% of the lesions and antifungal treatment usually led to
regression of the lesion. Subsequently, numerous studies have examined the
prevalence of and predisposing factors to denture stomatitis [3], Presence and
continuous wearing of dentures at night, availability of sucrose in the oral
environment through dietary intake, traumatic effects of the denture, antibiotics
and corticosteroid treatment, diabetes mellitus and smoking have all been
implicated as potential factors influencing the development of denture stomatitis.
The genetic inability to secrete ABO blood group antigens in body fluids has
been associated with a variety of infectious diseases [4], Non-diabetic individuals
and pregnant women who are non-secretors are prone to superficial Candida
infections [5], Non-secretors are also over-represented among carriers of Candida
albicans in normal subjects and patients with non-insulin dependent diabetes
mellitus (NIDDM) [6, 7],
The aims of the present study were :
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(1) To assess the influence of secretor status in the development of denture
stomatitis (DS) among patients with insulin-dependent diabetes (IDDM)
and those with non-insulin dependent diabetes (NIDDM).
(2) To assess the contributions of the following variables to the development of
DS: age; sex; duration of diabetic state; type of diabetes; control of
diabetes measured by glycosylated haemoglobin (HBAj); diabetic complica¬
tions - retinopathy, neuropathy and nephropathy; antibiotics; cortico¬
steroid treatment; smoking; alcohol; presence of dentures at night; type of
denture; denture fit, extension, occlusion, age and hygiene; presence of




A total of 439 subjects attending for routine follow up examination at the
Diabetic Outpatient Department (DOPD), Royal Infirmary Edinburgh were
sampled. An initial pilot study examined 80 individuals and was followed by a
study that sampled 359 individuals between September 1988 and March 1989. The
method of selection was stratified random selection according to sex and type of
diabetes.
Clinical history
Each subject was classified as insulin dependent (IDDM) or non-insulin
dependent (NIDDM) according to the clinical history of onset, requirement for
insulin and progression of the disease. Of the 439 subjects sampled, three could not
be classified.
A full medical history including the presence of diabetic complications
(retinopathy, neuropathy and nephropathy) was obtained during interview and
from the patients' records. A history of medications, with particular reference to
antibiotics or corticosteroid-containing preparations, within the past 6 months
was noted. A social history of alcohol consumption and smoking was recorded.
Subjects were questioned about history of superficial infections due to Candida.
Glycosuria and albuminuria were recorded as persistent if subjects had positive
urine samples on more than two consecutive appointments at the DOPD. None of
the subjects used any oral preparations containing antiseptics within the previous
6 months.
Clinical examination
A thorough oral examination of both soft and hard tissues was carried out by
the same examiner (FZA). Any of the following abnormalities were noted:
gingivitis, periodontitis, angular cheilitis, leukoplakia, median rhomboid glossitis;
fissured, geographic or hairy tongue; and denture stomatitis. Denture stomatis
has the characteristic appearance of chronic erythema of the portion of the palate
underlying the denture. The inflammation is generally diffuse, but may be
associated with fibrous hyperplasia of the palate giving it a granular appearance.
The occlusion, fit, extension and hygiene of a denture where present was recorded
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as ' good' or ' poorThe age of the denture was recorded as well as whether it was
left out of the mouth at night.
Samples
(1) Venous blood was obtained for ABO blood grouping and Lewis antigen
determination. Analysis for glycosylated haemoglobin (HBAjJ and random
plasma glucose carried out routinely were recorded.
(2) Swabs were obtained from five sites of the mouth including the palate and
inoculated immediately into malt broth.
(3) Subjects were requested to rinse with 10 ml of sterile phosphate-buffered
saline (PBS) for 1 min and to return the contents to a sterile container.
Laboratory analysis
All samples were collected between 09.00 and 12.00 h and processed within 1-2
h. ABO blood group was determined by slide agglutination with monoclonal anti-
A and anti-B antibodies (Scottish National Blood Transfusion Service). Secretor
status was determined by the presence of Lewis antigen on red blood cells by tube
agglutination with monoclonal anti-Lewisa and ant.i-Lewisb antibodies (Scottish
National Blood Transfusion Service). The haemagglutination inhibition method
with boiled saliva [8] was used to confirm the Lewis antigen results for 159
individuals.
The swabs were incubated at 37 °C for 36-48 h, plated onto malt agar and
incubated for a further 36-48 h.
The mouth rinse was concentrated by centrifugation at 2000 g and resuspended
in 1 ml of PBS; 20 /1\ of the suspension were inoculated onto malt agar plates and
incubated at 37 °C for 36-48 h. The number of colonies per sample were recorded.
Pure colonies were subcultured and identified with the API 20C AUX.
Additionally all were identified by the conventional methods [9] of germ-tube
production in horse serum, urease test and hyphae production on corn-meal agar
following incubation at 28 °C for 48 h.
Statistical methods
All results were coded and a computerized database was set up to facilitate
analysis using SPSSX. The relationship between prevalence of DS and other
factors was tested by y2 (with Yates' correction) or Wilcoxon rank sum tests.
Stepwise linear discriminant analysis was used to identify which combinations of
factors best predicted the presence or absence of DS.
RESULTS
Oral conditions among the patients examined are summarized in Table 1. Of the
216 denture wearers, 76 (35%) had DS (Table 2). In 18% (14/76) the rinsing
technique failed to isolate any yeasts. Similar results were obtained with the swab
taken from the palate. The species most frequently isolated from the palate of
patients with DS were C. albicans (33/76, 43%), followed by Torutopsis glabrata
(6/76, 8%) and C. tropicalis (3/76, 4%). In 9%, the isolate could not be identified
to a species level. Other species were isolated in 15% (11/76) of DS cases
(Table 3).
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Table 1. Prevalence of oral conditions among diabetic individuals
Prevalence in Prevalence
total population among dentu
screened wearers
Gingivitis 114 (28%) 39 (42%)
Angular cheilitis 42 (10%) 25 (12%)
Denture stomatitis 76 (35%) 76 (35%)
Fissured tongue 25 (6%) 15 (7%)
Dry mouth 15 (3%) 13 (6%)
Geographic tongue 11 (3%) 7 (3%)
Median rhomboid glossitis 10 (2%) 7 (3%)
Hairy tongue 8 (2%) 5 (2%)
Glossitis 7 (2%) 5 (2-3%)
Leukoplakia 2 (0-5%) 2 (1%)
Table 2. Prevalence of DS among patients with IDDM or NIDDM
+ DS — DS Total
IDDM 32(41%) 47(59%) 79(100%)
NIDDM 43(32%) 91(68%) 134(100%)
75 138 213
Missing, 3; y2 = 1-20; P = 0-27.
Table 3. Mycological profile of diabetic individuals (Palatal swab)
Denture wearers DS cases
Isolate no. (%) no. (%)
C. albicans 67 (31) 33 (43)
T. glabrata 13(6) 6(8)
T. beigelli 5(2) 3(4)
C. tropicalis 4(2) 3(4)
C. paratropicalis 3 (1) 2(3)
S. cereviciae 2(1) 0(0)
C. stellatoidea 1 (0-5) 1 (1)
T. inconspicua 2(1) 1 (1)
C. luscitaniae 1 (0-5) 0(0)
C. humicola 1 (0-5) 0 (0-5)
C. pseudotropicalis 1 (0-5) 1 (1)
Unidentified 24(11) 7 (9)
Missing 5(2) 2(3)
Other 4(2) 3(4)
No isolate 83 (38) 14 (18)
Total 216 76
Secretor status
There was a trend for non-secretors to be prone to DS (Table 4). Among
individuals of blood group O with DS, non-secretors (13/27, 48%) appeared to be
more prone to DS than secretors (19/68, 28%); x2 = 2-69, d.f. = 1, P = 0-1. This
was not seen among the 73 blood group A individuals. There were 10 (45%) A non-
secretors compared with 15 (29%) A secretors with DS (x2 = 1*1, d.f. = 1, P —
0-3).
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no. (%) no. (%) X2 P
Patient category
Total (n = 199)
Secretor 45 (31) 100 (69) 2-56 011
Non-secretor 24 (44) 30 (56)
IDDM
Secretor 18 (40) 27 (60) 0-03 0-87
Non-secretor 13 (45) 16 (55)
NTDDM
Secretor 27 (27) 72 (73) 1-90 017
Non-secretor 11 (44) 14 (56)
Table 5. Relationship between DS and presence of denture in the mouth at night
Denture stomatitis
A
Patient Presence of Present Absent
category denture No. (%) No. (%) X2 P
Total* Yes 45 (52) 42 (48) 23-2 < 0 00001
No 7(12) 53 (88)
IDDM Yes 18 (49) 19 (51) 3-50 0062
No 3(18) 14 (82)
NIDDM Yes 27 (54) 23 (46) 18-82 < 0 00001
No 4(9) 39 (91)
* Of a total of 216 denture wearers, 43 were recruited during the pilot study and were not
questioned about their denture wearing habits. For 26 individuals this information was not
recorded during the main study period.
Significant associations were found between DS and the following:
Presence of dentures in the mouth at night. Significantly more individuals who did
not remove their dentures at night (45) had DS compared with those who removed
their dentures at night (7) (P < 0-00001). This was found particularly among
NIDDM individuals (Table 5).
Number of colonies isolated by the mouth rinse technique. Subjects who did not
have DS had significantly fewer colony forming units (median = 10 c.f.u./ml)
than subjects with DS (median = 1850 c.f.u./ml, P < 0 0001). This was seen
particularly for patients with NIDDM (median = 1500 c.f.u./ml with DS and 25
c.f.u./ml without DS, P = 00003). Those with IDDM did not show this
relationship (median = 2400 c.f.u./ml with DS, 502-5 c.f.u./ml without DS, P =
0-07).
Random plasma glucose. Lower values for random plasma glucose were observed
among the 132 patients without DS (median = 9-55 mmol/1) than those observed
for the 72 patients with DS (median = 10-95 mmol/1, Mann-Whitney P = 0-02).
This was seen particularly among individuals with NIDDM (median = 10-75
mmol/1 with DS and 9-5 mmol/1 without DS, P = 0-04). Individuals with IDDM
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Sample predicted (%) Variables isolated
62-90 % Glycosuria (P < 0-05)
(n = 88)
81-82% Denture in at night (P < 0-01)
No. of yeast colonies (P < 0-01)
Non-secretion (P < 0-01)
did not show this relationship (median 11-250 mmol/1 with DS and 1015 mmol/1
without DS, P = 0-24).
History of candidiasis. Among individuals with a history of superficial
candidiasis 18/33 (55%) had DS compared with 58/182 (32%) with a negative
history of candidiasis (y2 = 5-33, d.f. = 1, P = 0-02). Separate analysis with
respect to insulin dependency revealed a trend for individuals with a history of
candidiasis to be more prone to DS: for IDDM individuals y2 = 1-2, d.f. = 1,
P = 0-3; for individuals with NIDDM, y2 = 3-26, d.f. = 1, P = 0-07.
No significant association was found between DS and the following variables:
sex; age; type of diabetes; control of diabetes (HBAj); duration of diabetic state;
ABO blood group; smoking; alcohol consumption; persistent glycosuria or
albuminuria; denture fit, hygiene, occlusion, age or type (partial or full); presence
of diabetic complications (neuropathy, nephropathy, retinopathy); contraceptive
pill; antibiotics; and corticosteroids (systemic or topical).
In order to determine the relative contributions of variables in the development
of DS, a stepwise discriminant analysis (SPSSX) was used. Initially, all variables
were screened at an F value of 4 (P < 0'05). Analysis was then confined to the
variables isolated as significant to increase the number of cases examined. Table
6 summarizes the contributory variables and the significance of their contribution
in predicting infection. For patients with IDDM, the only variable identified by
the analysis was persistent glycosuria (P < 0-05). For patients with NIDDM three
factors were identified: denture present at night (P < 0-0f), number of yeasts
isolated (P < 0-01) and non-secretion (P < 0-01).
All forms of the oral conditions listed in Table 1 are more prevalent among the
patients with dentures than those without dentures. Fissured tongue was
encountered in 6% of the diabetic individuals. This figure is similar to that
reported for 2478 dental patients [10]. The prevalence of geographic tongue and
median rhomboid glossitis was slightly higher among diabetics than among dental
and dermatology patients [11]. All the above conditions were much lower in
prevalence than those reported for diabetic individuals by Farman who examined
coloured South Africans [12]. These differences might be due to genetic and/or
environmental factors between the predominantly Northern European population
sampled here and that sampled by Farman. Dry mouth was a spontaneous
complaint in only 3% of the samples compared to 34% reported by Sharon and
colleagues [13].
DISCUSSION
Factors contributing to denture stomatitis 361
The univariate analysis showed that prevalence of DS was similar among
patients with IDDM or NIDDM. The prevalence of DS reported (35-2%) is within
the range (24-60%) reported for non-diabetic individuals [3].
C. albicans was isolated from only 43% of the patients with DS. Isolation of C.
glabrata (8%), and other yeasts (28%) from patients with DS indicate that, among
diabetic individuals, species other than C. albicans are an important cause of
disease.
Sex, denture trauma and hygiene [14-19], treatment with corticosteroids [21]
and antibiotics [3], have variably been reported to be associated with DS among
non-diabetic individuals. In this study, both the discriminant and univariate
analyses did not reveal any association between these factors and DS.
Among patients with Candida leukoplakia (CL), smoking is a significant factor
in the pathogenesis of the lesion [20] which develops in sites away from the
denture bearing area. In DS, smoking was not a factor in patients with either
IDDM or NIDDM. This is consistent with the fact that the palate is protected
from the effect of the smoke by the denture.
Control of diabetes as measured by glycosylated haemoglobin (HBAj) was not
associated with DS. Although this was unexpected at first sight, it is well
established that blood glucose levels and salivary glucose levels among diabetic
individuals do not correlate [13].
Discriminant analysis indicates that factors contributing to development of DS
among patients with NIDDM are clearly different from those with IDDM.
Patients with NIDDM who do not remove their denture at night, harbour a large
number of yeasts and non-secretors of blood group antigens are particularly at risk
of developing DS. In contrast, none of these factors influence the development of
DS among individuals with IDDM. This is further supported by the results of the
univariate analysis in which the P value for these factors among IDDM
individuals are consistently higher than the P value among NIDDM individuals.
Although secretor status did not show a significant univariate association with
DS among individuals with NIDDM, it was found to be significant in the
multivariate analysis when adjusted for denture wearing habits and density of
yeast colonization. This suggests that the univariate relationship might have been
obscured by the other two contributory factors.
Persistent glycosuria was the only predictor of DS development among IDDM
individuals. The presence of 11T mmol/1 or more of glucose in the arterial blood
results in the appearance of glucose in the urine. It was unexpected that neither
HBAj nor random plasma glucose were implicated as both are more precise
indicators of glucose availability than glycosuria. The possibility than glycosuria
was a chance isolation cannot be dismissed especially since the significance of this
variable was marginal. It appears that the discriminant analysis was not effective
in identifying variables important to the development of DS among IDDM
individuals.
Non-secretion of blood group antigens was a significant contributory factor
among NIDDM but not among IDDM individuals. Non-secretion has been
associated with carriage of yeasts among non-diabetic individuals [6] and patients
with NIDDM [7]. This complements the results relating to the development of DS
in these patients. It has been suggested that patients with IDDM are more
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immunocompromized than NIDUM so that any protective effect of secretion of
blood group antigens does not make a significant contribution to prevention of
colonization or disease. A previous study [22] did not find an association between
secretor status and DS among diabetics; however, the number of patients
examined was much smaller, there was no differentiation between IUDM and
NIDDM individuals and multivariate analysis was not applied to the data.
Identification of factors contributing to the development of DS among
individuals with IDDM and NIDDM might have implications for treatment of this
condition. Treatment of DS among patients with NIDDM might be similar to that
in non-diabetic individuals [23], i.e. removal of denture, especially at night, which
also reduces the density of colonization by yeasts. Among patients with IDDM,
treatment of DS seems likely to depend on improvement of poor diabetic control
reflected in persistent glycosuria.
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FACTORS INFLUENCING ORAL CARRIAGE OF YEASTS AMONG INDIVIDUALS
WITH DIABETES MELLITUS
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A total of 439 individuals with diabetes mellitus were examined for
carriage of yeasts by the oral rinse and palatal swab technique. The
differences between the two techniques are discussed. Factors
contributing to carriage of yeasts are distinct for individuals with
insulin-dependent diabetes mellitus (IDDM) compared with non-insulin
dependent diabetes (NIDDM). Introduction of a denture significantly
altered the risk, factors. Non-secretion of the ABH blood group
antigens was an important factor among NIDDM individuals who did not
wear dentures when carriage was assessed by the oral rinse.
3
INTRODUCTION
Oral candidiasis is most prevalent in the form of chronic atrophic
candidiasis1. Individuals with diabetes are prone to infections;
and, chronic atrophic candidiasis has been reported to be more
prevalent among diabetic individuals compared with non-diabetic
controls2. Since disease is preceded by colonization, it is important
to identify factors which predispose to colonization. Few studies
have examined the factors which predispose to colonization of diabetic
patients by Candida albicans 6; and, none of these specifically
analysed patients with insulin dependent diabetes mellitus (IDDM)
separately from those with non-insulin dependent diabetes mellitus
(NIDDM).
Both genetic7'8 and environmental factors9 have been reported to
affect carriage of Candida species. The genetically determined
inability to secrete the glycoprotein form of the ABO blood group
antigens into body fluids has been associated with susceptibility to
infections by bacteria and yeasts10,11. Among non-diabetic
individuals7 and individuals with NIDDM8 non-secretors of blood group
0 are over-represented among carriers of C. albicans compared with
secretors.
Environmental factors which are variably reported to be associated
with carriage of yeasts include: presence of a denture; continuous
wearing of a denture; denture fit, occlusion, trauma, hygiene and
age; smoking; and control of diabetes3,12.
The aims of the present study were:
1. to compare the oral rinse technique with the palate swab method
for isolating yeasts.
2. to examine in detail the species of yeasts isolated from
patients with IDDM or NIDDM.
3. to assess the association between secretor status and carriage of
yeasts among individuals with I DDM or NIDDM taking into
account denture status.
4. to dissect the contributions of the following variables to the
carriage of yeasts and, specifically, C. albicans: age; sex;
type of diabetes; control of diabetes as measured by
glycosylated haemoglobin A (HbA1); random plasma glucose levels;
persistent glysosuria and albuminuria; diabetic complications -
retinopathy, neuropathy, nephropathy; antibiotic usage;
corticosteroid treatment; smoking; alcohol consumption; presence
of the denture in the mouth at night; denture fit, extension,
occlusion, hygiene and age; presence of denture stomatitis; and
history of superficial candidal infections.
This is the first study which is designed to compare the risk factors
contributing to carriage of yeasts in individuals with IDDM or NIDDM.
4
MATERIALS AND METHODS
The study population, epidemiological data obtained, isolation and
characterization of yeasts has been described previously .
Glycosylated haemoglobin A^ (HbA,) was measured by corning
electrophoresis (normal range 4.5 - 8.0%, c.v = 4%). Results were
coded, entered into a data base and the SPSSX package was used for
analysis.
Statistical Analysis : the univariate analyses used were Chi square
with Yates' correction and Wilcoxon rank sum test as appropriate.
Frequencies of carriage of all yeasts and of C. albicans were
examined separately. A P value of < 0.05 was considered significant.
The stepwise linear discriminant analysis (Wllk's method) was the
multivariate analysis used to identify factors best predicting
carriers and non-carriers of yeasts (F - to enter > 4; p < 0.05).
5
RESULTS
Table 1 summarizes the proportion of males and females, individuals
with IDDM and NIDDM, the participants' denture status, the percentage
of patients with diabetic complications and those who had been
treated with local and/or systemic corticosteroids and/or antibiotics
within 6 months of the examination. Only 12% of the subjects
complained of recurrent Candida infection.
Mvcoloqical profile of the sample population
Table 2 compares the species of yeasts cultured from the five sites of
the mouth and from the oral rinse for individuals with IDDM and NIDDM.
In Table 3 the information presented in Table 2 is examined with
reference to the presence or absence of dentures; a similar pattern
was observed. T. glabrata and C. troplcalls were isolated more
frequently from those with dentures. Yeasts including C. albicans
were Isolated more frequently from each site tested among individuals
with IDDM (Table 4).
Only 29% (128/439) of the individuals examined had no yeasts in any of
the five sites swabbed; 12.8% (56/439) had the same isolate cultured
from all five sites. The swabbing technique compared well with the
oral rinse technique in which 34% of the individuals were culture
negative.
Of the 1551 isolates examined by API 20C Auxanogram Kits, 397 (25.6%)
could not be reliably identified. There were 120 isolates which were
identified as other than C. albicans by the kit but which produced
germ tubes when incubated at 37°C in horse serum for 2 hours. Of
these, 17 were sent to the Mycology Reference Laboratory at the
Western General Hospital, Edinburgh for identification, and, all were
found to be C. albicans (details to be reported separately).
Univariate Analysis:
Blood group and secretor status
Isolation of C. albicans or other yeasts from the palatal swab or from
the oral rinse was not associated with secretor status when the
results were analyzed by type of diabetes and/or denture status.
Blood group was not associated with palatal carriage of yeasts or C.
albicans; however, when carriage was assessed by the oral rinse,
individuals with NIDDM who wore dentures and who were of 0 blood group
were more likely to be carriers than those of blood group A (X2 =
7.93, P < 0.005) (Table 5).
Analysis of secretor status with reference to blood group revealed a
significant association between non-secretion and increased frequency
of carriage of yeasts among individuals with IDDM who were blood group
A and who wore dentures. (9/19 A-Se carriers compared with 12/12 A-
NS carriers X2 = 7.07 p = 0.008).
Variables associated with carriage
Age: Increase in age was associated with a decreased frequency of
isolation of yeasts including C. albicans from the palate of
individuals with IDDM (Table 6). Results obtained from the oral rinse
similarly indicated that younger individuals carried yeasts, including
C. albicans, more frequently (Table 7).
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Glycaemic control (KbA1): The HbA^ values of palatal carriers of
yeasts and C. albicans were significantly higher compared with non-
carriers. The contributions of type of diabetes and denture status is
clearly illustrated when the sub-categories are examined (Table 8).
Glycaemic control was a significant factor among individuals with IDDM
but not among those with NIDDM after correcting for denture status.
Subjects with IDDM who did not wear dentures were especially prone to
carriage if their HbA^ values were relatively high. The oral rinse
results showed a similar overall trend but less clearly (Table 9).
Smoking: The number of cigarettes smoked per day was on the whole
associated with isolation of yeasts including C. albicans from the
palate (Table 10). The oral rinse results were similar except for the
presence of a significant association between carriage and smoking
among individuals with IDDM who did not wear dentures (Table 11).
Presence of the denture in the mouth at night: Yeasts and C. albicans
were isolated more often from the palate of subjects who left their
dentures in the mouth at night; however, this was observed only among
individuals with NIDDM (Table 12). This pattern was not found when
carriage was assessed by the oral rinse method.
Type of diabetes: Irrespective of their denture status, individuals
with IDDM were more frequently carriers of yeasts compared with
patients with NIDDM. Both the palate swab and the oral rinse
technique results showed this trend (Table 4).
Variables not associated with frequency of isolation of yeasts: The
variables listed below were not associated with frequency of carriage
of C. albicans or other yeasts by either isolation technique used:
sex; duration of diabetes; complications - neuropathy, nephropathy
and retinopathy; alcohol consumption; contraceptive pill; systemic
corticosteroid treatment; topical corticosteroid application;
antibiotics; fit, occlusion or hygiene of denture; persistent
albuminuria; and history of superficial candidal infections. Among
individuals with NIDDM only, age of the denture and the presence of
persistent glycosuria among those who did not wear dentures was
significantly associated with frequency of carriage of C. albicans and
yeasts in general ( P < 0.05 in both cases). Denture status was not
significantly associated with either the frequency or the density of
colonization by yeasts.
Linear discriminant analysis: From the above results, it can be seen
that a univariate analysis does not present a clear picture of factors
contributing to carriage; associations are erratic when subgroups are
analysed. In addition, univariate analysis might incorporate a
dependent variable which needs prior knowledge to control for its
effect.
The multivariate analysis (Tables 13 & 14) identifies factors which
contribute to carriage of yeasts among denture wearing and non-denture
wearing individuals with IDDM or NIDDM.
Among individuals with IDDM who wore dentures, palatal carriage of
yeasts including C. albicans was associated with HbA-^ level. The
variable which was the most efficient predictor of carriage when
assessed by the oral rinse technique was, however, the presence of
retinopathy. Univariate analysis showed HbA^ to be associated with
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the palatal carriage of C. albicans.
Individuals with IDDM who did not wear dentures were best segregated
on the basis of their age into non-carriers and carriers of yeasts and
in particular C. albicans. This was true when carriage was assessed
by either technique. The univariate analysis showed similar
associations.
Individuals with NIDDM who wore dentures were at risk of carriage of
yeasts and specifically C. albicans if they smoked and,
additionally, wore dentures continuously. These risk factors were
identified by both sampling techniques. Comparison with univariate
analysis showed that continuous wearing of dentures and smoking were
significant factors only when carriage was assessed by palatal swab.
Individuals with NIDDM who did not wear dentures were more likely to
be palatal carriers of C. albicans or other yeasts if they had
persistent glycosuria and suffered from peripheral neuropathy.
Carriage assessed by the oral rinse method was influenced by
persistent glycosuria, higher random plasma glucose levels and non-
secretion of blood group antigens. Univariate analysis revealed an




The results obtained with the palate swab compared well with those
obtained by the oral rinse technique. C. albicans was the species
most frequently isolated from the swabs while species other than g.
albicans were isolated at greater frequency from the oral rinse. This
is probably due to the selective enrichment of C. albicans over other
species when swabs were incubated in malt broth. Studies in which a
mouth wash technique was used reported a prevalence of between 41% and
62% '3/5,6,13. In study 66% of the diabetics were carriers of
yeasts by the oral rinse technique.
Yeasts were isolated from the tongue most frequently followed by the
palate, floor of the mouth and the angles of the mouth. Similar
results have been reported"1.
Individuals with IDDM were significantly more prone to carriage of
yeasts compared to those with NIDDM. No other study has found this
association^' '. This might be due to the smaller sample size; and,
distinction of IDDM from NIDDM was based purely on the mode of
treatment of the diabetic condition. In this study subjects were
classified as IDDM or NIDDM according to clinical history of onset,
requirement for insulin and progression of the disease14.
T. alabrata and C. tropicalis were isolated more frequently from
patients with either IDDM or NIDDM who wore dentures. By the API
identification system, Fisher et al5 found that the majority of
isolates (89%) were C. albicans. In this study only 54% of the
isolates were C. albicans; this figure includes the proportion not
identified by API 20C Aux as C. albicans but were found to be so by
conventional methods and compares well with other studies which found
60% of isolates to be C. albicans3'1 . This emphasizes the need for
accurate identification as patients with diabetes are more likely to
carry and to have disease due to species other than C. albicans
which might not be sensitive to routinely prescribed oral antifungal
agents17.
The factors which were associated with the carriage of yeasts
collectively were similar to those influencing carriage of C,
albicans. This might be due to the majority of C. albicans in the
analysis of yeast carriage.
Distinct factors influence oral carriage of yeasts and the development
of disease in patients with IDDM compared with patients with NIDDM ,
This is the first study which considers the risk factors for
colonization by yeasts of individuals with IDDM as distinct from those
with NIDDM taking into account various environmental factors. The two
major types of diabetes appear similar; but, they differ with respect
to etiology and pathogenesis as well as development of complications.
The univariate analysis showed a significantly higher proportion of
blood group A non-secretors among patients with IDDM who wore dentures
and were carriers of yeasts. Patients with NIDDM who were of blood
group 0 were more frequently colonized than those of blood group A.
These relationships did not appear in the multivariate analysis. Non-
secretion was a marginally significant factor among patients with
NIDDM who did not wear dentures. This indicates that the univariate
contingency table incorporated dependent variables. The previous
s
study which showed NIDDM individuals prone to C. albicans carriage did
not take into account the denture status of its sample population®. A
study that did not find any association between secretor status and
carriage did not examine denture wearers separately from non-denture
wearers, multivariate analysis was not used and, the sample size was
much too small to discern the role of secretor status which is
marginal as shown above .
Palatal carriage of yeasts was not dependent on the secretor status.
The contribution of non-secretion and carriage must therefore arise
from oral sites other than the palate. This possibility is under
investigation. Secretor status does, however, influence the
development of disease in the palate among patients with NIDDM who are
denture wearers14.
Increase in age was associated with a decrease in the frequency of
carriage probably due to the efficiency of the mucosal immune defences
against yeasts with increased frequency of challenge. Age was not a
significant factor in the carriage of yeasts in two studies '3.
Another study5 reported an apparent increased risk of carriage of
yeasts with age. The difference might be due to their smaller sample
size.
Glycaemic control (HbA^) was a significant factor associated with
palatal carriage of yeasts among patients with IDDM whilst random
plasma glucose level was important among those with NIDDM. This is
consistent with the clinical value of HbA-^ and plasma glucose among
patients with IDDM or NIDDM respectively as indicators of control of
diabetes15. Studies that found no association between HbA-, levels
and carriage of yeasts did not differentiate between IDDM ana NIDDM,
and did not use multivariate analysis '5. The single study in which
multivariate analysis was used reported an association between HbA^
level and increase in frequency of colonisation5.
Random plasma glucose and HbA-^ levels were not correlated with oral
disease due to yeasts14; but, they have a very significant effect on
carriage. It would, therefore, appear that good diabetic control is
a preventive measure against the eventual development of disease by
reducing the probability of colonization. Although salivary levels
of glucose have been reported not to correlate linearly with plasma
glucose level15, increase in plasma glucose levels also means Increase
In salivary levels in a non-linear relationship.
Persistent glycosuria among patients with NIDDM who did not wear
dentures was isolated by both univariate and multivariate analyses as
a significant factor in the carriage of yeasts. It was highly
significant and indicates once more that good diabetic control reduced
the possibility of colonization. Glycosuria and plasma glucose were
reported to be significantly associated with yeast isolation among
diabetics13. Other studies did not find this association3'3'5.
Smoking was a significant risk factor for colonization among patients
with NIDDM who wore dentures; however, smoking was not associated
with disease development14. The effect of smoking is not direct since
the palate is protected by the denture; but, it might have an
indirect effect e.g. constriction of blood vessels and impairment of
the immune system. Smoking has been reported to be associated
variably with frequency of colonization when diabetics were compared
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to non-diabetics3'6.
Continuous wearing of a denture was a significant factor predisposing
to colonization only among individuals with NIDDM who wore dentures.
This agrees with the association between continuous presence of a
denture and the development of denture stomatitis among patients with
NIDDM14 and the reported increase in the proportion of carriers among
diabetics who continuously wore their dentures (70%) compared with the
proportion of carriers among those who did not (44%)3.
Retinopathy and neuropathy are specific complications of diabetes
which are due to microvascular changes. Microvascular derangement
might impair immune response through inadequate diffusion of tissue
mediators. Both these variables were of marginal significance but




This study shows that:
1. Individuals with IDDM are more prone to colonization by yeasts
compared to those with NIDDM. C. albicans was present in just
over half the patients who were carriers of yeasts.
2. In view of the differences in factors which influence carriage
and the comparative sensitivity of the two techniques,
examination of the site of interest is best assessed by a swab
especially as the sensitivities of the oral rinse and swab
techniques were similar.
3. Incubation of a swab in malt broth selectively enhances growth of
C. albicans over other species.
4. Among patients with IDDM who wear dentures, palatal carriage is
influenced by HBA^ value. Among those without dentures carriage
was more frequent among younger individuals.
5. In contrast to individuals with IDDM, denture wearers with NIDDM
were more frequently colonized if they smoked and, additionally,
wore their dentures continuously. Those with NIDDM who did not
wear dentures were at risk to carriage of yeast if they had
evidence of poorly controlled glucose levels.
6. Non-secretion of ABH blood group antigens was of marginal
significance in increasing the risk to carriage of yeast in the
oral cavity as a whole among patients with NIDDM who did not wear
dentures. Denture wearers and individuals with IDDM did not show
this relationship.
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Table 1. Characteristics of the sample population
No. (%) Missing (%)
Sex Males 226 (51.5)
Females 213 (48.5) 0
Type of diabetes IDDM 231 (52.6)
NIDDM 205 (46.7) 3 (0.7)
Dentures Full 165 (37.6)
Partial 50 (11.4)
None 221 (50.3) 3 (0.7)
♦Good fit 175 (81.4) 13 (6)
♦Good hygiene 171 (79.5) 19 (8.8)
♦Continuous wear 89 (41.4) 67 (31.6)
Presence of Retinopathy 100 (23) 9 (2.1)
diabetic Neuropathy-peripheral 73 (17) 11 (2.5)
complications -autonomic 23 (5) 11 (2.5)
Nephropathy 34 (8) 9 (2.1)
Drug consumption Antibiotics 121 (28) 6 (1.4)
Corticosteroids
- systemic 20 (4.6) 7 (1.6)
- local 10 (2.3) 7 (1.6)
Recurrent candidiasis 54 (12) 4 (0.9)
* Percentages obtained by dividing with 215 which is the number of denture
wearers.
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Table 4. Type of diabetes and isolation of C. albicans and other yeasts
from the palatal swab or by oral rinse










































































Table 5. Carriage of yeasts and c. albicans assessed by the oral rinse
and blood group



























































IDDM non- 0 22







































Table 6. Age and carriage of yeasts determined by palatal swab
Median (yrs) M-W
Category Non-carriers C. albicans* Yeasts P
All 56.50 46.00 50.00 *0.00001
(n) (170) (137) (189) 0.0001
IDDM 45.00 32.50 37.00 *0.002
(n) (70) (84) (106) 0.02
NIDDM 60.00 55.00 56.00 *0.02
(n) (100) (52) (82) 0.08
Denture wearers 61.00 55.00 56.00 *0.0005
(n) (83) (66) (103) 0.002
Non-denture wearers 49.00 32.00 34.00 *0.0001
(n) (87) (71) (86) 0.00001
Dentures (IDDM) 58.00 46.00 49.00 *0.03
(n) (22) (31) (44) 0.033
Non-denture (IDDM) 38.50 27.00 29.00 *0.003
(n) (48) (53) (62) 0.011
Dentures (NIDDM) 61.00 57.00 59.00 *0.013
(n) (61) (34) (58) 0.07
Non-denture (NIDDM) 56.00 49.50 50.50 *0.03
(n) (39) (18) (24) 0.09
Table 7. Age and carriage of yeasts determined by oral rinse
Median (yrs) M-V
Category Non-carriers C. albicans* Yeasts P
All 56.50 45.00 51.00 *0.00001
(n) (124) (131) (238) 0.002
IDDM 45.00 33.00 35.00 *0.05
(n) (57) (88) (137) 0.12
NIDDM 60.00 55.00 57.00 *0.0007
(n) (67) (42) (100) 0.123
Denture wearers 60.00 55.00 58.00 *0.003
(n) (62) (58) (121) 0.07
Non-denture wearers 48.00 32.00 35.00 *0.0004
(n) (62) (73) (117) 0.002
Dentures (IDDM) 56.00 53.00 53.00 *0.25
(n) (17) (31) (55) 0.17
Non-denture (IDDM) 39.00 29.00 29.00 *0.006
(n) (40) (57) (82) 0.013
Dentures (NIDDM) 60.00 55.55 61.00 *0.03
(n) (45) (26) (65) 0.87
Non-denture (NIDDM) 57.00 52.50 54.00 *0.02
(n) (22) (16) (35) 0.04
Table 8. Glycaemic control (HbAl) and carriage determined by palatal swab
Median HbAl Units M-tf
Category Non-carriers C. albicans* Yeasts P
All 9.25 10.50 10.20 *0.00001
(160) (121) (167) 0.00001
IDDM 9.50 10.60 10.60 *0.0009
(n) (63) (76) (93) 0.0008
NIDDM 9.10 9.80 9.60 *0.025
(n) (97) (45) (73) 0.05
Denture wearers 9.30 10.50 10.20 *0.003
(n) (75) (57) (89) 0.006
Non-denture wearers 9.20 10.20 10.20 0.002
(n) (85) (63) (76) 0.002
Dentures (IDDM) 9.55 11.40 11.10 *0.04
(n) (18) (27) (37) 0.067
Non-denture (IDDM) 9.30 10.20 10.60 *0.03
(n) (45) (48) (55) 0.017
Dentures (NIDDM) 9.30 9.70 9.50 *0.13
(n) (57) (30) (52) 0.15
Non-denture (NIDDM) 8.70 11.10 9.90 *0.15
(n) (40) (15) (21) 0.26
Table 9. Diabetic glycaemic control (HbAl) and carriage determined by
oral rinse
Median HbAl Units M-V
Category Non-carriers C. albicans* Yeasts P
All 9.40 9.90 10.00 *0.03
(117) (119) (214) 0.004
IDDM 9.50 10.20 10.60 *0.11
(n) (50) (81) (125) 0.02
NIDDM 9.30 9.50 9.55 *0.28
(n) (67) (38) (88) 0.21
Denture wearers 9.40 10.60 9.90 *0.03
(n) (57) (51) (103) 0.11
Non-denture wearers 9.35 9.75 10.00 *0.29
(n) (60) (68) (109) 0.02
Dentures (IDDM) 9.60 10.60 10.40 *0.66
(n) (13) (28) (48) 0.68
Non-denture (IDDM) 9.30 10.00 10.60 *0.149
(n) (37) (53) (76) 0.016
Dentures (NIDDM) 9.30 9.90 9.50 *0.06
(n) (44) (23) (55) 0.28
Non-denture (NIDDM) 9.40 8.90 9.60 *0.50
(n) (23) (15) (33) 0.68
Table 10. Smoking and carriage of yeasts determined by palatal swab
Mean cigarettes/day M-W
Category Non-carriers C. albicans* Yeasts P
All 4.54 8.45 7.83 *0.0006
(156) (130) (181) 0.0009
IDDM 6.43 18.63 8.13 *0.09
(n) (63) (81) (103) 0.104
NIDDM 3.27 8.33 7.53 *0.01
(n) (93) (48) (77) 0.01
Denture wearers 4.01 8.71 7.84 *0.003
(n) (77) (63) (99) 0.006
Non-denture 5.06 8.21 7.82 0.05
wearers
(n) (79) (67) (82) 0.05
Dentures (IDDM) 7.95 10.58 9.20 *0.17
(n) (20) (31) (44) 0.24
Non-denture (IDDM) 5.72 7.42 7.32 *0.421
(n) (43) (50) (59) 0.43
Dentures (NIDDM) 2.89 7.13 6.87 *0.05
(n) (57) (31) (54) 0.051
Non-denture (NIDDM) 4.28 10.53 9.09 *0.11
(n) (36) (17) (23) 0.13
Table 11. Smoking and carriage of yeasts determined by oral rinse
Mean of cigarettes/day M-V
Category Non-carriers C. albicans* Yeasts P
All 3.75 8.48 7.83 *0.0003
(115) (122) (226) 0.0001
IDDM 4.36 8,37 8.31 *0.011
(n) (53) (84) (132) 0.0063
NIDDM 3.23 8.95 7.24 *0.02
(n) (62) (37) (93) 0.012
Denture wearers 4.79 9.37 7.19 *0.08
(n) (58) (52) (114) 0.18
Non-denture 2.68 7.81 8.48 *0.005
wearers
(n) (57) (70) (112) 0.0001
Dentures (IDDM) 7.94 8.34 8.34 *0.50
(n) (17) ((29) (53) 0.59
Non-denture (IDDM) 2.67 8.383 8.29 *0.007
(n) (36) (55) (79) 0.006
Dentures (NIDDM) 3.49 11.14 6.3 *0.04
(n) (41) (22) (60) 0.33
Non-denture (NIDDM) 2.71 5.73 8.94 *0.09
(n) (21) (15) (33) 0.09
Table 12. Continuous wearing of denture and Isolation of yeasts from
the palate
No. (%)


























NIDDM Yes 20 (45) 16





Table 13. Variables contributing to palatal carriage assessed by Linear
Stepwise Discriminant Analysis (Vilks)
Category Variables












All yeasts IDDM with dentures
(n = 49)






64 1. Smoking 2. Continuous denture wear
NIDDM without dentures
(n = 49)
80 1. Glycosuria 2. Plasma glucose
3. Peripheral neuropathy
Table 14. variables contributing to isolation of yeasts from the oral rinse assessed
by Linear Stepwise Discriminant Analysis (Vilks)
Category % Variables
C. albicans IDDM with dentures 62 1. Retinopathy
(n = 47)
IDDM without dentures 67 1. Age
(n = 97)
NIDDM with dentures 74 1. Smoking 2. Continuous denture wear
(n = 51)
NIDDM without dentures 72 1. Glycosuria 2. Plasma glucose
(n = 32) 3. Secretor status
Other yeasts IDDM with dentures 58 1. Retinopathy
(n = 71)
NIDDM without dentures 68 1. Age
(n = 122)
NIDDM with dentures 1. Smoking 2. Continuous denture wear
(n =89)
NIDDM without dentures 79 1. Glycosuria 2. Plasma glucose
(n = 40) 3. Secretor status
